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Abstract 
Human papillomavirus (HPV) is the most common sexually transmitted virus, and is 
causally related to several cancers. HPV vaccination rates are far below HealthyPeople 
2020 targets and vary across geographic, socioeconomic, and demographic populations. 
The purpose of this research was to test the relationships among socioeconomic and 
demographic variables, HPV vaccination, social vulnerability, and physician 
recommendation within select local areas in the United States. Fundamental cause theory 
and behavioral economics informed this quantitative secondary analysis of National 
Immunization Survey-Teen and Social Vulnerability Index data (n = 43,271). Statistical 
analyses included chi-square and binomial logistic regression. Teens whose mothers had 
less than a college degree were more likely to initiate the HPV vaccine series (p < .01), 
while teens living in Hidalgo County and Houston were less likely to initiate the series (p 
< .001). Younger teens (p < .001), males (p < .001) and teens whose mothers had some 
college (p < .01) were less likely to complete the series, while older teens (p < .001) and 
teens living in Philadelphia and Houston (p < .01) were more likely to complete the 
series. Fewer teens in Bexar County received a physician recommendation (p < .01); 
there was no difference between vaccine initiation and select local area. These findings 
highlight the need to consider local sociodemographic influences on underlying 
disparities in health and physician behavior. Informed interventions may produce positive 
social change by reducing variance in health care quality, tailoring public health efforts to 
local needs, and moving persons experiencing disparities in health outcomes toward a 
healthy future. 
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Section 1: Foundation of the Study and Literature Review 
Introduction 
Human papillomavirus (HPV) is the most common sexually transmitted virus in 
the world; every sexually active person will likely be infected with HPV at least once in 
his or her lifetime (Centers for Disease Control and Prevention [CDC], 2017a). While 
90% of infections will clear on their own, the remaining 10%–known as high risk 
infections–are causally related to cervical, oropharyngeal, and anogenital cancers, genital 
warts, and recurrent respiratory papillomatosis (CDC, 2017a; Galbraith et al., 2016; 
Kulczycki, Qu, & Shewchuk, 2016; Palmer, Carrico, & Costanzo, 2015). To date, HPV 
infection cannot be treated, but in the past 10 years three vaccines were approved by the 
Food and Drug Administration (FDA) covering males and females ages 9 to 26 years to 
protect against HPV infection (FDA, 2016).  
A number of factors contribute to rates of HPV infection as well as receipt of 
HPV vaccination: age, sexual onset at a young age, socioeconomic status, racial or ethnic 
background, physician awareness and recommendation, and parental knowledge and 
attitudes (Burger et al., 2016; Small, Sampselle, Martyn, & Dempsey, 2014).  
The narrative around HPV vaccination is unique among other adolescent 
vaccines, as the focus has been on the behavior leading to infection (e.g., adolescent 
sexual activity) rather than the diseases prevented (e.g., cervical cancer) (Bailey et al., 
2016). In addition, the lack of a clear, strong physician recommendation for the vaccine 
contributes to parental misperceptions of the importance of the vaccine (Bailey et al., 
2016). The Advisory Committee on Immunization Practices (ACIP) recommends HPV 
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vaccination for boys and girls at age 11 to 12 years, as the vaccine is most effective when 
given prior to sexual activity, has greater immunoreactivity in adolescence, and can be 
bundled with other adolescent vaccines for efficient delivery (ACIP, 2016; Bailey et al., 
2016). In October 2016, ACIP, CDC, and FDA recommended a two-dose series for 
adolescents ages 9 to 14 years; three doses of the vaccination is still recommended for 
teens and young adults ages 15 to 26 years (ACIP, 2016; FDA, 2016; Kim, Riley, 
Harriman, Hunter, & Bridges, 2017).  
Although the prevalence of certain HPV types has decreased and vaccination rates 
have increased since the first HPV vaccine was introduced, initiation and completion of 
the vaccine series continues to be below the 80% target to achieve herd immunity and 
protect adolescents, teenagers, and young adults against infection (Berenson, Laz, & 
Rahman, 2016; Moss, Reiter, Rimer, & Brewer, 2016; Rahman, Laz, McGrath, & 
Berenson, 2015). As of 2015, only 41.9% of female and 28.1% of male ages 13 to 17 
years had completed the HPV vaccine series (Reagan-Steiner et al., 2016). Of primary 
concern for public health, vaccine initiation and completion vary across geographical 
region, gender, socioeconomic status, and with different race and ethnic background; low 
socio-economic status and minority populations are at higher risk for HPV infection and 
related morbidity and mortality (Bruno, Wilson, Gany, & Aragones, 2014; Collins, 
Holcomb, Chapman-Davis, Khabele, & Farley, 2014; Daniel-Ulloa, Gilbert, & Parker, 
2016; Henry, Stroup, Warner, & Kepka, 2016; Jeudin et al., 2014).  
Considering cervical cancer only for today’s cohort of female adolescents ages 12 
years and younger, CDC estimates the low rates of vaccination will contribute to over 
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50,000 cases of cervical cancer; for every year below the 80% target, an additional 4,400 
girls will develop cervical cancer (Hswen, Gilkey, Rimer, & Brewer, 2017). Given that 
African-American and Native American populations are expected to increase in the 
United States at a modest rate between today and 2050, and Hispanic and Asian 
populations are expected to grow more than double in that same time period, narrowing 
the gap in HPV-related disparities is a critical public health need (Colby & Ortman, 2015; 
Jeudin et al., 2014;). In addition, these minority population increases will require 
culturally sensitive and relevant interventions and policies to allow for appropriate 
allocation of resources and program planning, as each population may face unique 
barriers to HPV vaccination (Galbraith et al., 2016; Reiter et al., 2014).  
Researchers have identified lack of awareness of HPV, the cost of the vaccine and 
office visits, cultural norms, and lack of physician recommendation to be associated with 
disparities in HPV vaccination (Perkins, Brogly, Adams, & Freund, 2012; Rahman et al., 
2015). The strongest predictors of vaccine initiation and completion continue to be low 
socioeconomic and racial and ethnic minority status, physician recommendation, and 
provaccine policy (Choi, Eworuke, & Segal, 2016; Galbraith et al., 2016; Henry et al., 
2016; Jeudin et al., 2014; Palmer et al., 2015; Rahman et al., 2015; Rahman, Hirth, & 
Berenson, 2017). However, no researchers to date have examined all of these predictors 
together at the regional or county levels; while state-wide analyses offer larger sample 
sizes for greater statistical accuracy, many public health decisions are made at the local 
level (Waldrop, Moss, Liu, & Zhu, 2017). In addition, physician recommendations vary 
across geography, minority status, age, socioeconomic status, and gender; policies are 
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patchwork and often ineffectual; and guidelines lack the rigor of legislative mandate 
(Galbraith et al., 2016; Jeudin et al., 2014; Moss et al., 2016; National Conference of 
State Legislatures [NCSL], 2017; Perkins et al., 2012; Rahman, Islam, & Berenson, 
2015).  
Vaccination rates against other diseases near or above 80% needed for herd 
immunity, in large part due to childcare and school-entry requirements (see Table 1). Of 
note, Hepatitis B, a viral infection transmitted by sexual activity or sharing drug 
paraphernalia, has the highest immunization rates (National Center for Health Statistics 
[NCHS], 2016). National HPV rates are less than half those for other diseases (NCHS, 
2016).   
Table 1 
 
Immunization Rates for Select Recommended Adolescent Vaccines, 2014-2015 
Disease 
 
Immunization Rate 
(%), 2014 
 
Immunization Rate 
(%), 2015 
Measles, mumps, rubella (≥ 2 doses) 90.7 90.7 
Hepatitis B (≥ 3 doses) 91.4 91.1 
Varicella (≥ 2 doses, or a history of 
varicella) 
85.0 86.1 
Tetanus, diphtheria, pertussis (≥ 1 
dose) 
87.6 86.4 
HPV (≥ 1 dose, females) 60.0 62.8 
HPV (≥ 3 doses, females) 39.7 41.9 
HPV (≥ 1 dose, males) 41.7 49.8 
HPV (≥ 3 doses, males) 21.6 28.1 
 
Note. From Table 67 in the National Center for Health Statistics report (2016). 
Many interventions focus on increasing awareness and education of vaccination 
(including HPV); these efforts may be necessary but insufficient when making a decision 
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to accept vaccination (Brandt, Pierce, & Crary, 2016). Policy-level interventions for HPV 
vaccination are underutilized, if used at all, despite the use of public health policy in 
many of the great achievements in public and population health (Brandt et al., 2016). In 
particular, public health departments make little use of the public health authority as an 
alternate to legislative action (Abiola, Colgrove, & Mello, 2013; Brandt et al., 2016; 
Colgrove, Abiola, & Mello, 2010).  
Clinics and physicians are not consistently implementing recommended practices 
for HPV vaccination, especially among low socioeconomic and racial and ethnic minority 
patients (Askelson, Edmonds, Momany, & Tegegne, 2016). Evidence-based guidelines 
and recommendations published by ACIP, American Academy of Pediatrics, CDC, 
Community Preventive Services Task Force, and others include:  
• immunization information systems, 
• alerts and reminders for physicians and parents, 
• standing orders for non-physicians to administer vaccines, 
• participation in Vaccines For Children program, 
• strategies to discuss the vaccine with parents who request delays or refuse, 
• scheduling wellness visits for children 11 and 12 years old, 
• allowing walk-in vaccination visits, 
• vaccinating during sick visits, 
• scheduling visits for subsequent doses at the time of vaccination, and 
• individual physician feedback on vaccination rates (Askelson et al., 2016; 
Bailey et al., 2016). 
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These recommendations and guidelines reflect the importance of the social 
determinants of health and the context in which people make decisions and behave 
(Ferrer, Audrey, Trotter, & Hickman, 2015). A large number of HPV vaccination studies 
are grounded in individual or interpersonal health behavioral theories, which tend to view 
people as rational, logical actors wanting to maximize the benefit of health (Ferrer et al., 
2015). Yet physicians and patients often make decisions that do not align with evidence-
based science to maximize health, and behavior is influenced not only by individual 
psychology but also structural, economic, social, and political factors (Askelson et al., 
2016; Ferrer et al., 2015). As stated by Vanderpool, Crosby, and Stradtman (2014), “The 
annual death rate from HPV-related cancers demands much more than minor alterations 
to our current patchwork approach to prevention” (p. 2560). Such comprehensive, 
evidence-based programs are needed to make progress toward the Healthy People 2020 
goals of HPV vaccination coverage and reduction of HPV infection and associated 
cancers, as well as reduce the nearly $8 billion in annual costs for HPV-associated 
management (Palmer et al., 2015).  
After a decade of research supporting the conclusion that HPV vaccines are safe 
and effective, vaccine initiation and completion continue to be low; additional research is 
needed to better understand how to reach those who are eligible for vaccination to protect 
against multiple HPV-related cancers (Maness, Reitzel, Watkins, & McNeill, 2016; 
Perkins, 2016). In addition, researchers recently have begun to explore potential 
relationships among health, local geographic areas, and social vulnerability – a composite 
of socioeconomic status, household composition and disability, minority status and 
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language, and housing and transportation (Boscoe et al., 2014; Henry et al., 2016; Henry, 
Swiecki-Sikora, Stroup, Warner, & Kepka, 2017; Rutten et al., 2017). While researchers 
have published recent analyses on HPV vaccination data and policy, I am not aware of 
any to date that have tested the influence of the socioeconomic, demographic, cultural, 
geographical, and health history variables on HPV vaccine initiation and completion 
alongside the social vulnerability context in which these relationships exist. This will also 
be the first test of a potential relationship between social vulnerability and HPV 
vaccination in the literature, to my knowledge.  
These implications, such as the identification of the factors most strongly 
associated with HPV vaccination and common error decision points in physician 
recommendation, can advance social change by highlighting the need to consider local 
social and demographic influences on physician behavior. Informed interventions may be 
able to reduce variance in quality, increase culturally competent health care, and move 
those persons experiencing disparities in health outcomes toward a positive and healthy 
future. As noted in Andre et al. (2008), “a comprehensive vaccination programme is a 
cornerstone of good public health and will reduce inequities” (p. 144).  
The remainder of this chapter contains a review of the research problem, the 
purpose of the study, the research questions and hypotheses, the theoretical foundation 
and relation to the research questions, and the nature of the study. 
Problem Statement 
The Chicago Department of Health reported in July of 2015 that a recent in-
person training and public education campaign increased rates of HPV vaccination by 
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nearly 20%, as indicated in the 2014 National Immunization Survey-Teen data (City of 
Chicago, 2015). However, no discussion of data based on key determinants of 
vaccination, including socioeconomic and racial and ethnic minority status or physician 
recommendation, has occurred (City of Chicago, 2015). 
The hypotheses of minority poverty and diminishing returns suggest that minority 
populations start life with poorer health and any gains in socioeconomic status result in 
smaller health improvements than non-minority populations with equivalent gains 
(Farmer & Ferraro, 2005; Kish et al., 2014; Lu et al., 2015). However, the higher burden 
of HPV infection, morbidity, and mortality and lower vaccination rates in vulnerable 
populations have the potential to exacerbate disparities in health outcomes (Braveman, 
Cubbin, Egerter, Williams, & Pamuk, 2010; Galbraith et al., 2016).  
Researchers have focused on individual-level efforts targeting patients, but these 
programs have yielded little progress in vaccination completion (Ferrer et al., 2015). In 
addition, despite recommendations and policies set by federal bodies and national 
associations, physicians continue to recommend the HPV vaccine at lower rates than for 
other adolescent vaccines (Galbraith et al., 2016; Henry et al., 2016; Osazuwa-Peters et 
al., 2015; Teplow-Phipps et al., 2016; Vadaparampil et al., 2014). 
The relationship between population- and structural-level factors influencing the 
predictors of HPV vaccination has not yet been clarified, so there is no consensus on 
which variables may be most appropriate to target in interventions (Ferrer et al., 2015; 
Oliver, Frawley, & Garland, 2016; Small et al., 2014). While overall HPV vaccination in 
the United States is rising slowly, incidence and prevalence of HPV-associated cancer in 
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the United States are growing quickly, and disparities in vaccination rates and cancer 
mortality persist. Without knowledge of factors that influence vaccination in each 
population, public health practitioners may have difficulty designing effective methods to 
reduce these disparities. The newly released 2015 NIS-Teen data will provide the 
opportunity to update relationship and distribution patterns of socioeconomic and 
demographic variables across the nation. Understanding these patterns and their 
relationship with persistently low HPV vaccination initiation and completion can inform 
more cost-effective, culturally-grounded efforts in policy development and other changes 
to the environment in which vaccine decisions are made (Burger et al., 2016; Ferrer et al., 
2015; Small et al., 2014; Zimet, Rosberger, Fisher, Perez, & Stupiansky, 2013).  
Purpose of the Study 
The purpose of this retrospective quantitative study is to test the relationship 
between HPV vaccine initiation and completion, socioeconomic status, and demographic 
variables in eight select local areas in the United States. In addition, I will test the 
relationship between HPV vaccine initiation, physician recommendation, and social 
vulnerability in four select local areas.  
Research Questions and Hypotheses 
I will attempt to answer four research questions: 
Research Question 1: Is there a relationship between HPV vaccination initiation 
(1 dose) and socioeconomic status and demographic variables in selected local areas, 
using data from the 2015 NIS-Teen?  
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H01: There is no relationship between HPV vaccination initiation and 
socioeconomic and demographic variables in selected local areas. 
Ha1: There is a relationship between HPV vaccination initiation and at least one 
socioeconomic or demographic in selected local areas. 
Research Question 2: Is there a relationship between HPV vaccination completion 
(3 doses) and socioeconomic status and demographic variables in selected local areas 
using data from the 2015 NIS-Teen? 
H02: There is no relationship between HPV vaccination completion and 
socioeconomic and demographic variables in selected local areas. 
Ha2: There is a relationship between HPV vaccination completion and at least one 
socioeconomic or demographic variable in selected local areas. 
Research Question 3: Is there a relationship between HPV vaccination initiation 
(1 dose) and social vulnerability by select local area county in the United States using 
data from the 2014 NIS-Teen and 2014 Social Vulnerability Index?  
H03: There is no relationship between HPV vaccination initiation and social 
vulnerability by select local area county in the United States. 
Ha3: There is a relationship between HPV vaccination initiation and social 
vulnerability by select local area county in the United States. 
Research Question 4: Is there a relationship between physician recommendation 
(yes/no) and social vulnerability by select local area county in the United States using 
data from the 2014 NIS-Teen and 2014 Social Vulnerability Index?  
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H04: There is no relationship between physician recommendation and social 
vulnerability by select local area county in the United States. 
Ha4: There is a relationship between physician recommendation and social 
vulnerability by select local area county in the United States. 
Theoretical Foundation for the Study 
Two theories provide useful constructs with which to interpret the study results: 
fundamental cause theory, addressing the presence and persistence of socioeconomic and 
minority disparities in health, and behavioral economics, establishing a need to consider 
the context and key influences of an environment on physician decision making.  
Fundamental cause theory. Fundamental cause theory (FCT), developed by 
Link and Phelan (1995), is built on the idea that disparities develop alongside 
improvements in health care access and innovations due to the unequal distribution of 
health-promoting resources (Phelan, Link, & Tehranifar, 2010; Polonijo & Carpiano, 
2013). The associations between disparities in health and health outcomes for preventable 
diseases by socioeconomic status and racial and ethnic backgrounds are well established, 
with poor and minority populations often experiencing poorer health and shortened 
lifespans (Howlader et al., 2017; Polonijo & Carpiano, 2013; Tehranifar et al., 2009). 
Those with access to flexible resources are able to take advantage of health-promoting 
assets in their environment and adapt to future health challenges, while those without 
access may experience some overall health improvement but at a lower level (Phelan et 
al., 2010; Polonijo & Carpiano, 2013).  
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For example, with the advent of cervical cancer screening, overall deaths 
declined, yet incidence and mortality continues to be highest in Hispanics, African 
Americans, and Native Americans (Howlader et al., 2017). According to FCT, these 
populations have fewer resources for learning about and attaining benefits of health 
innovations such as screening (Phelan et al., 2010). The HPV vaccine is another 
innovation in knowledge and technology, yet a gradient has emerged in which low 
socioeconomic status and racial and ethnic minority populations are less likely to be 
vaccinated (Phelan et al., 2010). The implication of FCT is that interventions must 
minimize the degree to which flexible resources engender better health (Polonijo & 
Carpiano, 2013). HPV vaccination is thus an important test of theory; if specific causes 
are not identified and addressed in interventions and resources are distributed unequally, 
disparities in HPV-related cancers will persist (Polonijo & Carpiano, 2013).  
Behavioral economics theory. Traditional economic models assume people are 
rational actors who make decisions independent of social or environmental contexts; 
however, there is consensus among researchers that behavior is strongly influenced by 
social determinants, and people are consistently irrational in making decisions (Getzen, 
2013; Hoff & Stiglitz, 2016; Volpp, Loewenstein, & Asch, 2015). Researchers use the 
theory of behavioral economics, credited to Kahneman and Tversky (1979), to augment 
traditional economic models with social influence on human decisions. This theory 
advocates for the inclusion of common decision errors in interventions with a goal of 
improving health beyond a quantitative increase or decrease in behavior change in a cost-
effective way (Bickel, Moody & Higgins, 2016; Getzen, 2013; Volpp et al., 2015). Of all 
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health economic models, Frank (2004) and Glanz, Rimer, and Viswanath (2015) 
suggested that physician behavior is most associated with behavioral economics, which 
can be used to help explain why physicians often deviate from evidence-based medicine; 
these findings can subsequently be used to inform more appropriate measures of behavior 
change. 
Physicians make decisions about the intensity of treatment within the context of 
an asymmetrical power relationship with the patient, rigid time constraints, and risk 
aversion with patient outcomes. In this setting, physicians are influenced by constructs of 
stereotype and availability heuristics, time discounting, loss aversion, and choice 
architectures–all suggesting that physicians understandably use shortcuts in assessing 
patients, stick with treatments that have worked in the past, and select intensity of 
treatment based on local rather than national norms and evidence-based data (Frank, 
2004; Hoff & Stiglitz, 2016). In behavioral economics, framing or choice architecture 
matters and many common decision error points can be redirected toward making health-
promoting, evidence-based decisions. Understanding the internal barriers (such as 
heuristics) and external factors (such as physician prompts in electronic medical records) 
that motivate physicians to recommend the HPV vaccine may help guide individual, 
community, and population-level changes to facilitate physician recommendation for all 
patients (Dovidio & Fiske, 2012; Emanuel et al., 2016; Gesser-Edelsburg, Walter, Shir-
Raz, & Green, 2015; Kao, 2015). 
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Nature of the Study 
The nature of this study is a quantitative retrospective secondary analysis of 
national, publicly available data. Secondary analysis of large, reliable data sets such as 
NIS-Teen is less time-consuming and expensive than conducting primary quantitative 
research, and provides a sufficiently large sample size to make generalizations to the 
whole population, analyze data with a high level of statistical accuracy, and allow 
analysis among subgroups (Dale, 2004). Retrospective analysis is similarly a timely and 
cost-effective way to gather data, rather than waiting for events to occur, and can be 
reliable when data are objective events and can be verified by other sources (de Vaus, 
2006). Gathering and analyzing generalizable data in a timely fashion can help identify 
potential factors, modifiable or not, that can be used to develop policies and programs 
aiming to increase U.S. HPV vaccination rates in the near future. 
CDC conducts the annual NIS-Teen to monitor vaccination initiation and 
completion of adolescents aged 13 to 17 years among a stratified probability sample of all 
50 states, the District of Columbia, and territories (Henry et al., 2016; Rahman et al., 
2015). In addition, selected local areas that receive federal Section 317 funds to purchase 
vaccines, particularly for priority populations, are sampled and analyzed separately 
(Reagan-Steiner et al., 2016). The NIS-Teen gathers data in two phases, a telephone 
survey (both landline and cellular as of 2011) of parents or guardians of the target 
adolescents to obtain socioeconomic and demographic data, and a mailed survey to 
parent or guardian-identified providers to verify immunization records (CDC, 2016a; 
Henry et al., 2016; Rahman et al., 2015).  
15 
 
All analyses will include appropriate sampling weights when determining 
estimates to account for survey design. As the dependent variables are considered to be 
nominal (yes / no), statistical tests will include Chi-square and binomial logistic 
regression. This approach will be used to assess the relationship among a number of 
independent variables hypothesized to influence the dependent variables: HPV 
vaccination initiation and completion and physician recommendation of the HPV vaccine 
(Rahman et al., 2015; Perkins, 2016). Key variables as described in the 2014 and 2015 
Data User’s Guide (CDC, National Center for Immunization and Respiratory Diseases, & 
National Center for Health Statistics, 2015, 2016) are defined as follows.  
Ethnic and racial minority status. A categorical independent variable describing 
the race/ethnicity of the adolescent or teen. Options are Hispanic, Non-Hispanic White 
Only, Non-Hispanic Black Only, Non-Hispanic Other + Multiple Races, and Other + 
Multiple Race (a recode of NHO + Multiple Races) (CDC et al., 2015, 2016). 
HPV vaccination completion. A nominal dependent variable indicating the 
adolescent or teen has received three or more doses of the HPV vaccine. Some teens may 
have received more than three recommended doses; a secondary calculation by the CDC 
refers to a teen who, among those who received one or more HPV dose and over a 
minimum of 24 weeks between the first dose and the interview date, received a total of 
three or more doses (Reagan-Steiner et al., 2015).  
HPV vaccination initiation. A nominal dependent variable indicating the 
adolescent or teen has received one or more doses of the HPV vaccine (Reagan-Steiner et 
al., 2015). 
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Physician recommendation. A categorical dependent variable (research question 
4) indicating whether the person participating in the survey recalls receiving a 
recommendation from a physician or health care professional for the adolescent or teen to 
receive the HPV vaccination (CDC et al., 2015; 2016). 
Selected local areas. Seven specific estimation areas highlighted in the 2015 
NIS-Teen dataset (Bexar County, TX; Chicago, IL; El Paso County, TX; Hidalgo 
County, TX; Houston, TX; New York City; and Philadelphia County, PA) (CDC et al., 
2015; 2016). As Washington, D.C. is sampled separately, I have included it as one of the 
select local areas. These local areas receive federal Section 317 funds to purchase 
vaccines, particularly for priority populations, and are sampled and analyzed separately; 
El Paso County and Hidalgo County were oversampled (Reagan-Steiner et al., 2016). 
Given the demonstrated differences in HPV vaccination by geography, as well as the 
hypothesized relationship between social vulnerability and HPV vaccination, inclusion of 
local areas will add significant value to the research. In order to compare county-level 
data from the Social Vulnerability Index (described below) and the NIS-Teen database, I 
will include only four selected local areas that are stand-alone counties from the 2014 
NIS-Teen in the SVI portion of my analysis: Bexar County, District of Columbia, El Paso 
County, and Philadelphia (Hidalgo County was added in 2015). 
Social vulnerability. As defined by the CDC and Agency for Toxic Substances 
and Disease Registry [ATSDR], social vulnerability refers to the extent to which the 
health of communities is likely to be affected by socioeconomic and demographic factors 
(CDC & ATSDR, 2017). Vulnerable populations are those who are disproportionately 
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burdened by a combination of factors, are less likely to be able to cope with stressors, and 
whose needs are inadequately accounted for in resource allocation plans (Flanagan, 
Gregory, Hallisey, Heitgerd, & Lewis, 2011). The CDC and ATSDR’s Social 
Vulnerability Index ranks each census tract or county on overall vulnerability, comprised 
of four themes and 15 social factors affecting health: socioeconomic status (below 
poverty, unemployed, income, no high school diploma); household composition and 
disability (aged 65 and older, aged 17 or younger, civilian with a disability, single-parent 
households); minority status and language (minority, speak English less than well); and 
housing and transportation (multi-unit structures, mobile homes, crowding, no vehicle, 
group quarters) (CDC & ATSDR, 2017). As the most recent data set was published in 
2014, I will compare the 2014 NIS-Teen dataset with the 2014 SVI.  
Socioeconomic status. Categorical independent variables including income 
(poverty status, family income), health insurance and education (the current level of 
education of the adolescent or teen and the mother) (CDC et al., 2015; 2016). 
Literature Review 
In the decade since the first HPV vaccine was approved for use, researchers have 
proposed many theories and arguments to explain the low levels of HPV vaccine uptake. 
In this chapter, I present the literature on the themes relevant to my study: health 
disparities and social determinants of health including racial and ethnic minority status, 
socioeconomic status, and geography; policy and guidelines relating to vaccination; and 
physician recommendation of the HPV vaccine. In addition, I will present the literature 
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on epidemiology of HPV for context, as well as propose two theories that may be useful 
for guiding future interventions in HPV vaccination research.   
Literature Search Strategy 
The literature search was conducted using search engines and databases in the 
Walden University Library, specifically CINAHL & MEDLINE Simultaneous Search, 
Expanded Academic ASAP, Google, Google Scholar, PsycINFO, PubMed, SAGE 
Premier, and ScienceDirect. In addition, a small number of journals featuring issues 
dedicated to HPV research (including Human Vaccines & Immunotherapeutics in June 
2016 and Vaccines in November 2012) and an annually published journal 
(Papillomavirus Research) were reviewed for relevant publications. 
Search terms within these databases and search engines included behavioral 
economics theory (with or without health or health behavior), fundamental cause of 
health, fundamental cause theory (with or without health), HPV or human 
papillomavirus (with or without vaccin*), papillomavirus history, and social 
determinants of health (with or without policy). In addition, HPV or human 
papillomavirus with or without vaccin* was combined with behavioral economics, 
cancer, disparities, fundamental cause theory, minority, physician recommendation, 
policy, and socioeconomic. The scope of the literature review in terms of years included 
(a) 1935-2017 for seminal literature regarding the history of HPV research, fundamental 
cause theory, and behavioral economics, (b) 2010-2017 for statistics on the most current 
data available on applicable variables, and (c) 2011-2017 for current peer-reviewed 
articles; peer-reviewed articles published 2015 through 2017 were prioritized. 
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Selection criteria for peer-reviewed articles included (a) publication in English, 
(b) original research or review articles, commentary, and editorials, (c) discussion or 
description of the aforementioned variables and their relationships to health and health 
outcomes in the United States, (d) HPV vaccination research with a primary focus on 
adolescents and teenagers ages 11 to 17, and (e) discussion or description of the 
theoretical foundations of this proposal and their application to health, policy, and 
economics. Literature on the application of the selected theoretical foundations to HPV 
vaccination was scarce; therefore, articles discussing these theories and their application 
to health in general were reviewed. In addition, literature regarding global trends in the 
aforementioned variables was reviewed if information was directly relevant to, or 
including a data collection component within, the United States. 
Epidemiology of Human Papillomavirus and HPV-Associated Disease 
Over 200 types of human papillomaviruses have been isolated and characterized 
and classified as one of two types: (a) low-risk, causing benign or low-grade tissue 
abnormalities, anogenital warts, and recurrent respiratory papillomatosis; and (b) high-
risk, causing cervical, vaginal, vulvar, penile, anal, and oropharyngeal cancers (Hutter & 
Decker, 2016).  
Global infection and cancer. HPV is the only cancer-causing virus to be 
endemic worldwide and is one of the most important infectious carcinogens in humans 
(Chan, Wong, Qin, & Chan, 2016; zur Hausen, 2009). HPV infects an estimated 12% of 
women of all ages worldwide, with a peak infection rate of 24% for those under 25 years 
old (Handler, Handler, Majewski, & Schwartz, 2015). Over half a billion cancers 
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annually are associated with HPV infection annually worldwide; the population-
attributable fraction (PAF), or the proportional reduction in disease that would occur if 
HPV were not present, is nearly 90% (Forman et al., 2012; World Health Organization, 
2016).  
U.S. incidence. Both HPV and genital wart figures are estimates; testing for HPV 
in cancer diagnoses does not happen routinely, nor do registries collect data on HPV 
status (with the exception of New Mexico for cervical cancer), so HPV infection rates are 
calculated based on the estimated infection rate within tissue known to be associated with 
HPV (CDC, 2016b; Katzel, Merchant, Chaturvedi, & Silverberg, 2015). Genital wart 
incidence is estimated based on persons who seek treatment, so true incidence is likely 
underrepresented (CDC, 2016b). However, previous studies support 70-80% concordance 
between estimates and direct measurement of HPV infection, and therefore national 
estimates are considered reliable (Katzel et al., 2015). 
In the United States, annual incidence of HPV infection is 14 to 20 million 
people, while prevalence is 79 to 110 million (CDC, 2017b; Handler et al., 2015). An 
estimated $8 billion are spent annually managing HPV-related morbidity and mortality, 
second only to HIV (Chesson, Markowitz, Hariri, Ekwueme, & Saraiya, 2016). Initial 
visits to physician’s offices for genital warts has increased over 730% in the past 50 
years, with over 465,000 initial visits in 2014 (CDC, 2017c). Finally, annual incidence of 
HPV-associated cancers has increased over time, with an estimated 40,000 cases annually 
(8 per 100,000), although estimates vary by cancer site, ethnicity, study methodology, 
and geographic location (Handler et al., 2015; Viens et al., 2016). The incidence of HPV-
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associated cancers differs by geography, from 7.5 per 100,000 in Utah to 14.7 per 
100,000 in Kentucky (Saraiya et al., 2015; Viens et al., 2016).  
U.S. HPV infection by cancer site. The estimated detection of HPV in the 
United States is (a) 99% in cervical cancer and cervical cancer in situ, (b) 91% in anal 
cancer, (c) 75% in vaginal cancer, (d) 70% to 90% in oropharyngeal cancer, (e) 70% in 
vulvar cancer, (f) 63% in penile cancer, and (g) 53% in oral cavity and laryngeal cancer 
(Bailey et al., 2016; Garland et al., 2016; Saraiya et al., 2015). Cervical, anal, and 
oropharyngeal cancers are of particular interest to researchers given their incidence and 
risk factors.  
Cervical cancer. Knowing patterns of preventable, evidence-based population 
risk factors contributing to incidence of HPV infection and associated cancers are key for 
creating benchmarks in public health policy and planning efforts (Franco, Shinder, Tota, 
& Isidean, 2015). For example, mortality for cancers for which early detection, 
prevention, and/or treatment exist and were adequately implemented was reduced by 50% 
between 1990 and 2015 (Byers, Wender, Jemal, Baskies, Ward, & Brawley, 2016). Of 
the HPV-associated cancers, only cervical cancer has an established early detection 
program and treatment algorithm; cervical cancer efforts are a model for programs that 
can reliably detect precancerous lesions and effectively remove the tissue, and have 
reduced cervical cancer mortality by 60% since 1955 (Dizon et al., 2016; Ferlay et al., 
2015; Franco et al., 2015; Hutter & Decker, 2016). However, screening is not 100% 
effective: many women infected with high-risk HPV may have normal Papanicolaou 
(Pap) test results; screening is less effective in preventing cervical adenocarcinoma than 
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squamous cell carcinoma; and only 81% of women get up to date regular pap smears 
(Castanon, Landy, & Sasieni, 2016; Hutter & Decker, 2016; Viens et al., 2016).  
Cervical screening compliance is even lower among women who are of minority 
descent, uninsured or publicly insured, and low socioeconomic status (Reiter et al., 2013; 
Viens et al., 2016). This is particularly troubling, as Blacks clear HPV more slowly than 
White women, and cervical cancer incidence is highest among Blacks and Hispanics, 
women in poverty, and women with low educational attainment (Reiter et al., 2013; 
Viens et al., 2016). It is therefore crucial to understand HPV prevalence and vaccination 
coverage among populations to more effectively address existing and potential future 
cervical cancer disparities (Reiter et al., 2013). 
Anal cancer. Anal cancer is one of only five cancers whose incidence has 
increased in the past 40 years (another HPV-associated cancer, HPV-positive 
oropharyngeal squamous cell carcinoma, is among the five) (Amini et al., 2016; Jemal et 
al., 2013). Incidence and mortality rates of anal cancer in the United States are highest in 
White females and Black males; overall, anal cancer is slightly more common in females 
(Viens et al., 2016). Receptive anal sex is strongly associated with HPV infection and 
anal cancer in males; men who have sex with men (MSM) have higher rates of anal 
cancer than men who have sex with women (Handler et al., 2015). Rates of anal cancer in 
U.S. HIV-positive MSM are on par with rates of cervical cancer sub-Saharan African 
women, which are the highest in the world (Forman et al., 2012). However, even 
individuals who do not participate in anal sex are still at risk given the proximity of the 
anal canal and genitals (Hutter & Decker, 2016).  
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Oropharyngeal cancer. Head and neck squamous cell carcinoma incidence 
overall is declining in the United States., including a 50% reduction in HPV-negative 
oropharyngeal cancer in less than 20 years, as tobacco and alcohol use have declined in 
recent birth cohorts (Allison & Maleki, 2016; Amini et al., 2016; Chaturvedi, Engels, 
Anderson, & Gillison, 2008; Chaturvedi et al., 2011; Gillison, 2016). Conversely, HPV-
positive oropharyngeal cancer (HPV OSCC) has risen steeply, jumping 225% during the 
same time period (Allison & Maleki, 2016; Chaturvedi et al., 2011). Given that smoking 
tobacco is an established risk factor for HNSCC but smoking rates have decreased, 
another causal agent–HPV–must be driving the rise in HPV OSCC in younger individuals 
(Allison & Maleki, 2016; Chaturvedi et al., 2011). Researchers estimate incidence of 
HPV OSCC will surpass incidence of HPV-positive cervical cancer by 2020, if not 
sooner; the dramatic increase of HPV OSCC as smoking has decreased has been 
described as virus-related epidemic (Allison & Maleki, 2016; Marur, D’Souza, Westra, & 
Forastiere, 2010).  
HPV OSCC is distinctive from HPV-negative OSCC not only in incidence, but in 
molecular pathophysiology, presentation, and prognosis (Mallen-St Clair et al., 2016). 
The differences are so great that survival rates for HPV OSCC patients cannot be 
predicted using the current TNM staging system; to aid researchers and physicians, the 
American Journal of Cancer will publish an updated staging manual including HPV 
OSCC in late 2016 (Mallen-St Clair et al., 2016). If treated with radiation, HPV OSCC is 
associated with improved overall survival rates (Allison & Maleki, 2016). Researchers 
have yet to identify a lesion or map progression to HPV OSCC, however, and have not 
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determined why HPV-positive tumors are more sensitive to radiation treatment than 
HPV-negative tumors (Mallen-St. Clair et al., 2016).  
Risk factors and other considerations. HPV infection and HPV-associated 
cancers share a number of risk factors–sexual behavior, smoking marijuana, and other 
epidemiological considerations including age, educational attainment, health care 
coverage, socioeconomic status, and racial and ethnic minority background (Mullins et 
al., 2016). Although these issues will be explored more fully later in the remainder of this 
section, a brief discussion on their relevance to incidence is warranted. 
HPV infection (and consequently development of HPV-associated cancers) is 
associated with early age of first sexual encounter, high number of sexual partners, and 
smoking marijuana (Chaturvedi et al., 2011; Chesson, Dunne, Hariri, & Markowitz, 
2014; Mullins et al., 2016). Immunosuppressed and HIV-positive individuals are at much 
higher risk of HPV infection than the general population, as their immune systems cannot 
clear the infection as effectively (Forman et al., 2012).  
Prevalence of male HPV infection is generally correlated with female HPV 
infection, while prevention of infection in males protects both females in heterosexual 
relationships and males in homosexual relationships (Allison & Maleki, 2016; Fairley, 
Zou, Zhang, & Chow, 2017). Incidence of infections leading to cervical cancer tends to 
peak near the age of sexual debut (teens to early 20s) while incidence of infections 
leading to HPV OSCC and anal and penile cancers has a bimodal peak, one at 30 to 34 
years and another at 60 to 64 years (Allison & Maleki, 2016). The age at which 
individuals develop cancer influences outcomes, as younger individuals with HPV-
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associated cancers often present at higher stages and are exposed to toxic treatments that 
affect long-term quality of life (Amini et al., 2016; Gillison, 2016).  
Finally, incidence of HPV infections and associated cancers tends to be 
disproportionately higher in persons of low socioeconomic status and racial and ethnic 
minority populations; one exception is HPV OSCC, which occurs more often among 
young, educated, affluent White males (Allison & Maleki, 2016, Byers et al., 2016).  
In the past decade, the Food and Drug Administration approved three prophylactic 
HPV vaccines (see Table 2) (Onon, 2011). Currently, clinical trials are testing efficacy in 
alternate dosing schedules, efficacy and safety in pediatric and immunocompromised 
patients, safety when administered in combination with other vaccines, and efficacy of 
behavioral interventions to increase vaccine uptake (Onon, 2011). 
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Table 2 
 
Approved HPV Vaccines and Their Indications 
 
 
Initial 
Approval 
 
Initial Indication Subsequent 
Approvals 
Covered 
HPV Types 
Gardasil  
(Merck & Co) 
June, 2006 Girls and women ages 
9 to 26 years: Cervical 
cancer; genital warts; 
cervical 
adenocarcinoma in 
situ; cervical, vulvar, 
and vaginal 
intraepithelial lesions 
Vulvar and vaginal 
cancer (September 
2012).  
Males and females 
ages 9 to 26 years, 
anal cancer and 
anal intraepithelial 
lesions (December 
2010) 
HPV6, 11, 
16, 18 
Cervarix 
(GlaxoSmithKline) 
October, 
2009 
Girls and women ages 
10 to 25 years: 
Cervical cancer; 
cervical 
adenocarcinoma in 
situ; cervical 
intraepithelial lesions 
Girls aged 9 years 
(2011) 
HPV16, 18 
 
 
 
Gardasil-9  
(Merck & Co) 
December, 
2014 
Girls and women ages 
9 to 26 years: 
Cervical, vulvar, 
vaginal, and anal 
cancer; genital warts; 
cervical, vulvar, 
vaginal, and anal 
intraepithelial lesions.  
Boys ages 9 to 15 
years: anal cancer; 
genital warts, anal 
intraepithelial lesions 
Men ages 16 to 26 
(December 2015) 
Two-dose regimen 
for individuals 
ages 9 to 14 years 
(October 2016) 
HPV6, 11, 
16, 18, 31, 
33, 45, 52, 
58 
 
Note. From FDA (2016). Approvals current as of July 1, 2017. 
 
Health Disparities and Social Determinants of Health 
Health is shaped by the social determinants of health, or “conditions in the 
environments in which people are born, live, learn, work, play, worship, and age” 
(Healthypeople.gov, 2017, “Understanding Social Determinants of Health,” para. 1). 
Researchers have demonstrated strong links between a number of determinants and 
27 
 
disparities in health and health outcomes, including race and ethnicity, socioeconomic 
status, and geographic location (CDC, 2013). Of particular relevance to my study, these 
determinants, along with physician recommendation, have been linked with HPV 
vaccination (Burger et al., 2016). These determinants underpin how health-promoting 
resources are distributed, as in the fundamental cause theory, and inform physician 
decision-making, as in behavioral economics. Although these data on vaccination and 
relationships with health determinants are useful and consistent, there continue to be gaps 
in HPV vaccine research. To date, most research in the HPV vaccine space has focused 
on individual-level determinants in isolation, or has been analyzed at the aggregate level, 
masking inter- and intra-population differences in HPV vaccine rates (Bodson et al., 
2017; Kreuter, McQueen, Boyum, & Fu, 2016; Romaguera et al., 2016; Rutten et al., 
2017; Whittemore et al., 2016).   
This leads to the questions about the relationships among a number of individual 
and structural determinants known to interact with HPV vaccination, as well as whether 
there are other determinants that have not yet been examined (Kreuter et al., 2016). 
Testing the relationships of these determinants on multiple levels with HPV vaccine 
uptake is necessary if researchers are to identify modifiable factors that contribute to 
existing inequalities in HPV-related morbidity and mortality (Bodson et al., 2017). I will 
address this gap and build on the body of research in this space by testing socioeconomic 
and demographic variables and social vulnerability as independent variables, with HPV 
vaccine initiation and completion and physician recommendation as dependent variables. 
In the following discussion, I present the literature supporting the importance of 
28 
 
disparities in race and ethnicity, socioeconomic status, and geography, and how I will 
address gaps in the literature through this study.  
Racial and ethnic minority status. Researchers have established strong 
relationships among disparities in health due to cumulative, differential experience of 
racial and ethnic minorities with structural and interpersonal inequities; these disparities 
have been linked to HPV-related health outcomes and HPV vaccination rates (Benz et al., 
2011; Braun et al., 2015; Chang, Moonesinghe, Athar, & Truman, 2016; Gelman et al., 
2013; Jeudin et al., 2014; Reagan-Steiner et al., 2016; Williams, Priest, & Anderson, 
2016). An individual’s racial and ethnic background is a non-modifiable factor, but is so 
strongly linked with other social determinants and health outcomes that any examination 
of disparities HPV vaccine uptake must include this variable to be valid and useful for 
knowledge and practice (Burger et al., 2016). 
Tehranifar et al. (2009) suggested that racial and ethnic disparities in cancer 
incidence and mortality have been consistent despite the advancement of screening 
techniques and treatment. This is supported by Burger et al. (2016) and others, who 
presented data showing differential burden of incidence and mortality by racial and ethnic 
background (see Table 3) (Bakir & Skarzynski, 2015; Gelman et al., 2013; Ramer et al., 
2016; Reagan-Steiner et al., 2016). For example, the U.S. Cancer Statistics Working 
Group (2016) showed that White and Black populations tend to have higher incidence of 
anal and oropharyngeal cancer. In another example, Bakir & Skarzynski (2015) reported 
that while Black women are slightly less likely to develop cervical cancer than Hispanic 
women, they are substantially more likely to die from the disease.  
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Table 3 
 
Age-Adjusted Cancer Incidence and Mortality by Primary Tumor Site and Race 
Primary 
Site 
Anus Cervix Oropharynx 
 Incidence Mortality Incidence Mortality Incidence Mortality 
 
All Races 1.8 0.2 7.2 2.3 11.5 2.4 
White 1.9 0.3 7.0 2.2 11.8 2.4 
Black 1.8 0.3 9.0 3.9 9.0 2.8 
A/PI 0.5 0.1 5.9 1.9 7.8 1.9 
AI/AN 0.9 c 6.3 1.7 7.1 1.0 
Hispanic 1.3 0.1 9.2 2.5 6.7 1.4 
 
Note. From Adapted from 2013 data from United States Cancer Statistics (the most recent 
year available). A/PI: Asian / Pacific Islander. AI/AN: American Indian / Alaska Native. 
a Female only. Anus and Oropharynx represent male and female data. b Incidence and 
mortality rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard 
population. c Not sufficient data 
 
Conclusions regarding incidence and mortality by racial and ethnic background 
are similar and researchers consistently show that disparities exist over time, in different 
age groups, and from different population-level data sets (the National Health Interview 
Survey, NIS-Teen, National Program of Cancer Registries, Surveillance, Epidemiology, 
and End Results Program, and others). The number of races and ethnicities included, 
however, varies by research methodology. For example, Reagan-Steiner et al. (2016) and 
Burger et al. (2016) tested the relationships among non-Hispanic White, Black, Hispanic, 
Asian, and American Indian / Alaska Native and HPV vaccine uptake, providing a 
comprehensive snapshot of national vaccination trends (see Table 4). In contrast, Jeudin 
et al. (2014) focused on subpopulations of Black, Hispanic, and Asian females and 
reviewed drivers of vaccination, while Daniel-Ulloa et al. (2016) tested vaccination by 
sexual orientation among Black, Hispanic, and White females. The scope of this research 
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is to test the relationships among specific determinants of health and vaccination at local 
and national levels, and thus inclusion of all races and ethnicities available is appropriate. 
Table 4 
 
HPV Vaccine Coverage among Females Ages 13-17 Years, by Race  
Race ≥1 dose 
 
≥3 doses 
 2013 2014 2015 2013 2014 2015 
 
White 53.1% 56.1% 59.2% 34.9% 37.5% 39.6% 
Black 55.8% 66.4% 66.9% 34.2% 39.0% 40.8% 
Hispanic 67.5% 66.3% 68.4% 44.8% 46.9% 46.2% 
AI/AN 73.3% 71.2% 70.5% 43.2% 39.4% 38.7% 
Asian 57.0% 54.9% 63.8% 40.4% 35.7% 53.5% 
 
Note. Adapted from Elam-Evans et al. (2014; 2013 data), Reagan-Steiner et al. (2015; 
2014 data), and Reagan-Steiner et al. (2016; 2015 data). ≥1 dose indicates HPV vaccine 
initiation, ≥3 doses indicates HPV vaccine completion. Overall in 2015, 42% of females 
completed the HPV vaccine series (Hswen et al., 2017). 
 
Khan et al. (2016) predicted that the consistently observed differences in cancer 
incidence and mortality by racial and ethnic minority background will persist despite the 
introduction of the HPV vaccine until the ecological factors influencing the health of 
these populations have been addressed (Alligood-Percoco & Kesterson, 2015; Burdette, 
Webb, Hill, & Jokinen-Gordon, 2016; DeSantis et al., 2016). However, researchers 
including a comprehensive set of such variables (a) explored associations within small 
subgroups in specific locations (Romaguera et al., 2016), limiting external validity; or (b) 
tested relationships among the population as a whole (Galbraith et al., 2016), obscuring 
differences at the local level. Given available data and other constraints, these approaches 
are logical but do little to capture the diversity of resources and barriers to health in 
heterogeneous populations.  
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To account for external validity as well as relevance to local public health 
officials, I will test the relationship of the major racial and ethnic minority categories 
available in a national dataset with HPV vaccination at the national and county level. As 
asserted by Burger et al. (2016), the lack of targeted interventions may result in future 
differential outcomes in HPV-related incidence and mortality despite the current 
availability of an efficacious vaccine. Testing the relationship between race and ethnicity 
and HPV vaccine is only one piece of the puzzle, however; other local variables such as 
socioeconomic status and geography influence health outcomes and must be considered 
for a more comprehensive understanding of local resources and needs. 
Socioeconomic status. Socioeconomic status (SES) is a multi-dimensional 
variable and has a strong and significant association with health (Cutler, Lleras-Muney, 
& Vogl, 2008). The socioeconomic-health gradient has been firmly established through 
decades of research and observation across societies; the most commonly used proxies 
for assessing SES including education, income, and occupational status. 
Despite the clear links between dimensions of SES and health outcomes, one or a 
few dimensions tested in isolation is insufficient to explain health outcomes, as the 
dimensions are inextricably linked. As stated by Cutler et al. (2008) and Krieger et al. 
(2005), the unique mix of individual-, community-, and population-level factors 
influencing health poses a significant challenge in creating a unified theory to explain the 
relationship between SES and health outcomes. Researchers must extend SES 
considerations beyond a single or small number of SES dimensions in order to address 
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heterogeneous and multidimensional fundamental needs for public health programs to 
truly be effective.  
The challenges and resulting health outcomes vary even among a population with 
the same income, education, or occupation. For example, Kreuter et al. (2016) found that 
while one family living below the poverty level may have adequate housing and a strong 
social support network, another may face food insecurity and cultural isolation. 
Interpreting any tested relationships between SES and vaccine uptake through the lens of 
an ecological perspective, as in the FCT, Farmer and Ferraro’s (2005) minority poverty 
hypothesis, or the economic principle of diminishing returns as described by Phelan et al. 
(2010) may contribute to more comprehensive research designs and program planning. 
An ecological perspective to SES. Farmer and Ferraro (2005) developed the 
minority poverty hypothesis from the observation that the greatest disparities in health are 
concentrated among low-socioeconomic, racial and ethnic minority populations as a 
result of the compound stressors of poverty and racial and ethnic minority background on 
these populations (Kish et al., 2014). In contrast, diminishing returns is used to predict 
that the greatest disparities in health will be concentrated among high-socioeconomic 
status, racial and ethnic minority populations, as these populations do not experience the 
same return on health investment as non-Hispanic Whites do at the same SES level 
(Getzen, 2013; Kish et al., 2014). Finally, the FCT is interpreted to suggest that low-
socioeconomic populations do not benefit from advances in health care at the same rate 
or level as high-socioeconomic populations do, no matter the racial and ethnic minority 
status of the population (Phelan et al., 2010). In sum, both SES and race and ethnicity are 
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consistently and strongly linked with access to health-promoting resources and associated 
with health outcomes. This raises the question of whether SES and race and ethnicity 
contribute equally to health outcomes, and whether race and ethnicity can be considered a 
component of SES (Polonijo, Carpiano, Reiter, & Brewer, 2016).  
In general, SES and race and ethnicity are positively correlated. Davids, Hutchins, 
Jones, and Hood (2014) and others have shown that the best health outcomes tend to be 
found in high-socioeconomic communities with large Asian or native-born non-Hispanic 
White populations, while the worst health outcomes are found in low-socioeconomic, 
mainly Black or immigrant communities (Froment, Gomez, Roux, DeRouen, & Kidd, 
2014). This is supported by Proctor, Semega, and Kollar (2016), who reported that a 
higher percentage of racial and ethnic minority populations live in poverty, compared 
with non-Hispanic Whites – while 9.1% of NHW lived in poverty in 2015, 21.4% of 
Hispanics and 24.1% of Blacks lived below the poverty level.  
The association between SES and racial and ethnic minority status extends to 
HPV vaccination as well. Reagan-Steiner et al. (2016) showed that among males ages 13 
to 17 years living below the poverty level, HPV vaccine initiation rates in 2015 were 
higher among Hispanics (70.8%) than Blacks (60.2%). Even within the same racial and 
ethnic populations, Reagan-Steiner et al. (2016) found differences in HPV vaccine 
initiation rates, with lower rates in Black males living at or above the poverty level 
(51.9%) than those below the poverty level. In support of these findings, Henry et al. 
(2016) showed that female initiation rates followed similar trends, with the highest rates 
in low-SES urban communities with predominantly Hispanic or Black populations. Thus, 
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although the link between racial and ethnic minority background and SES is clear, one 
can argue that it is not perfectly dependent, whether in the context of HPV vaccine uptake 
or not. Consequently, I will separate racial and ethnic minority status from an SES 
variable in my study.  
Health insurance and SES. Researchers consistently have shown a positive 
gradient between health insurance and SES components (income, occupation, and 
education) (DeNavas-Walt, Proctor, & Lee, 2006). Rather than subsume health insurance 
status under SES, however, I agree with Barnett and Vornovitsky (2016), Churilla et al. 
(2016), and others that health insurance should be tested as a separate variable. The type 
of health insurance an individual has not only differs between income levels, but within 
income levels as well. For example, Barnett and Vornovitsky (2016) reported that of 
Americans living below the poverty level–and therefore all considered low 
socioeconomic status–in 2015, 28.6% had a private plan, 62.1% had government health 
insurance, and 17.4% were uninsured. In contrast, of those at or above 400% of the 
poverty level, 86.4% had a private plan, 22.6% had a government plan, and 4.5% were 
uninsured (Barnett & Vornovitsky, 2016).  
In addition, different types of insurance may result in different health outcomes, 
Abdus and Selden (2013) and Churilla et al. (2016) observed that the type of insurance 
coverage an individual has is associated with stage at diagnosis of cancer, treatment, and 
mortality. The authors demonstrated that privately insured patients with cervical cancer 
tend to have a usual source of care, and as such tend to present earlier in their disease 
course and live longer. Medicaid-insured patients with cervical cancer tend to present at a 
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later stage and die sooner than privately insured patients, while uninsured patients have 
the poorest outcomes in terms of stage of diagnosis and survival than both privately 
insured and Medicaid patients.  
These differences by insurance type and outcomes extend to HPV vaccine uptake 
as well. Agawu et al. (2015) found that adolescents who were covered by Medicaid and 
lived below the poverty level were more likely to initiate the HPV vaccine than children 
with non-Medicaid insurance and living at or above the poverty level; these rates were 
reportedly due to the Vaccines for Children program, which provides vaccines for 
Medicaid-insured children and adolescents. These data were supported by Henry et al. 
(2016), and Reagan-Steiner et al. (2016), who found significant differences in HPV 
vaccine initiation by racial and ethnic minority status, SES, and health insurance type. 
Finally, Kish et al. (2014) and others stated that access to the same type of health 
insurance does not guarantee better health outcomes. For example, Booth, Li, Zhang-
Salomons, and Mackillop (2010) and Du, Lin, Johnson, and Altekruse (2011) expressed 
their surprise at finding disparities in cancer morbidity and mortality in Canada and the 
U.K., where everyone has access to the same basic health care coverage. Based on these 
findings, I will test the types of health insurance separately from SES and racial and 
ethnic minority status, provided each subgroup has sufficient sample size. Understanding 
the relationship between components of SES, health insurance, and racial and ethnic 
minority status could advance knowledge in the field and encourage researchers to look 
at variables in more detail to better target their interventions. However, given the 
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importance of social determinants in health decisions, additional factors such as 
geography should be included for a more comprehensive analysis. 
Geography. While national estimates of disease and vaccination rates are more 
readily available and may be useful metrics to measure change in population health, state 
and local-level data are more relevant to the local contexts in which needs exist and 
resources are allocated (Hunt, Tran, & Whitman, 2015). For example, the National 
Program of Cancer Registries [NPCR] (2015) reported that the age-adjusted incidence 
rate of cervical cancer in the United States fell to 7.6 per 100,000 between 2009 and 
2013, yet rates ranged from 4.6 per 100,000 in New Hampshire to 10.0 per 100,000 in 
West Virginia.  
As reported in Kish et al. (2016), incidence among similar racial and ethnic 
minorities also varied by state. For example, rates of cervical cancer in Hispanic women 
ranged from 5.5 per 100,000 in Maryland to 19.5 per 100,000 in Arkansas, while rates for 
Black women in those same states ranged from 8.0 per 100,000 in Maryland to 12.9 per 
100,000 in Arkansas.  
Even in neighboring states with significant interstate interaction and access to 
health care, racial and ethnic groups may have different health outcomes. For example, 
the NPCR (2015) reports that in New York, Hispanic women have lower incidence of 
cervical cancer but are more likely to die from the disease than Hispanic women in New 
Jersey; in New York; Black women have higher incidence of cervical cancer but are less 
likely to die than Black women in New Jersey; and in New York Non-Hispanic White 
women are less likely to be diagnosed with and die from cervical cancer than in New 
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Jersey. The varying rates cannot be solely a product of access to state-specific preventive 
measures, as Blacks and Hispanics have equal rates (and greater than rates of White 
women) of Pap screenings (and greater than rates of White women) in both New York 
and New Jersey (NPCR, 2015). 
These data lead to the question about differences within and between states 
among the same racial and ethnic populations. While state-level data are useful in 
monitoring shifts in disease and disease outcomes, a single statistic does not represent the 
differential burden experienced by subpopulations within the state. Therefore, as 
suggested by Egen, Beatty, Blackley, Brown, and Wykoff (2017), an additional level of 
detail is needed to capture intra-state differences hidden by state-level data and highlight 
the areas of greatest vulnerability. 
The smallest unit of analysis in national databases tends to be the county or 
census tract, and although sample sizes are smaller, researchers have found significant 
differences in health and health outcomes. Egen et al. (2017) showed that individuals 
living in the poorest counties of a state may have similar life expectancy to populations in 
developing countries, and live 7 to 10 fewer years than those in the wealthiest counties in 
the same state. Lin, Schootman, and Zhan (2015) and McCarthy, Dumanovsky, 
Visvanathan, Kahn, and Schymura (2010) are among the very few researchers who have 
conducted studies on differences in health outcomes at the local level; they cited concerns 
with external validity and small sample sizes as main barriers to this approach. However, 
Lin et al. (2015) and McCarthy et al. (2010) have maintained that their results are 
consistent with researchers using larger state- or national-level datasets: namely, race and 
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ethnicity tend to be predictive of later-stage cervical cancer diagnosis (especially for 
Black and Hispanic women), while race and ethnicity, geography, and other contextual 
factors tend to predict mortality. I interpret these data as supporting the need for local-
level data to best inform resource needs and program planning, in combination with state- 
or national-level data to monitor changes in population health. Furthermore, these data 
raise the question of how HPV vaccine uptake differs by county when broken down by 
social determinant variables.  
HPV vaccine uptake and geography. As reported by Galbraith et al. (2016), 
Glenn et al. (2015) and others, HPV vaccination initiation and completion have been 
shown to vary significantly both inter- and intra-state (see Figure 1 and Tables 5 – 6) 
(Henry et al., 2016; Rahman, Islam, & Berenson, 2015). While Bharmal, Tseng, Kaplan, 
and Wong (2012) and many others have examined relative differences between states, 
few have examined absolute differences within states. In one such study, Reagan-Steiner 
et al. (2016) showed that while rates for female adolescents in Texas were 56%, 51%, and 
60% in 2013, 2014, and 2015, respectively, Bexar County rates did not match the state 
during that time period (see Figure 1 and Table 5). By reporting only state-level HPV 
vaccinations, researchers may unintentionally mask intrastate variation in health 
determinants and thus reduce effectiveness of targeted program planning and resource 
allocation. 
(a) 
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Figure 1. Percent females, ages 13-17, receiving >1 dose HPV vaccination, 2013–2015. 
(a) Percent females, ages 13–17, receiving ≥1 dose HPV vaccination, 2013. Adapted 
from Elam-Evans et al. (2014). (b) Percent females, ages 13–17, receiving ≥1 dose HPV 
vaccination, 2014. Adapted from Reagan-Steiner et al. (2015). (c) Percent females, ages 
13–17, receiving ≥1 dose HPV vaccination, 2015. Adapted from Reagan-Steiner et al. 
(2016). Charts created using mapchart.net.  
Table 5 
 
HPV Vaccine Coverage (1 dose) among Females Ages 13-17 Years by Location, 2013-
2015 
Year 
 
United 
States 
 
Rhode 
Island 
Kansas Chicago (IL) Bexar 
County (TX) 
 
2013 57.3% 76.6% 39.9%  61.8% 54.8% 
2014 60.0% 76.0%  38.3%  78.1% 47.7% 
2015 62.8% 87.9%  50.9% 70.8% 56.2% 
 
Note. From Adapted from Elam-Evans et al. (2014; 2013 data), Reagan-Steiner et al. 
(2015; 2014 data), and Reagan-Steiner et al. (2016; 2015 data). ≥1 dose indicates HPV 
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vaccine initiation. For all years, Rhode Island had the highest coverage nationwide, while 
Kansas had the lowest in 2013-2014 (in 2015, Wyoming had the lowest, with 47.7%). 
 
Table 6 
 
HPV Vaccine Coverage (1 dose) among Males Ages 13-17 Years by Location, 2013-2015 
Year 
 
United 
States 
 
Rhode 
Island 
Kansas Chicago (IL) Bexar 
County (TX) 
 
2013 34.6% 69.3% 25.1%  50% 32.4% 
2014 41.7% 69.0%  32.8%  64.9% 35.6% 
2015 49.8% 80.6%  36.0% 68.1% 40.3% 
 
Note. Adapted from Elam-Evans et al. (2014; 2013 data), Reagan-Steiner et al. (2015; 
2014 data), and Reagan-Steiner et al. (2016; 2015 data). ≥1 dose indicates HPV vaccine 
initiation. For all years, Rhode Island had the highest coverage nationwide; Kansas 
provided for comparison to females (Table 5). Lowest male coverage was in Utah 
(11.0%, 2013), Indiana (23.2%, 2014), and Kentucky (34.8%, 2015) 
 
Burger et al. (2016) concluded that the intent of increasing HPV vaccination 
among those who are most burdened by HPV-related morbidity and mortality is to 
decrease disparities in health outcomes. However, disparities will persist and potentially 
increase if the underlying structural issues contributing to these differences in HPV 
infection, vaccination, and related morbidity and mortality are not addressed at the state 
and local level in a culturally appropriate way. I will advance public health practice and 
knowledge in the field by being the first (to my knowledge) to test the relationships 
between HPV vaccine uptake and certain social determinant variables at the county level.  
Expanding HPV vaccine research beyond the individual. Despite an 
understanding among the public health community that multiple levels of determinants 
influence HPV vaccine uptake, the bulk of intervention research for HPV vaccination has 
focused on the individual level, particularly with constructs including belief, knowledge, 
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and attitudes of parents and adolescents. While these constructs do play a role in parental 
willingness to vaccinate, awareness of the vaccine is near saturation after a decade on the 
market, and changes in knowledge and awareness are reported to be insufficient to 
increase receipt of the vaccine (Joseph et al., 2016; Rahman et al., 2015; Wilson et al., 
2016). Joseph et al. (2016) suggested that even among hard-to-reach populations with 
limited knowledge of the vaccine, intention to vaccinate is high. Future research efforts 
will benefit from inclusion of structural and interpersonal variables alongside individual 
factors (Galbraith et al., 2016; Joseph et al., 2016). 
Structural and interpersonal variables influencing differences in HPV vaccine 
initiation and completion are reported to include school vaccine requirements; vaccine 
policy implementation; physician recommendations; physician decision-making 
processes; national, regional, and local partnerships funding HPV vaccine work; 
immunization information systems; technical assistance and funding by CDC; and 
clinical quality improvement strategies (Elam-Evans et al., 2014; Reagan-Steiner et al., 
2015; 2016). Jeudin et al. (2014), Perkins (2016), and Rahman et al. (2015) have refined 
these suggestions and focused on physician recommendation as one of the most critical 
factors to influence HPV vaccine uptake. The following discussion reviews potential 
causes and implications of physician recommendation. 
HPV Vaccination and Physician Recommendation 
In reviews of the past decade of HPV vaccine research, Gilkey and McRee (2016) 
and others have suggested that a physician’s recommendation is one of the most 
significant and strongest predictors of HPV vaccine uptake across sociodemographic 
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categories (Hswen et al., 2017; Mohammed et al., 2016; Perkins, 2016). Despite a strong 
consensus that physician recommendation significantly increases HPV vaccine uptake 
across racial and ethnic minority background, socioeconomic status, and other variables, 
there are few links between research, theory, and practice. Specifically, a minority of 
studies comprehensively address the most documented factors influencing physician 
recommendation of HPV vaccine: provider factors, audience, and message content 
(Gilkey, Malo, Shah, Hall, & Brewer, 2015; Gilkey & McRee, 2016). Two additional 
factors, guidelines and policy, will be discussed later. As physician recommendation is so 
strongly correlated with vaccine initiation and completion, I will test this as an 
independent variable in my research.  
Physician recommendation rates for adolescents have increased overall in the 
years since the vaccine has been available, from fewer than 50% of female adolescents 
ages 13 to 17 receiving a recommendation in 2008 to nearly 66% of females in 2014. 
(Burdette et al., 2017). The increase in recommendations has accompanied a concurrent 
increase in HPV vaccinations, but Burdette et al. (2017), Hswen et al. (2017), and others 
have challenged the idea that the increase in recommendation has been solely responsible 
for vaccination rates. The authors also maintained that physicians do not consistently 
recommend the vaccine across gender, racial and ethnic minorities, or age groups (Jeudin 
et al., 2014; Perkins et al., 2016; Rahman et al., 2015; Ylitalo, Lee, & Mehta, 2013). 
Zimet (2015) contended that years of reports from parents corroborate these claims, as 
parents noted lack of physician recommendation, or a weak or ambivalent 
recommendation, as among the most important reasons to delay or refuse vaccination. As 
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the drivers behind this inconsistency are multifaceted, the nominal measurement of 
physician recommendation in NIS-Teen survey restricts any assessment of causal 
determinants in the decision-making process.   
Gilkey et al. (2015) argued that physicians do not consistently adhere to or 
implement evidence-based strategies to increase vaccination among patients, with 
physicians citing barriers in interpersonal, clinical, and political environments to 
recommendation. Gilkey and McRee (2016), Hswen et al. (2017), Mohammed et al. 
(2016), and others suggested that interpretation of physician recommendation data from 
NIS-Teen include the context of these environments. As several of the factors in these 
environments are reflected in the theoretical underpinnings of this research, I will briefly 
describe how provider-, audience-, and message-level factors influence physician 
recommendation of the HPV vaccine. 
Providers. Pediatricians are reported to have the highest recommendation rates, 
likely due to more favorable attitudes toward and routine administration of childhood 
vaccines. Building on the general consensus in the literature, Gilkey et al. (2015) found 
that family physicians had second-highest recommendation rates, followed by 
gynecologists and internists (Berkowitz, Malone, Rodriguez, & Saraiya, 2015; Dempsey 
et al., 2015). Current surveys such as NIS-Teen include only pediatricians, general and 
family practitioners, OB/GYNs, and internists in their sample (CDC et al., 2015, 2016; 
Gilkey et al., 2016). Osazuwa-Peters et al. (2016) has argued that dentists should be 
included in HPV vaccine interventions, given the growing rates of oropharyngeal cancer 
and dentists’ yearly visits with children and adolescents. Limited data exist for 
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recommendation rates among dentists, however, so I will exclude them from this 
discussion of provider factors. 
Across qualitative, quantitative, and mixed methods approaches with physician, 
parent, and adolescent samples, researchers have observed consistent and significant 
inverse relationship between HPV vaccine recommendation and provider factors: 
physician comfort discussing sexuality; physician perception of parental hesitation; 
physician self-efficacy of discussing HPV vaccination; and physician assessment of an 
adolescent’s risk of infection. As discussed in a review by Gilkey and McRee (2016), 
data reported on the association between knowledge of the HPV vaccine and 
recommendation were mixed; no data were observed that supported a correlation between 
perceptions of vaccine safety and recommendation, likely due to relatively less common 
concerns about vaccine safety among physicians. These data are not collected in NIS-
Teen but provide important context for interpretation and suggestions for future research. 
Whether by direct admission from physicians or through indirect analyses of 
physician knowledge and beliefs, physicians have limited ability to accurately assess risk 
of infection and sexual activity among their adolescent patients, and reportedly 
overestimate parental concern about the vaccine (Dempsey, Gebremariam, Koutsky, & 
Manhart, 2008; Gilkey et al., 2015; Healy, Montesinos, & Middleman, 2014; Kepka, 
Berkowitz, Yabroff, Roland, & Saraiya, 2012). Such risk-based strategies reportedly have 
not been effective, given the ubiquity of HPV in the population, and researchers have 
suggested these strategies are counter to guidelines and the self-reported expectations of 
adolescents and parents (Alexander et al., 2014; Alexander et al., 2016; Gilkey & McRee, 
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2016; Zimet, 2015). These strategies are directly linked to the behavioral economics 
construct of stereotype heuristics, as described in Frank (2004), in which physicians make 
decisions based on limited or erroneous information. 
Although physicians reported feeling competent in taking a patient’s sexual 
history, they have expressed discomfort and lack of self-confidence in discussing sex and 
sexuality (Alexander et al., 2014; Alexander et al., 2016; Bynum et al., 2014; Fuzzell, 
Fedesco, Alexander, Fortenberry, & Shields, 2016). This reported discomfort is not new; 
Alexander et al. (2016) and Merzel et al. (2004) argued that even prior to the launch of 
the HPV vaccine, physicians discussed sex and sexuality less often than what guidelines 
from professional organizations recommended. When sex and sexuality are discussed 
during patient visits, Alexander et al. (2014) and (2016) observed that conversations 
tended to be short, vary widely in content, and omit key education on topics including 
sexually transmitted infections. The lack of consistent opportunity for adolescents to 
discuss questions and concerns about sex, sexuality, and behavior is a missed opportunity 
for the physician to engage with the patient on healthy behaviors including HPV 
vaccination. Although not captured in NIS-Teen, understanding these provider factors 
can inform interpretation of physician recommendation. However, additional contexts in 
which these communications take place may facilitate or hamper an effective interaction 
with a patient. One is audience, the other is the message. 
Audience. Disparities in HPV vaccine recommendation – in which minority 
parents and adolescents receive recommendations less often than non-Hispanic Whites – 
have been observed across national datasets, statewide vaccine registries, managed care 
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databases, qualitative and quantitative approaches, longitudinally and in single-timepoint 
studies (Gilkey & McRee, 2016; Jeudin et al., 2014; Kepka, Balch, Warner, & Spigarelli, 
2015; Mohammed et al., 2016; Rahman et al., 2015; Ylitalo et al., 2013). 
As discussed in Mohammed et al. (2016), recommendation rates are reportedly 
lower among populations living below the poverty level; mothers with less than a high 
school education; living in the South; and no well-child or preventive visits with a 
physician in the prior 12 months. Even among adolescents who are adherent with well-
child visits, physicians reportedly are not consistently recommending the vaccine, so 
adolescents who do not have a usual source of care are at even greater risk of a missed 
opportunity for vaccine recommendation if the only physician interaction is with acute 
care (Ford et al., 2016; Gilkey & McRee, 2016; Vadaparampil et al., 2011). In addition, 
family physicians and internists, who are less likely than pediatricians to recommend the 
HPV vaccine, tend to be the sole providers in rural or low socioeconomic areas. These 
observations helped refine my selection of independent variables among the data 
collected in NIS-Teen. 
Gilkey and McRee (2016) and others showed that physicians cite low self-
confidence in influencing parental decision-making with vaccines through 
recommendation. Aragones, Genoff, Gonzalez, Shuk, and Gany (2016) argued that these 
concerns are unfounded, and showed that parents ranked physician recommendation as 
one of the strongest factors in their decision to initiate, delay, or refuse the vaccine. This 
argument expanded on observations by Bhatta and Phillips (2015) and Maurer, Harris, 
and Uscher-Pines (2014), who found that parents are significantly more likely to trust and 
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follow a physician’s advice about vaccination, whether the recommendation is for a 
yearly influenza shot or the HPV vaccine. The authors maintained that levels of trust are 
even higher among parents of racial and ethnic minority and low socioeconomic 
populations. This discordance in trust – a behavioral economics construct – between a 
physician’s lack of confidence in his or her capabilities and a parent’s trust of the 
physician’s advice is a significant barrier that has not yet been addressed in research or 
practice (Polonijo et al., 2016). Although outside the scope of this research, these data 
link to behavioral economics, a theory underpinning this research. For example, 
physicians have been reported to be influenced by biases such as omission (the potential 
for harm to a relationship is worse if a physician discusses HPV vaccination, versus not 
initiating a conversation), impact (physicians inaccurately estimate emotional states of 
parents), and availability (physicians inaccurately estimate the likelihood of a parent 
pushing back on a recommendation, or their own ability to convince a parent, based on 
recall rather than evidence).   
In addition to disparities by racial and ethnic minority background, 
recommendation rates reportedly vary significantly by age of the patient (see Table 7). 
Vadaparampil et al. (2016) and others have found that few physicians, even pediatricians, 
follow the guidelines to recommend the HPV vaccine at age 11 to 12 years, despite data 
supporting stronger vaccine efficacy when given at this age (Elam-Evans et al., 2014; 
Reagan-Steiner et al., 2016; Vadaparampil et al., 2011; Vadaparampil et al., 2014). The 
delay in vaccine initiation may reduce vaccine effectiveness as well as the likelihood of 
series completion. Although I cannot assign causality to variables in my study, I will 
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consider age independently, as controlling for this variable would obscure the 
demonstrated differences in physician recommendation. 
Table 7 
 
HPV Vaccine Coverage (1 dose) among Females, by Age at NIS-Teen Interview 
Year 
 
13 
 
14 15 16 17 All Ages 
2013 50.6% 55.1% 58.8%  60.0% 62.3% 57.3% 
2015 56.4% 61.2%  62.7% 63.0% 70.6% 62.8% 
 
Note. Adapted from Elam-Evans et al. (2014; 2013 data) and Reagan-Steiner et al. (2016; 
2015 data). ≥1 dose indicates HPV vaccine initiation. 2014 data by age not provided; 
total all females ≥1 dose in 2014 was 60% (Reagan-Steiner et al., 2016). 
 
As noted in the discussion above, physicians have been reported to express 
discomfort discussing sex and sexuality, especially as parents and physicians assume 
adolescents are not sexually active at such an early age, and in the first few years of the 
vaccine’s availability reportedly had concerns that the vaccine may encourage sexual 
behavior (Vadaparampil et al., 2016). However, consistent, replicated quantitative, 
qualitative, longitudinal, and single time point studies using data from schools and 
universities, population-based datasets, and medical and insurance databases in countries 
around the world have shown that there is no evidence of risky sexual behavior (such as 
decreased contraceptive use), age of sexual debut, number of partners, or increased STI 
diagnoses after HPV vaccination (Hansen et al., 2014; Kasting, Shapiro, Rosberger, 
Kahn, & Zimet, 2016; Madhivanan et al., 2016; Mullins et al., 2016; Smith, Kaufman, 
Strumpf, & Levesque, 2015). Of note, many researchers observed an increase in 
protective behaviors when engaging in sexual activity after HPV vaccination, although to 
date, there have not been studies published addressing the drivers behind this observation 
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(Mullins et al., 2016). Based on the preponderance of evidence, I will not consider 
concern about increased sexual behavior as a driver of vaccine recommendation 
hesitation. 
Given the reported importance of physician recommendation and the high level of 
intent to vaccinate among racial and ethnic minority populations, the inconsistent rate of 
physician recommendation in these populations should be of great concern to public 
health practitioners and physicians (Jeudin et al., 2014; Kepka et al., 2015; Perkins, 2016; 
Rahman et al., 2015; Ylitalo et al., 2013). I will test physician recommendation as a 
dependent variable in relation to social vulnerability (pending an appropriate sample 
size). By doing so, I may provide researchers with knowledge on potential determinants 
of recommendation trends as well as confirm relationships with HPV vaccination.  
Message. Researchers have observed in recent years that the who and what in the 
context of a recommendation plays a large role in vaccine uptake, in addition to whether 
a recommendation is given (Caskey, Andes, & Walton, 2016; Darden & Jacobson, 2014; 
Ford et al., 2016; Gilkey et al., 2016; Gilkey & McRee, 2016; Moss, Gilkey, Rimer, & 
Brewer, 2016; Perkins, 2016; Shay et al., 2016).  
Tdap and MCV vaccines, launched within the same year as HPV, are at or above 
herd immunity levels and Healthy People 2020 goals (see Table 1) (Moss et al., 2016). 
Darden and Jacobson (2014), Moss et al. (2016) and others have found that rather than 
presenting the HPV vaccine as routine and required, some physicians presented the HPV 
vaccine separately from other required adolescent vaccines, and reportedly used language 
encouraging parents to question the need for the vaccine (Caskey et al., 2016; Gilkey & 
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McRee, 2016; Perkins, 2016). This approach, the authors suggested, conveyed a sense of 
physician ambiguity about the vaccine, and framed the vaccine as optional rather than 
routine or required–creating an environment in which some parents delayed or refused 
vaccination. For example, Shay et al. (2016) observed that Hispanics and Non-Hispanic 
Blacks were more resistant to vaccination when the physician used a participatory style 
for the HPV vaccine, encouraging questions, versus those whose physicians used a 
presumptive style. These observations may in part explain why initiation and completion 
are not the same within or across racial and ethnic and socioeconomic subgroups, and I 
will include these considerations in my interpretation of this study’s findings. 
Health Policy and Professional Guidelines 
Medical organization guidelines tend to reflect best evidence-based practice for 
health care providers, but in most instances, lack the compulsion of policy; health care 
policies may not reflect the latest scientific evidence, and may be weakened by broad 
language or provisions (Camargo & Grant, 2015; Descourouez & Hayney, 2013; Omer, 
Richards, Ward, & Bednarczyk, 2012). Without clear, specific guidelines and policies, 
health care providers may interpret or implement language differently and not adopt best 
practices for their patients (Camargo & Grant, 2015). Both guidelines and policy are 
developed using scientific data, and some guidelines dictate clinical practice. For 
example, guidelines published by the National Comprehensive Cancer Network are 
typically used to update treatment algorithms and determine insurance coverage for 
oncology drugs (NCCN, 2017). I will briefly discuss guidelines for HPV vaccination to 
provide context into professional pressure for physicians regarding vaccination. 
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Guidelines. Hswen et al. (2017) and others have shown that nearly half of family 
physicians and pediatricians surveyed have cited professional organizations as their 
preferred source of information. Researchers also found that surveyed physicians who 
reportedly perceived such organizations as influential were more likely to recommend the 
HPV vaccine to patients (Bynum, Malo, Lee, Guiliano, & Vadaparampil, 2011; Gilkey & 
McRee, 2016; Scherr, Augusto, Ali, Malo, & Vadaparampil, 2016). As outlined by 
Saslow et al. (2016) and others, a number of professional organizations support ACIP’s 
guidelines on strong, consistent recommendations for the HPV vaccine and ask their 
members to follow these guidelines (Bailey et al., 2016; IPVS, 2016; Kulczycki et al., 
2016):  
• American Academy of Family Physicians 
• American Academy of Pediatrics 
• American Cancer Society 
• American College of Obstetrics and Gynecology 
• American College of Physicians 
• American Dental Association 
• American Head and Neck Society 
• American Nurses Association 
• American Pharmacists Association 
• American Society of Clinical Oncology 
• Association of Immunization Managers 
• International Papillomavirus Society  
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• Society of Adolescent Medicine 
• Society of Gynecologic Oncology 
 
Physician practices do not always align with professional guidelines, however. 
For example, Kulczycki et al. (2016) observed that many family physicians and 
pediatricians do not follow evidence-based recommendations regarding HPV vaccination, 
particularly among adolescents 11 years to 12 years old. Using the same American 
Medical Association database, Malo, Perkins, Lee, and Vadaparampil (2016a) showed 
that some family physicians, pediatricians, and obstetrician/gynecologists use HPV and 
Pap test results as a pre-vaccination assessment for eligibility, contrary to evidence-based 
guidelines. These findings suggest that despite expert recommendations, physicians only 
moderately adhere to HPV vaccine guidelines (Malo et al., 2016a). While guidelines can 
and do play a role in daily practice decisions, they may not have the same power to 
compel physician behavior as policies. 
In addition to the lack of full adherence to guidelines, Vadaparampil et al. (2016) 
and many others have demonstrated that a majority of physicians do not use tools 
developed by national organizations and agencies such as the CDC to facilitate adoption 
of best practices (Askelson et al., 2016; Berkowitz, Nair, & Saraiya, 2016; Roland, 
Benard, Greek, Hawkins, & Saraiya, 2014; Scherr et al., 2016). For example, Askelson et 
al. (2016) and others have described the numerous evidence-based strategies for health 
care providers published by the CDC and Guide to Community Preventive Service to 
improve vaccination coverage (Dempsey et al., 2015; Community Preventive Services 
Task Force, 2015): 
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• Implementation of an Immunization Information System for state-wide 
access to patient records 
• Parent reminders and recalls when immunizations and well-child visits for 
11 to 12 year olds are due or overdue 
• Provider reminders and recalls in electronic or paper records when 
immunizations are due or overdue 
• Standing orders for non-physician health care providers – pharmacists, 
obstetrician/gynecologists, nurses, medical assistants – to provide 
education and vaccination services  
• Participation in Vaccines for Children program to reduce cost of the HPV 
vaccine series 
• Reduce or eliminate clinic wait times for vaccination, such as instituting 
walk-in immunizations for second and third doses 
• Partner with community organizations and services including schools as 
alternate immunization service locations 
• Bundle the HPV vaccine with other routine, recommended adolescent 
vaccines 
 
Askelson et al. (2016) reported that few clinics have reminder / recall processes in 
place for parents or physicians or standing orders for other health care providers to 
vaccinate adolescents, yet found that clinic managers most frequently cited parents 
forgetting to bring their adolescents in to complete the series as the biggest barrier to 
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HPV vaccine initiation and completion. Askelson et al. (2016) and others found that 
another barrier named by providers was the lack of opportunity to vaccinate adolescents, 
as these patients reportedly did not visit the clinic regularly (Gilkey & McRee, 2016; 
Kulczycki et al., 2016). However, rates for other adolescent vaccines are near or above 
90% per guidelines and policies (see Table 1), suggesting that other factors beyond 
guidelines have a stronger influence specifically on HPV vaccination (see HPV 
Vaccination and Physician Recommendation) (Askelson et al., 2016; Gilkey & McRee, 
2016; Kulczycki et al., 2016). Based on these observations, my interpretation of 
physician recommendation data will be applicable to HPV vaccines only, rather than 
immunization in general. 
Policy. Public health policy is one of the most effective ways to protect 
population health, as evidenced by seat belt use, tobacco control, or immunizations (Calo, 
Gilkey, Shah, Moss, & Brewer, 2016; Hawkes, Kismödi, Larson, & Buse, 2014; Mello et 
al., 2013). Policy, however, is often not considered as a means to changing population 
health: 
Law remains an underutilized resource in public health. … Some interventions 
require new law, whereas others simply require stronger or more creative use of 
existing authority. At the same time, some laws with unintended adverse effects 
have not been amended, clarified, or repealed. (Mello et al., 2013, p. 1979) 
Carey and Crammond (2015) and Embrett and Randall (2014) argued that 
policymaking does not follow a rational process, in which knowledge is transferred and 
policy is changed; nor does it move quickly or adopt the latest science. For example, 
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current HPV vaccine policies do not reflect oropharyngeal cancer rates and the role of 
HPV in the disease, how HPV is transmitted, views of adolescents receiving the vaccine, 
or recent vaccine efficacy and safety data (Osazuwa-Peters, 2013; Parrella et al., 2016).  
Knight, Benjamin, and Yanich (2016) and others suggested that policy cannot be 
separated from politics, and the political environment is especially important when 
considering health issues traditionally associated with individual behaviors such as 
smoking, obesity, or sexually transmitted infections (Abiola et al., 2013; Hawkes et al., 
2014). Policymaking is a complex effort in which competing priorities, short attention 
spans, and capacity for action mix with evidence, expert testimony, and values of those in 
power (Carey & Crammond, 2015; Embrett & Randall, 2014; Knight, Benjamin, & 
Yanich, 2016; Lillvis, Kirkland, & Frick, 2014; Moreland-Russel et al., 2015; 
Speybroeck, Harper, de Savigny, & Victora, 2012). Knight et al. (2016) stated that most 
efforts in health policy are focused on medical solutions to health care, rather than social 
determinants of health and preventive measures. Carey and Crammond (2015) suggested 
that this may in part be due to policymakers’ reported unfamiliarity with the importance 
of social determinants of health, and public health advocates’ analogous “out of touch” 
perceptions of the policymaking process. HPV vaccine policy is an excellent example of 
this disconnect, in which policymakers have been observed to support policies not based 
on evidence and best practices, and public health advocates have reportedly not engaged 
the political process in an efficient way to promote health (Carey & Crammond, Knight 
et al., 2016).  
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States introduced and passed a number of policies after the HPV vaccine came to 
market, but with a few exceptions focused solely on increasing education to parents and 
adolescents, providing funding, and adjusting private insurance coverage for the vaccine 
(Brandt et al., 2016; Laugesen et al., 2014). However, education policies reportedly have 
had little if any return on investment; for example, Moghtaderi and Adams (2016) found 
that vaccination rates in states with education policies were not significantly different 
from states with no education policies. The authors argued that this finding may in large 
part be due to the lack of evidence that parents access and understand educational 
materials, and school districts are not required to include information about HPV in the 
curriculum. 
In contrast to education policies, Durham et al. (2016) observed that funding and 
coverage policies had significantly improved HPV vaccination rates, albeit inconsistently 
across states. Although the United States does not have a national vaccination program, 
Brandt et al. (2016) stated that the federal government does fund some immunizations 
through the Vaccines for Children program for un- or under-insured, Medicaid-eligible, 
or American Indian / Alaska Native children up to 18 years old, but states have the final 
say on who qualifies. Of the states and jurisdictions with expanded coverage and 
supplemental resources from the CDC’s Prevention Public Health Fund and national 
organizations, Durham et al. (2016) concluded that these areas had higher rates of 
vaccination compared with those that did not. However, given the extended latency 
period between exposure and HPV-associated cancer and the prevalence of interstate 
travel, states may not capture the true benefit of their policies (Durham et al., 2016).  
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School-entry mandates. Perkins et al. (2016) and others have claimed that the two 
most potent and polarizing policy options to influence vaccination rates are school-entry 
mandates and exemptions (Brandt et al., 2014; Califano, Calo, Weinberger, Gilkey, & 
Brewer, 2016; Calo et al., 2016). Both the state legislature and state health agency have 
the power to require vaccines for school entry, but the legislature must allocate funds for 
the logistics in implementing the mandate, and the vaccine must meet several criteria to 
be considered for mandated status (Calo et al., 2016; Perkins, Lin, Wallington, & 
Hanchate, 2016). Perkins et al. (2016) concluded that the HPV vaccine meets most 
criteria: ACIP recommendation; proven efficacy, safety, cost-effectiveness; reduction of 
transmission risk; prevention of significant morbidity and mortality related to the disease; 
and reasonable burdens on parents and adolescents to comply with the mandate. Perkins 
et al. (2016) contended that HPV vaccine does not meet the two remaining criteria: the 
potential administrative burden on schools and health care providers may be considered 
unreasonable given low vaccination rates and disjointed immunization infrastructure; and 
vaccine acceptability to the community and the public is not uniformly positive.  
For example, researchers have found low to moderate support among parental and 
physicians for a school-entry mandate if religious, personal, or philosophical exemptions 
are not allowed (Brandt et al., 2016; Califano et al., 2016; Calo et al., 2016; Horn, 
Howard, Waller, & Ferris, 2010; Perkins et al., 2016; Robitz et al., 2011). If these 
exemptions are allowed alongside school-entry mandates, the level of support increases 
significantly. Calo et al. (2016) found that parents’ willingness to accept a mandate 
increased from 21% to 57%. The authors reported that parents had several reasons for 
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opposing a mandate, including infringement of their autonomy in making decisions for 
their children and the perception from physician interactions that the HPV vaccine is 
optional. In this study, Calo et al. (2016) observed that parents of racial and ethnic 
minority background and lower socioeconomic status had slightly higher approval ratings 
of a school entry mandate, compared with non-Hispanic White, higher socioeconomic 
parents. Separately, Califano et al. (2016) showed that physicians’ support increased from 
47% to 74%. Despite this strong support from physicians, and considering nearly 90% of 
pediatricians and family physicians believe delaying vaccination is risky for adolescents, 
Califano et al. (2016) reported that just over 70% of physicians were willing to 
accommodate parents’ wishes in order to build trust.  
Although several states have attempted to pass legislation requiring the HPV 
vaccine for school entry, currently the HPV vaccine is mandated only in two states and 
one jurisdiction (Barraza, Weidenaar, Campos-Outcalt, & Yang, 2016; Brandt et al., 
2016; Lemons, 2016; Perkins et al., 2016). As of 2008, girls in Virginia must initiate the 
vaccine prior to entering sixth grade; as of 2009, girls and boys in the District of 
Columbia must initiate the vaccine at 11 years old and prior to entering the sixth grade; 
and as of 2015, girls and boys in Rhode Island must initiate the first dose prior to entering 
seventh grade and complete the series prior to entering ninth grade (Barraza et al., 2016; 
Brandt et al., 2016; Calo et al., 2016; Lemons, 2016; Perkins et al., 2016). Virginia and 
D.C. passed the mandate through the legislative process, while Rhode Island used the 
Department of Health’s authority to require vaccination for school entry (Barraza et al., 
2016). Since October 1, 2017, only New York has proposed legislation in the 2017 
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session requiring HPV vaccination for all children entering seventh grade (S.B. 132, A.B. 
933, 2017). Although outside the scope of this research, it will be important for future 
scholars to consider the political context in which physicians must operate in each of the 
select local areas in the results discussion.  
HPV Vaccination: Theoretical Considerations 
Glanz et al. (2015) noted that theory and practice are not diametrically opposed, 
but inform each other and provide a foundation for transforming data and experience into 
evidence-based interventions. For particularly complex issues, such as HPV vaccination, 
theories and practices must reflect the milieu in which vaccination decisions are made 
(Ferrer et al., 2015). However, as Ferrer et al. (2015) outlined in a systemic review, the 
most frequently cited theories in HPV literature are individual, rational models such as 
the theory of planned behavior and the health belief model. The authors reported that 
fewer than half of reviewed interventions based on individual-level theory were effective 
or sustainable, with determinants varying widely across populations. Ferrer et al. (2015) 
argued that these interventions could not account for interactions among individuals and 
their environments, or for scenarios in which people do not make decisions and behave in 
a rational manner. The following two models, fundamental cause theory and behavioral 
economics, address each of these shortcomings in the individual, rational models. I will 
use these theories as the lens through which I will interpret the data, focusing on the 
importance of considering systemic variables and the irrational players that make up 
these systems. 
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Fundamental cause theory. Link and Phelan (1995) developed the fundamental 
cause theory during the time period in which epidemiologists could not explain why 
elimination of risk factors for certain diseases did not reduce inequalities in morbidity 
and mortality, and in some instances, gave rise to new risk factors. In the first iteration of 
the FCT, Link and Phelan (1995) observed that a relationship between socioeconomic 
status and mortality persists in modifiable risk factors and disease outcomes despite, and 
sometimes as a result of, advances in knowledge and treatment (Phelan et al., 2010). 
Clouston, Rubin, Phelan, and Link (2016) maintained that in the two decades since its 
introduction, FCT has been tested and refined, with its constructs applied across 
conditions including HIV, cardiovascular disease, a number of cancers, suicides, kidney 
infections, diabetes, multiple sclerosis, tuberculosis, polio, and others.  
Øversveen, Rydland, Bambra, and Eikemo (2017) contended that in developing 
the FCT, Link and Phelan introduced the importance of fundamental or root causes, or 
the “risk of being at risk,” focusing on upstream social determinants and the complex 
interactions leading to health outcomes. Phelan et al. (2010) defined a cause as 
fundamental if it gives rise to multiple diseases, affects disease outcomes through 
multiple risk factors, involves access to flexible resources, and persists over time. As 
reviewed in Mackenbach (2017) and others, access to flexible resources is a unique and 
key component of the FCT, and encompasses a person’s access to money, knowledge, 
power, prestige, and social connections (Goldberg, 2014; Polonijo & Carpiano, 2013). 
Clouston et al. (2016) and Mackenbach (2017) argued that if access to such resources is 
unequal, the benefits of any innovation in technology or knowledge will be distributed 
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unequally; thus, the capacity to avoid risks or minimize consequences of a disease will be 
unequal and give rise to social inequalities in health and health outcomes. Polonijo and 
Carpiano (2013) maintained that the HPV vaccine may act as an empirical test of the 
FCT, as the fundamental causes behind HPV-related morbidity and mortality give rise to 
other diseases, HPV vaccines are the result of an innovation in cancer knowledge, the 
vaccines themselves are innovations in preventive care, and significant disparities exist in 
HPV vaccine uptake.  
Two well-researched fundamental causes of HPV vaccine rates and other diseases 
are low socioeconomic and racial and ethnic minority status (Goldberg, 2014; Phelan et 
al., 2010). When an innovation or improvement occurs, a new mechanism appears in 
which an individual’s health outcome will change disproportionately with their income 
level or racial and ethnic minority status (Øversveen et al., 2017; Polonijo & Carpiano, 
2013). Øversveen et al. (2017) stated that as long as the structural and social determinants 
of a population remain stable, inequalities in health based on root causes will persist. 
Similarly, Goldberg (2014) noted that targeting only proximal risk factors, as in the risk-
reduction model practiced in medicine, will be ineffective in addressing health disparities 
as the risk factors arise from the underlying structural and social determinants of disease. 
For example, during infectious diseases outbreaks in the mid-1800s, wealthy 
Americans had resources to flee their cities or prevent entry of infected people into their 
neighborhoods; as public health efforts in the 1900s improved structural determinants 
such as sanitation and hygiene standards – indoor plumbing, chlorination of drinking 
water, animal and pest control, universal vaccination, and improved housing conditions – 
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the socioeconomic gradient disappeared and many of these diseases were eradicated 
(CDC, 1999; Phelan et al., 2010). Expanding on these ideas, Epstein (2017) claimed that 
these innovations in public health played a significant role in reducing inequalities long 
before modern medical interventions.  
In contrast, Viens et al. (2016) and others asserted that despite the introduction of 
the innovative Pap screening test for cervical cancer nearly 70 years ago, disparities in 
cervical cancer screening, incidence, and mortality by SES and racial and ethnic minority 
status persist today (Malagón, Drolet, Boily, Laprise, & Brisson, 2015; Phelan et al., 
2010; Polonijo & Carpiano, 2013). Efforts to increase access to resources such as health 
insurance and screening programs for cervical cancer, which is highly preventable, have 
not mitigated disparities in outcomes – even in countries such as England and Canada, 
where universal safety nets are designed to reduce such inequalities (Phelan et al., 2010; 
Polonijo & Carpiano, 2013). Based on these examples, I agree with Polonijo and 
Carpiano (2013) that HPV vaccination could be an appropriate test of FCT, and will 
discuss this idea in the context of future directions based on my findings. 
For example, Phelan et al. (2010) predicted that, as alluded to in the FCT, 
disparities will persist and new mechanisms will arise as individual risk factors for 
cervical cancer change if the underlying structural population issues are not addressed. 
An effective intervention such as a vaccine to prevent cervical cancer may reduce or 
eliminate disparities in the population if administered universally, but researchers have 
shown a strong gradient for physician recommendation of vaccination along racial and 
ethnic minority and socioeconomic status lines (Jokinen-Gordon, 2014; Polonijo & 
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Carpiano, 2013). Therefore, through the lens of the FCT, disparities in HPV-associated 
cancer rates will persist as long as researchers focus on individual behaviors or isolated 
risk factors, such as cost of the vaccine (Polonijo & Carpiano, 2013). In my study, I will 
test relationships among variables on multiple levels in order to provide potential targets 
for future fundamental cause research in HPV vaccination. 
While the assumptions of the FCT are generally borne out in studies, Øversveen 
et al. (2017) and others have noted some limitations of the theory’s application to 
practice, including the temporal nature of rising and declining mechanisms of 
inequalities; the difficulty in conducting systemic research; and the definition of variables 
and at-risk populations (Clouston et al., 2016; Goldberg et al., 2014; Mackenbach, 2017; 
Phelan et al., 2010). 
For example, Clouston et al. (2016) used FCT to link the control of preventable 
disease with development of social inequalities, suggesting that the time period in which 
inequality mechanisms rise, stabilize, and decline may vary. The authors proposed adding 
a four-stage temporal component to the FCT: (a) natural mortality of a disease, prior to 
any knowledge or capacity to control disease; (b) increasing inequalities, in which 
innovations and resources are diffused unequally; (c) reducing inequalities, perhaps 
through increased access to health knowledge and resources; and (d) reduced mortality, 
in which prevention and treatment resources are universally available. Clouston et al. 
(2016) contended that the time spent in each stage will vary by disease type, risk factors, 
the innovation, and the underlying social, economic, and political structures. In the case 
of HPV infection and vaccination, the underlying mechanisms are multifaceted, and thus 
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the time to equitable vaccine uptake and reduced mortality may be longer than other 
infectious disease scenarios (Clouston et al., 2016). Any reductions in mortality due to 
HPV vaccination will not be detected for decades, given the long latency period between 
infection and cancer, so I will focus my analysis only on the factors related to HPV 
vaccine initiation and completion.  
Regarding the difficulty in conducting systemic research, Mackenbach (2017) and 
others suggested that upstream interventions may result in more equitable outcomes than 
individual downstream interventions by changing underlying power structures that 
contribute to inequity, but are less feasible to conduct and may face stronger opposition 
by those in power (Golden, McLeroy, Green, Earp, & Lieberman, 2015). Mackenbach 
(2017) and Golden et al. (2015) stated that most research conducted, even on 
organizational or political levels, is done with individual behavior change as an end goal; 
while less efficient and sustainable, individual and interpersonal variables and 
relationships tend to be more easily defined and the results more immediate and tangible.  
For example, socioeconomic status is a multi-faceted, dynamic measure that 
would require changes to education, employment, and wage; nested within each of these 
metrics are issues surrounding transportation, nutrition, perinatal care, childhood 
development, safe housing, and many more ancillary variables that contribute to the 
capacity of an individual to learn, work, and earn a living wage (Joshua, Zwi, Moran, & 
White, 2015; Mechanic & Tanner, 2007). Researchers may have limited ability to 
identify the true causes of persistent unequal distribution of resources, but by using 
known and suspected fundamental cause variables, they may be able to test potential 
66 
 
relationships on many levels (Øversveen et al., 2017). How these variables are defined, 
however, can change the statistical analyses and interpretation of findings (Ratnapradipa, 
McDaniel, & Barger, 2017; Willis & Fitton, 2016). Given the importance of social 
determinants of health in the FCT and inequalities in HPV vaccine uptake specifically, 
and my use of social vulnerability as a variable in this study, a brief discussion of how 
social vulnerability is defined is warranted.  
Social vulnerability. Ratnapradipa et al. (2017) argued that determinants of 
vulnerability and exposure to risk factors are multifaceted and evolving, and direct 
measurement may not be possible. The Institute of Medicine and the National Research 
Council (2011) claimed that there is no universal consensus on how to determine 
vulnerability; for convenience, most assessments use symptoms of vulnerability such as 
poverty or low educational attainment as proxy measures of risk factors or outcomes 
(Joshua et al., 2015). Burnell (2012) suggested that exposure to a risk factor does not 
always equate to vulnerability; for example, while the entire population may have a 
similar likelihood of exposure to an infectious agent such as HPV, not everyone will 
share the same burden of morbidity and mortality. Researchers have found that 
relationships exist between social vulnerability and incidence of Lyme’s Disease, erectile 
dysfunction treatment, physician recommendation in prostate cancer, diabetes, 
acceptance of an oral cholera vaccine, and HIV treatment outcomes (An & Xiang, 2015; 
Grabovschi, Loignon, & Fortin, 2013; Ratnapradipa et al., 2017; Socio-economic 
Inequalities and HIV Working Group, 2017; Sundaram et al., 2016). If not addressed, the 
inequities in systemic structures governing a hierarchy of human value and differential 
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resource allocation will persist horizontally and vertically across generations (Quiroga, 
Medina, & Glick, 2014). 
At a high level, social vulnerability may be defined as the differential capacity of 
an individual or population to anticipate, cope with, resist, and recover from the impact of 
cumulative external stressors (Gallagher et al., 2016; Joshua et al., 2015). Stressors, such 
as determinants in the built, natural, social, economic, and political environments, may be 
difficult to measure, but if identified could be mitigated to maximize the opportunity for 
healthy choices (Ratnapradipa et al., 2017; Willis & Fitton, 2016). The bulk of 
vulnerability literature focuses on mapping vulnerability predictors to protect against 
natural and human-made disasters, but a tool developed by the Agency for Toxic 
Substances and Disease Registry (ATSDR) has the potential for linking social 
vulnerability with HPV vaccination uptake and providing context to the predictors of 
vaccination in the NIS-Teen survey (Gay, Robb, Benson, & White, 2016; Juster et al., 
2016). I will be the first, to my knowledge, to test the relationships between scores from 
the Social Vulnerability Index and HPV vaccine uptake. By using this tool, I may identify 
new variables for future researchers to consider in systemic interventions.  
Social Vulnerability Index. Flanagan et al. (2011) stated that until the mid-2000s, 
disaster management mapping tools focused exclusively on natural and built environment 
hazards at the local and population level. In response to a growing recognition of the 
importance of social vulnerability in outcomes and the need to identify particularly 
vulnerable communities for disaster planning, ATSDR collaborated with the CDC and 
National Center for Environmental Health to create the Social Vulnerability Index (SVI) 
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(ATSDR, 2014; Flanagan et al., 2011). The SVI draws from U.S. Census data and ranks 
each census tract or county on 15 factors contributing to social vulnerability; each tract or 
county is then given a vulnerability score on four different themes (encompassing the 15 
social factors) and an overall vulnerability score (see Section 2 for more details) 
(ATSDR, 2014). The tool was constructed to support resource allocation before, during, 
and after a disaster, but a small number of researchers have recognized the utility in 
linking compounded vulnerability factors and disparities in health care (An & Xiang, 
2015; Grabovschi et al., 2013). To date, researchers have used the tool to assess the level 
of vulnerability with physical fitness and obesity (An & Xiang, 2015; Gay et al., 2016). 
Individuals and populations living in areas of social vulnerability experience 
economic, physical, political, and social barriers to understanding and making healthy 
choices, yet few studies consider multiple barriers simultaneously (An & Xiang, 2015; 
Gay et al., 2016; Grabovschi et al., 2013). Many of these same barriers exist for HPV 
vaccine uptake, such as low socioeconomic and racial and ethnic minority status (see 
Table 8).  
Table 8 
 
Correlating Social Vulnerability Index Themes and Predictors of HPV Vaccine Uptake 
SVI Themes a 
 
Example SVI Variables a 
 
Association with HPV 
Vaccination b 
 
Minority 
Status and 
Language 
Minority Race / Ethnicity 
Speak English “Less than Well” 
Significant and persistent 
relationship among racial and 
ethnic minority status, physician 
recommendation, language, and 
HPV vaccine uptake 
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Household 
Composition 
and Disability 
Aged 17 or Younger 
Single-Parent Households 
Significant relationship between 
age of patient and physician 
recommendation and marital 
status of parent and vaccine 
uptake 
Socioeconomic 
Status 
Below Poverty 
Unemployed 
Income 
No High School Diploma 
Significant and persistent 
relationship among 
socioeconomic status variables, 
HPV vaccine uptake, and 
physician recommendation 
Housing and 
Transportation 
Multi-Unit Structures 
No Vehicle 
Significant difference in HPV 
vaccine uptake by urban versus 
rural location, as well as within 
urban centers 
 
Note. Adapted from Gay et al., 2016. a ATSDR, 2017. b Reagan-Steiner et al., 2016. 
 
The SVI is a useful tool to indicate available flexible resources and understand 
community-level social factors that influence health and health decisions, such as HPV 
vaccination. No researchers testing the relationship between social vulnerability and 
health to date have connected a theoretical perspective to their published research, and to 
my knowledge only five articles to date have examined sociodemographic and 
geographic variation in HPV vaccination (one in a 7-county region, one in the 
Intermountain West region of the United States., and three in the United States overall) 
(Bodson et al., 2017; Grabovschi et al., 2013; Henry et al., 2017; Monnat, Rhubart, & 
Wallington, 2016; Pruitt & Schootman, 2010; Rutten et al., 2017). A small number of 
researchers also have recently published articles looking at geographic factors and HPV 
vaccination (Henry et al., 2016; Tsui et al., 2013). Given the FCT’s emphasis on flexible 
resources, which may be limited in areas of vulnerability, and the need to identify 
fundamental causes to best mitigate disparities in health outcomes, the use of the SVI in 
this research will add context to the quantitative data in the NIS-Teen database.  
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FCT, SVI, and HPV. Few studies have tested the association between multiple 
social variables and predictors of HPV vaccine (Jokinen-Gordon, 2014). By testing 
relationships among known fundamental causes of disease such as socioeconomic status 
and racial and ethnic background, as well as other influences specific to HPV vaccine 
such physician recommendation, this research may help researchers design more 
comprehensive interventions that reduce disparities in vaccine uptake (Schmeler & 
Sturgis, 2016).  
Dovidio and Fiske (2012) asserted that even with access to flexible resources or 
professional commitment to optimizing health, human decision-making is not always 
rational (Phelan et al., 2010; Polonijo & Carpiano, 2013). Mackenbach (2017) and others 
contended that researchers should consider these implicit or cognitive biases that may 
result in irrational behaviors when assessing factors influencing the unequal distribution 
of resources in a free market economy (Arrow, 1963; Dovidio & Fiske, 2012). I will use 
a theory of action describing these behaviors; behavioral economics will complement 
FCT’s theory of the problem in identifying why health disparities exist and how 
interventions should be designed (Glanz et al., 2015). Although testing specific 
components of behavioral economics and HPV vaccine rates is not feasible for this study, 
the theory has been linked to physician decision-making and could provide important 
context for interpreting physician recommendation.  
Behavioral economics. Emanuel et al. (2016), Hoff and Stiglitz (2016), and 
others suggested that standard economic theory and many public health promotion 
programs rely on the assumptions that, given sufficient information about specific choice 
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sets and motivation to act, individuals will make rational decisions to improve their 
circumstances out of self-interest. However, Hansen, Skov, and Skov (2016) and others 
argued that individuals often include seemingly irrelevant factors in their decision-
making processes and are predictably unpredictable, whether making an economic 
decision such as buying a new or used car, or a health decision such as going to the gym 
or sitting on the couch (Dovidio & Fiske, 2012; Hoff & Stiglitz, 2016). As MacLeod 
(2016) noted, “rational choice per se is not required to explain why humans are able to 
perform at such a high level in a wide variety of tasks, while at the same time capable of 
making some really dumb mistakes” (p. 24).  
In addition, behavior change is more than just increasing or decreasing frequency; 
individuals may adopt or reverse behaviors at different rates or need more help than 
others to stabilize behavior change (Bickel et al., 2016; Bickel, Quisenberry, & Snider, 
2016). Frank (2004) and Hansen et al. (2016) asserted that, given the potential for 
irrational decision-making at different rates, health policies and interventions created 
using rational, linear models fall short in bridging the gaps between preferences, 
decision-making, and behavior change. These observations are particularly important 
when interpreting physician behavior, as physicians are expected to be sufficiently 
informed and motivated to act in the best interests of the patient. As described in the HPV 
Vaccination and Physician Recommendation section, however, physicians may 
unconsciously and unintentionally act in their own self-interests (Mohammed et al, 
2016). Understanding the key processes in behavioral economics may help provide 
context to any differences in physician recommendation in this study. 
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Social determinants play a role in physician and patient decisions about health, 
whether through access to flexible resources or influence on cognitive development, 
preferences, and perceptions (Hansen et al., 2016; Hoff & Stiglitz, 2016). Expanding on 
this observation, Alm and Sheffrin (2017) suggested that the way a choice is framed, the 
individual’s cognitive capacity, perceptions of the costs, self-control, social norms, and 
the current environment all play a role in the decision process. Researchers designing 
interventions and advocating for policies, therefore, should take cognitive processes, 
social determinants, and structural factors into account. The theory of behavioral 
economics provides researchers with a conceptual approach to understanding behavioral 
decision-making in light of these important influencers, potentially improving the 
efficiency and efficacy of interventions and policies (Alm & Sheffrin, 2017). 
Behavioral economics (a) allows researchers the opportunity to measure behavior 
change beyond simply increasing or decreasing in frequency; (b) highlights the 
application of learnings across diseases and contexts, much like a fundamental cause; (c) 
uses technology to maximize cost-effectiveness, generalizability, and efficacy of 
interventions; and (d), integrates economic, psychological, and social frameworks to 
inform more real-world programs and policies (Alm & Sheffrin, 2017; Bickel et al., 
2016; Gennetian, Darling, & Aber, 2016). Behavioral economics is both a complement 
and counterpoint to the FCT; the two theories informing this study are used to highlight 
the importance of social determinants and the need to address behavior on multiple levels 
(Link & Phelan, 1995; Bickel et al., 2016).  However, the FCT is often used to identify 
bottom-up causes of disparities, while behavioral economics is often used to identify top-
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down cognitive processes in the context of bottom-up causes and promote behavior 
change (Link & Phelan, 1995; Bickel et al., 2016). A small number of researchers have 
considered HPV vaccination using the FCT or behavioral economics, but no one to my 
knowledge has considered the two theories together.  
Arrow (1963) and Frank (2004) argued that nowhere are these advantages of 
using behavioral economics more closely linked than with physician behavior. Physicians 
may unconsciously and repeatedly make suboptimal choices in the face of clinical 
uncertainty regarding patient response and outcomes (Bickel et al., 2016; Frank, 2004). 
Researchers have found that physicians are creatures of habit and may unconsciously 
work through a number of cognitive processes to make health care decisions (Arrow, 
1963; Bickel et al., 2016; Frank, 2004). Saposnik, Redelmeier, Ruff, and Tobler (2016) 
observed that few studies on cognitive processes that influence physician decisions in 
health care exist, despite the strong link between physician recommendation and HPV 
vaccination. I argue that the dearth of published research on this topic is a missed 
opportunity for researchers designing physician-targeted interventions, and will note in 
my discussion of the results how reporting quantifiable data on physician 
recommendation has limited use for researchers without the context of why physicians 
vary in their recommendations. While collecting these qualitative data is outside the 
scope of my research, I will provide a brief description of key processes cited in 
behavioral economics for context in this later discussion. 
Heuristics. Given time constraints and clinical uncertainty, physicians reportedly 
often rely on heuristics, or rules of thumb to make decisions (Frank, 2004; Shuval et al., 
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2017). The availability heuristic is reliance on a personal memory, a story from a 
colleague, or discussion at a local meeting – in other words, a physician may extrapolate 
the probability of a singular outcome or small number of events to the population, as a 
personal story is more top-of-mind than representative data (Blumenthal-Barby & 
Krieger, 2015). Frank (2004) proposed that this heuristic is in large part responsible as 
one of the two core questions of health economics: what causes persistent geographic 
variation in treatment patterns. The author reported that physicians, whether consciously 
or not, follow the advice of trusted colleagues, even at the expense of using newer or 
evidence-based practices, as these sources are readily available and more personal. The 
availability heuristic is a critical process to consider when assessing physician 
recommendation patterns and designing programs or policies to influence HPV vaccine 
recommendation, as it highlights the importance of intervening at the local level 
(Blumenthal-Barby & Krieger, 2015; Saini et al., 2017). 
As first mentioned in Tversky and Kahneman’s (1975) seminal article on 
heuristics and biases, the stereotype heuristic is a reliance on a physician’s perception of 
how closely the patient resembles another patient based on personal attributes. When the 
resemblance is perceived to be high, then the probability that one patient’s outcomes will 
be similar to another also is perceived to be high (Blumenthal-Barby & Krieger, 2015; 
Frank, 2004; Tversky & Kahneman, 1975). For example, if a physician believes that 
White female adolescents are less likely to engage in sexual activity at a younger age and 
her parents are more likely to challenge the HPV vaccination, the physician will likely 
stereotype the next young White female adolescent patient and delay recommendation. 
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The limited ability of physicians to accurately assess patient and parental needs and 
wishes already has been discussed, and can lead to biases in care that unintentionally 
influence patient outcomes (Frank, 2004). Thus, heuristics may play a role in influencing 
physician recommendation, particularly if this differs by geography. I will test physician 
recommendation by select local areas listed in NIS-Teen. 
Biases. Cognitive bias, or a systematic error in decision-making informed by 
heuristics, leads to the second core question of health economics: what accounts for 
disparities in health care (Blumenthal-Barby & Krieger, 2015; Frank, 2004). Biases are 
not all negative, nor are they all explicit; rather, implicit (unconscious) biases often 
influence physician behavior and impact recommendations and communication with 
patients (Dovidio & Fiske, 2012). In a large, critical review of studies on heuristics and 
biases among health care providers, Blumenthal-Barby and Krieger (2016) found 
confirmation of biases in 80% of the studies (Blumenthal-Barby & Krieger, 2015). 
Blumenthal-Barby and Krieger (2015) and Hoff and Stiglitz (2016) argued that 
physicians may allow their beliefs and expectations to affect interpretation of a patient, 
data, or patient outcomes (confirmatory bias), and reportedly recommended the current 
practice or default option (default or status quo bias) rather than change prescribing 
habits. The authors also found that when considering a recommendation or a particular 
course of therapy for a patient, physicians reportedly focused on the losses rather than the 
gains of the action (loss / gain framing bias), under- or over-estimated the future impact 
of an action (impact bias), or viewed the harm from an action as more damaging than the 
harm of doing nothing at all (omission bias).  
76 
 
Finally, Blumenthal-Barby and Krieger (2015) showed that family physicians 
reportedly had a greater susceptibility to biases and heuristics (91%), followed by 
obstetricians and gynecologists (85%). Again, while not all biases and heuristics are 
explicit or negative, they significantly influence a physician’s ability to process 
information and estimate probabilities, which are central to the practice of health care 
(Dovidio & Fiske, 2012). While data on biases and heuristics are not collected for NIS-
Teen and are thus outside the scope of my analysis, I will consider these factors when 
discussing my findings of physician recommendation.  
Discounting. Delayed or hyperbolic discounting is a well-researched process in 
economics (Bickel et al., 2016). In simple terms, the value of a reward received at a 
future point is perceived to be worth less than the value of a reward received immediately 
– individuals discount the reward if it is delayed (Bickel & Marsch, 2001; Bickel et al., 
2016; Emanuel et al., 2016; Murphy & Dennhardt, 2016). While delayed discounting is 
accounted for in traditional economics, Bickel et al. (2016) suggested that behavioral 
economics expands the concept and considers that individuals may reverse their 
preference for immediate versus future rewards. Supporting this idea, Emanuel et al. 
(2016) and others showed that not all individuals discount delayed rewards to the same 
degree, with some having greater self-control and a more balanced consideration of 
future benefits than others (Murphy & Dennhardt, 2016; Shuval et al., 2017).  
Although the most frequently reported discounting studies are with patients and 
use financial incentives for smoking cessation, weight loss, or sobriety, delayed 
discounting may be an important process for physicians as well (Bickel et al., 2016; 
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Buttenheim et al., 2016). For example, Siegler, Kable, and Chatterjee (2016) argued that 
the benefits of prescribing opioids for patients in pain or antibiotics to a child with an 
illness are more immediate on many levels, while the risks of not adhering to best 
practices and potentially contributing to opioid dependence or antibiotic resistance are 
delayed. In HPV specifically, the benefit of not recommending the vaccine to parents (or 
giving a weak recommendation) may allay the physician’s immediate discomfort of 
discussing sex or fear of upsetting the parents, while the risk that the adolescent will not 
be vaccinated or develop a disease is delayed. Given the responsibility costs of the 
physician’s decision for the patient’s health and wellbeing, a physician may err on the 
side of caution as a near-term reward (Frank, 2004). These observations may play a role 
in researchers’ findings that physicians reportedly discuss the HPV vaccine more often 
with older adolescents, rather than with 11 and 12-year-olds as advised by ACIP. I will 
consider these factors when discussing my findings of physician recommendation by age. 
Nudging. Bickel et al. (2016) and Hansen et al. (2016) concluded that nudging is 
a cost-effective population-level strategy, as it makes use of framing and default bias 
processes to nudge individuals toward optimal choices and minimize some of the 
irrational factors influencing decision-making. The authors suggested that behavior 
patterns influenced by heuristics and biases could be shifted by promoting salient, 
endorsed choices, creating a choice architecture in which the easiest course of action is 
the optimal one. As with discounting, nudging has been tested in a variety of health 
settings with patients, such as placing fruit and vegetables at eye level in grocery stores, 
providing graphic warning images on cigarette packages, changing organ donation on 
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driver’s license applications to opt-out, smaller plates in restaurants, or showcasing a 
choice that a majority of the population makes to leverage social norms (Bickel et al., 
2016; Hansen et al. 2016).  
With the increased use of technology in daily medical practice and knowledge of 
behavioral economics processes, however, nudges may be a useful tool in shifting 
physician behavior. For example, a small number of researchers have demonstrated that 
automatic prompts during a patient visit increased the number of conversations 
physicians had with patients about a particular health issue; setting specific treatment 
algorithms or diagnostics as the default in automated systems reduced unnecessary 
ordering and spending; and bundling adolescent vaccines that were often ordered together 
decreased the focus on any one component, such as HPV (Bickel et al., 2016; Olson, 
Hollenbeak, Donaldson, Abendroth, & Castellani, 2015; Patel et al., 2016). Such nudges 
were particularly effective when physicians were given immediate and public feedback, 
such as sharing vaccination rates with peers or the public (MacLeod, 2016). 
Nudging may be particularly useful in HPV vaccination, as the strategy inherently 
avoids restricting freedom of choice (Hansen et al., 2016). Mariner (2014) asserted that 
the fundamental argument against vaccine mandates is the tension between government 
authority to protect the public from harm and parental rights to decide for their children. 
As outlined in Mariner (2014) and Hansen et al. (2016), nudging does not take away or 
ban choices, impose mandatory obligations, regulate a specific individual’s behavior, or 
rely on rational behavior. Rather, the modified choice architecture targets cognitive 
biases to protect the public from harm and makes the optimal choice easier to make 
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(Mariner, 2014). By designing and evaluating policies that reduce cognitive errors that 
influence health outcomes, rather than policies that restrict individual freedom of choice, 
nudging may be a more palatable strategy to address disparities in health (Frank, 2004). 
These observations on nudging will provided context in my interpretation of the data.  
Definitions 
The independent and dependent variables and covariates are defined as follows. 
Ethnic and racial minority status. A categorical independent variable describing 
the race/ethnicity of the teen. Options are Hispanic, Non-Hispanic White Only, Non-
Hispanic Black Only, Non-Hispanic Other + Multiple Races, and Other + Multiple Race 
(a recode of NHO + Multiple Races) (CDC et al., 2015; 2016). 
HPV vaccination completion. A nominal dependent variable indicating the teen 
has received three or more doses of the HPV vaccine among those who have initiated the 
series (Gilkey et al., 2016). Some teens may have received more than three recommended 
doses; a secondary calculation by the CDC refers to a teen who, among those who 
received one or more HPV dose and over a minimum of 24 weeks between the first dose 
and the interview date, received a total of three or more doses (Reagan-Steiner et al., 
2015). However, using the Gilkey et al. (2016) measure allows for capturing teens who 
continue the vaccine series, albeit not in the recommended time-frame.  
HPV vaccination initiation. A nominal dependent variable indicating the teen 
has received one or more doses of the HPV vaccine (Reagan-Steiner et al., 2015). 
Physician recommendation. A categorical dependent variable (research question 
4) indicating whether the person participating in the survey recalls receiving a 
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recommendation from a physician or health care professional for the teen to receive the 
HPV vaccination (CDC et al., 2015; 2016). 
Selected local areas. Seven specific estimation areas highlighted in the 2015 
NIS-Teen dataset (Bexar County, TX; Chicago, IL; El Paso County, TX; Hidalgo 
County, TX; Houston, TX; New York City; and Philadelphia County, PA) (CDC et al., 
2015; 2016). As Washington, D.C. is sampled separately, I will include D.C. as one of 
the select local areas. These local areas receive federal Section 317 funds to purchase 
vaccines, particularly for priority populations, are sampled and analyzed separately 
(Reagan-Steiner et al., 2016). Given the demonstrated differences in HPV vaccination by 
geography, as well as the hypothesized relationship between social vulnerability and 
HPV vaccination, inclusion of local areas will add significant value to the research. In 
order to compare county-level data from the Social Vulnerability Index (described below) 
and the NIS-Teen database, I will include only selected local areas that are stand-alone 
counties from the 2014 NIS-Teen in the SVI portion of my analysis: Bexar County, El 
Paso County, Philadelphia, and Washington, D.C. (Hidalgo County was added in 2015.) 
Social vulnerability. As defined by the CDC and Agency for Toxic Substances 
and Disease Registry [ATSDR], social vulnerability refers to the extent to which the 
health of communities is likely to be affected by socioeconomic and demographic factors 
(CDC & ATSDR, 2017). Vulnerable populations are those who are disproportionately 
burdened by a combination of factors, are less likely to be able to cope with stressors, and 
whose needs are inadequately accounted for in resource allocation plans (Flanagan et al., 
2011). The CDC and ATSDR’s Social Vulnerability Index ranks each census tract or 
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county on overall vulnerability, comprised of four themes and 15 social factors affecting 
health: socioeconomic status (below poverty, unemployed, income, no high school 
diploma); household composition and disability (aged 65 and older, aged 17 or younger, 
civilian with a disability, single-parent households); minority status and language 
(minority, speak English less than well); and housing and transportation (multi-unit 
structures, mobile homes, crowding, no vehicle, group quarters) (CDC & ATSDR, 2017).  
Socioeconomic status. Categorical independent variables including income 
(poverty status, family income), health insurance status, and education (the current level 
of education of the mother) (CDC et al., 2015; 2016). 
Assumptions 
Multiple government agencies developed the questionnaires and provided the 
datasets for NIS-Teen, as well as the index and dataset for the Social Vulnerability Index. 
For the NIS-Teen, participants self-report the data, and I assume they answer honestly. 
Boakye et al. (2016) demonstrated that parental and provider recall of HPV vaccine 
initiation in the 2014 NIS-Teen dataset is comparable; parental and provider recall are 
slightly less comparable for HPV vaccine completion, although still substantial (κ = 
0.64). Although sensitivity and specificity may differ in other NIS-Teen dataset years, I 
assume this level of agreement indicates the self-report data is generally trustworthy. 
Scope and Delimitations 
The scope of this study is to test the relationship between HPV vaccine initiation 
and completion, socioeconomic status, and demographic variables in eight select local 
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areas in the United States. In addition, I will test the relationship between HPV vaccine 
initiation, physician recommendation, and social vulnerability in four select local areas.  
Internal validity of the study data is supported by random sample selection in the 
NIS-Teen using landline and cell phone numbers across the United States, application of 
sampling weights, and validation of both the NIS-Teen and Social Vulnerability Index 
instruments and outcomes (Brewer, 2004; Flanagan et al., 2011; Reagan-Steiner et al., 
2016). External validity of the study data is supported by the national sample set and real-
world observation rather than a laboratory setting (Ondercin, 2004). However, there are 
limitations that affect the ability to draw causal inferences about the data and generalize 
the findings to the entire U.S. population. Overall, there may be unknown confounders 
influencing the relationship between the independent and dependent variables; these may 
be masked by aggregate data, not currently measurable, or be in flux as dynamic 
processes influencing health and health outcomes.  
The NIS-Teen survey is cross-sectional, and thus it can support inferences but not 
prove causality. The household response rates for NIS-Teen vary from year to year, with 
approximately 60% and 31% response rates for landline and cell phones, respectively, in 
2014 (compared with 56% and 30% in 2015), and approximately half of respondents 
have adequate provider data (Reagan-Steiner et al., 2015; Reagan-Steiner et al., 2016). 
Estimates may be biased due to errors in respondent recall, non-responders or small 
sample sizes in specific variables or selected local areas (Reagan-Steiner et al., 2016).  
As with the NIS-Teen, the SVI is cross-sectional. Although the SVI incorporates 
multiple facets of social vulnerability, it is an incomplete list; others may include specific 
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built environment structures or diffusion of information (Flanagan et al., 2011). In 
addition, the SVI uses decennial census data, and may not accurately reflect the most 
current measurements in a community (Flanagan et al., 2011). 
Conclusions 
Human papillomavirus (HPV) is the most common sexually transmitted infection 
in the world and causes an estimated 700,000 cancer cases each year worldwide (Perkins, 
2016). In the decade since the first vaccine against HPV came to market, researchers and 
health care providers have made progress in reducing disparities in vaccine uptake among 
racial and ethnic minority and low socioeconomic status populations (Galbraith et al., 
2016; Rahman et al., 2017). However, sociodemographic and geographic variation in 
HPV vaccine uptake persists, as do differences in physician recommendation, 
determinants of vulnerability, and state laws regarding vaccination (Perkins, 2016; Rutten 
et al., 2017). Given the multifactorial influences on cognitive and behavioral decision-
making in HPV vaccination, a more ecological approach to research may uncover 
relationships influencing HPV vaccine uptake that are missed when studying 
determinants in isolation (Yanez, McGinty, Buitrago, Ramirez, & Penedo, 2016). 
This study may lend support to findings of experts in the field regarding variation 
in vaccine uptake by a number of variables, including sociodemographic factors and 
physician recommendation. In addition, this study may expand on data supporting 
geographic variation in HPV vaccination. This study may advance knowledge in the 
discipline by being the first, to my knowledge, to test the influence of the socioeconomic, 
demographic, cultural, and health history variables on HPV vaccine initiation and 
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completion alongside the social vulnerability context in which these relationships exist. 
This will also be the first test of a potential relationship between social vulnerability and 
HPV vaccination nationwide in the literature.  
These implications, such as the identification of the variables most strongly 
associated with HPV vaccination and local factors in physician recommendation, can 
advance social change by highlighting the need to consider local socioeconomic and 
demographic influences on health behavior, with a focus on physician recommendation. 
Informed interventions may help local, state, and national efforts to improve vaccination 
efforts and reduce disparities in health care.  
The following chapter describes the research methodology, including the design 
and data collection procedures.  
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Section 2: Research Design and Data Collection 
Introduction 
The purpose of this study is to test the relationship between HPV vaccine 
initiation and completion, socioeconomic status, and demographic variables in eight 
select local areas in the United States. In addition, I will test the relationship between 
HPV vaccine initiation, physician recommendation, and social vulnerability in four select 
local areas. 
The remainder of this chapter will describe the research design and rationale, 
followed by the methodology, including sampling, data analysis, threats to validity, and 
ethical considerations. 
Research Design and Rationale 
I will conduct a quantitative secondary analysis of the NIS-Teen, a cross-sectional 
study, and the Social Vulnerability Index, a cross-sectional analysis tool, to test 
relationships among the study variables. The independent variables are socioeconomic 
status indicators, demographic variables, and county-level social vulnerability. The 
dependent variables are HPV vaccine initiation and completion and physician 
recommendation. 
Secondary analysis is an efficient and cost-effective way to generalize findings 
from a large sample size to a population for greater external validity, analyze the findings 
using statistical procedures, and identify subgroups with sufficient sample size for 
additional analyses (Creswell, 2009; Dale, 2004). In addition, use of validated, reliable 
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instruments increases confidence in internal validity and the minimization of bias in data 
collection to the extent possible (Creswell, 2009).   
Quantitative analysis of county- and national-level databases will advance 
knowledge in the field regarding relationships likely to influence HPV vaccine uptake by 
identifying specific variables to assess and resources needed at each level.  
Methodology 
The NIS-Teen is a well-known and much-used instrument to examine 
relationships among variables of interest and immunization behaviors in the United 
States. The Social Vulnerability Index is used frequently by emergency planners and 
other officials responsible for disaster planning and recovery.   
Population 
The Centers for Disease Control and Prevention conducts the annual NIS-Teen to 
monitor vaccination initiation and completion of adolescents aged 13 to 17 years in non-
institutionalized households in the United States. In 2015, NIS-Teen collected data from 
61 geographic strata: all 50 states, the District of Columbia, three territories, and seven 
selected local areas (Chicago, New York, Philadelphia, Bexar County [TX], Houston, El 
Paso County [TX], and Hidalgo County [TX]).  
Sampling and Sampling Procedures 
NIS-Teen uses dual-frame sampling, with both landline and cell-phone sampling 
frames with households, followed by a mailed questionnaire to the identified vaccine 
providers. Interviewers use independent, quarterly updated samples provided by 
Marketing Systems Group; the landline sampling frame includes banks of numbers with 
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at least one directory-listed telephone number, while the cell-phone sampling frame 
includes all banks of cell phone numbers (CDC, 2015). Numbers that are non-working, 
non-residential, or on the NIS do-not-call list are eliminated prior to release to a 
telephone center. Interviewers contact households to identify those with adolescents aged 
13 to 17 years; if more than one child is eligible, one child is randomly selected to be the 
subject of the interview. Households that do not have adolescents at this age are 
excluded. Interviewers use the NIS-Teen household questionnaire to collect household-
reported vaccination and health information, demographic and socioeconomic 
information, geographic information, and vaccine provider information from a parent or 
guardian (CDC, 2015). As adolescents and teens under age 18 must have parental or 
guardian consent to be vaccinated, the parent or guardian is the appropriate respondent 
(Burdette et al., 2017).  
For households who provide sufficient information and consent to contact the 
vaccine provider, a questionnaire is mailed to vaccine providers to obtain immunization 
history from an adolescent’s medical records. The provider is asked to mail or fax the 
immunization history form; in some instances, histories are completed over the phone 
during follow-up phone calls to providers who have not yet responded. In 2015, 61.4% of 
parents or guardians from the landline sample gave consent to contact providers (2014: 
64.4%), while 58.1% from the cell-phone sample gave consent (2014: 61.2%) (CDC et 
al., 2015; 2016). Of the questionnaires mailed to providers, 93.4% of questionnaires from 
the landline sample and 93.6% of questionnaires from the cell-phone sample were 
returned (2014: 94.9% and 94.8%, respectively) (CDC et al., 2015; 2016). Finally, of the 
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questionnaires returned, 53.4% of adolescents from the landline sample had adequate 
provider data, and 48.9% of adolescents from the cell-phone sample had adequate 
provider data (2014: 57.1% and 52.3%, respectively) (CDC et al., 2015; 2016). 
The sample size was designed specifically with a target coefficient of variation of 
6.5% from provider-reported vaccine histories in each geographic area, to give a true 
coverage parameter of 50% (CDC et al., 2015; 2016). Overall, the coverage parameter in 
2015 was 49.9% (2014: 54.4%); for landlines, a total of 84.4% of households were 
successfully screened, 5.7% of households had an age-eligible teen, and 81.3% of these 
households completed the interview (2014: 87.2%, 6.2%, and 83.8%, respectively) (CDC 
et al., 2015; 2016). For cell phones, 73.4% of households were successfully screened, 
6.9% were eligible, and 71.7% completed the interview (2014: 72.9%, 6.9%, and 72.7%, 
respectively) (CDC et al., 2015; 2016). A total sample of 10.1 million telephone numbers 
resulted in completed household interviews for 44,773 teens, of which 22,214 [including 
133 unvaccinated children] had adequate provider data to verify whether the adolescent 
was up to date on vaccines (2014: a total of 38,703 teens, 21,057 [including 92 
unvaccinated adolescents] with adequate provider data) (CDC et al., 2015; 2016). The 
revised definition of adequate provider data, beginning in 2014, is any adolescent for 
whom a provider reports vaccine history, or any adolescent who is unvaccinated as 
reported by parent or provider (CDC et al., 2015; 2016).  
Selected local areas that receive federal Section 317 funds to purchase vaccines, 
particularly for priority populations, are sampled and analyzed separately (Reagan-
Steiner et al., 2016). Researchers may analyze all completed household interviews or 
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only those with adequate provider data, as well as choose whether to include adolescents 
from territories in the analysis (CDC et al., 2015; 2016). Adolescents from the territories 
are excluded from national estimates (CDC et al., 2015; 2016). 
Both the NIS-Teen and Social Vulnerability Index are public-use data files and do 
not require permission to gain access to the data.  
Instrumentation  
The National Immunization Survey was launched in 1994 to monitor vaccine 
coverage among children ages 19 months to 35 months after a series of measles outbreaks 
in the early 1990s (CDC, 2017d). The NIS-Teen was launched in 2006 to monitor 
vaccine coverage among adolescents and teens for routine immunizations and provide a 
consistent dataset for tracking needs and outcomes related to routine vaccines in a single 
year and over time (CDC, 2017d; Jain, Singleton, Montgomery, & Skalland, 2009). Prior 
surveys, such as the National Health Interview Survey, relied on personal immunization 
cards or parental recall, but few households kept immunization cards and parental recall 
was less accurate than the cards (Jain et al., 2009). Other surveys relied on local data or 
registries. In NIS-Teen, analysts use weights to estimate vaccine coverage for the entire 
nation, as well as by state and selected local area; researchers can also stratify by 
variables of interest (CDC, 2017d).  
Researchers collect data from both parents and vaccine providers of adolescents 
to enhance the validity and reliability of the self-reported data in NIS-Teen (CDC, 
2017d). Dorell, Jain, and Yankey (2011) and others reported that parent-reported vaccine 
histories varied by vaccine, especially for recently recommended vaccines, and the use of 
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provider validation of parent reports increased the validity of the NIS-Teen. Analysts also 
use adequate-provider data when reporting estimates of vaccine coverage, given the 
differences between estimates obtained from households with and without adequate 
provider data in the early years of the survey (Jain et al., 2009). 
Researchers use the dual-frame design to increase reliability of sampling in NIS-
Teen and validity of survey results (Dorell et al., 2011). Shin, Molinari, and Wolter 
(2008) determined that dual-frame sampling, versus the single random-digit dialing 
frame, increased statistical efficiency and cost-effectiveness of the survey without 
introducing new bias into immunization coverage estimates. For example, the public-use 
data file for the 2014 NIS-Teen includes only dual-frame weights as a way to minimize 
any bias resulting from incomplete landline sampling (CDC et al., 2015; 2016). 
In addition to these methodological designs, validity and reliability of NIS-Teen 
can be assessed by comparing results with other immunization data sources, such as 
registries, the National Health Interview Survey-Child, or the Behavioral Risk Factor 
Surveillance System, and by comparing results among researchers using the same data set 
and the same questions (Boakye et al., 2016; Jain et al., 2009).   
Operationalization of Variables 
The objective of this study is to test the relationship between HPV vaccine 
initiation and completion, socioeconomic status, and demographic variables in eight 
select local areas in the United States. In addition, I will test the relationship between 
HPV vaccine initiation, physician recommendation, and social vulnerability in four select 
local areas. 
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What follows is a description of the dependent and independent variables (see 
Table 9 for a brief overview of the variable levels).  
Table 9 
 
Measurement Levels of Variables in Analysis 
Measurement 
Level 
 
Variables 
 
Nominal HPV vaccine initiation 
HPV vaccine completion 
Physician recommendation 
Ethnicity and racial background 
Health insurance status 
Gender 
Select local area  
Ordinal Poverty 
Education 
Social Vulnerability Index ratings 
Interval Age 
 
Note. HPV vaccine initiation, completion, and physician recommendation are 
dichotomous variables, which indicates binomial logistic regression as the appropriate 
final statistical model. 
 
HPV vaccination completion. One of the key dependent variables, HPV 
vaccination completion reflects whether the respondent indicates that his or her 
adolescent child had received three or more doses of the HPV vaccine series. Although 
the NIS-Teen survey collects data on up to 9 reported HPV shots received for variable 
HPVI_NUM_TOT (HPV1_NUM_REC in 2014; position 113-114), the series is made up 
of 3 shots, with recent recommendations to administer 2 shots for eligible adolescents. 
Only 145 responses of 33,809 completed household interviews and 89 of 16,875 
interviews with adequate provider data answered 4 or more shots, with the majority 
answering 4. I will consider 3 and 4 shots as ≥3 shots received, indicating completion, 
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and will recode as 3 in analysis. 
HPV vaccination initiation. Another key dependent variable, HPV vaccination 
initiation reflects whether the respondent indicates that his or her adolescent child had 
received at least one dose of the HPV vaccine series. I will consider 1 and 2 shots as 
reported for variable HPVI_NUM_TOT as ≥1 shot received, indicating initiation, and will 
recode as 2 in the analysis. For adolescents reporting 0 HPV shots received, I will recode 
as 1 to indicate unvaccinated status. 
Physician recommendation. As a dependent variable in research question 4, 
physician recommendation reflects whether the respondent recalls receiving a 
recommendation from a physician or health care professional for the adolescent or teen to 
receive the HPV vaccination. As indicated in the NIS-Teen codebook for variable 
HPVI_RECOM (position 167-168), I will code yes as 1 and no as 2. Based on prior 
research, I will exclude don’t know, refused, or missing responses from my analysis, as 
these answers comprise only 4,630 responses of the 44,773 completed interviews and 
2,005 responses of 22,214 interviews with adequate provider data. 
Ethnic and racial status. One of the key independent variables, ethnic and racial 
status reflects the race / ethnicity of the adolescent. Responses to the question in NIS-
Teen for variable RACEETHK (position 311-311) may be Hispanic, Non-Hispanic White 
Only, Non-Hispanic Black Only, and Non-Hispanic Other + Multiple Races. Based on 
prior studies in which researchers focus on Hispanic, White, and Black in their studies 
given the sufficient sample size in the survey, and the lack of any additional 
subcategorization for the 4,488 responses for other out of 44,773 household interviews 
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(2,202 responses of the 22,214 teens with adequate provider data) in the public-use data 
file, I will use only Hispanic, White, and Black in my analysis. As indicated in the 
codebook, I will code Hispanic as 1, White as 2, and Black as 3. 
Social vulnerability. The CDC and ATSDR’s Social Vulnerability Index ranks 
each census tract or county on overall vulnerability, comprised of four themes and 15 
social factors affecting health: socioeconomic status (below poverty, unemployed, 
income, no high school diploma); household composition and disability (aged 65 and 
older, aged 17 or younger, civilian with a disability, single-parent households); minority 
status and language (minority, speak English less than well); and housing and 
transportation (multi-unit structures, mobile homes, crowding, no vehicle, group quarters) 
(CDC & ATSDR, 2017). Two adjunct variables, estimates for uninsured persons and 
daytime population, are included in the SVI 2014 data but are excluded from the ranking 
calculations. 
SVI data can be mapped and analyzed at the national level, ranking tracts or 
counties against each other, or at the individual state level, where tracts or counties are 
ranked only against those in the same state. I will use counties in this research as a more 
appropriate comparison for counties in NIS-Teen. Percentile ranks closer to zero indicate 
lower vulnerability, while ranks closer to 1 indicate high vulnerability. CDC and ATSDR 
calculate percentile ranks for each county for the 15 variables, and sum the percentiles to 
generate the theme score (variables RPL_THEME1 for socioeconomic, RPL_THEME2 
for housing composition and disability, RPL_THEME3 for minority status and language, 
and RPL_THEME4 for housing and transportation). Finally, the sum of each theme is 
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added together to calculate the overall percentile ranking (variable RPL_THEMES). I will 
code the themes using their designated numbers from the SVI (1 through 4), and the 
overall ranking as 5.   
Socioeconomic status. Socioeconomic status is reflected through a collection of 
independent variables including income and education. While American Psychological 
Association (2007) and Diemer, Mistry, Wadsworth, Lopez and Reimers (2013) 
suggested including a number of measures such as resources, absolute and relative 
poverty, and subjective social status, data are collected only on resource-based measures 
(total family income) and absolute poverty (federal poverty threshold). While family 
income is a more nuanced measure, there may not be sufficient sample size for subgroup 
analysis, and poverty status is an accepted variable in reports by CDC and other 
researchers.   
As noted in the NIS-Teen codebook, poverty status, the variable INCPOV1 
(position 298-298), is calculated as above poverty (income greater than $75,000, coded 
1), above poverty (income less than or equal to $75,000, coded 2), and below poverty 
(coded 3). Responses to variable EDUC1 (position 279-279), the mother’s level of 
education, are less than 12 years (coded 1), 12 years (coded 2), more than 12 years / non-
college graduate (coded 3), and college graduate (coded 4).  
Selected local areas. An independent variable describing where the teen lives at 
the time of the survey. Responses are drawn from ESTIAPT15 and ESTIAPT14 from the 
2015 and 2014 NIS-Teen surveys, respectively. Eight specific estimation areas in 2015 
will be tested, as well as the four that are stand-alone counties from the 2014 NIS-Teen in 
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the SVI portion of my analysis: Bexar County, District of Columbia, El Paso County, and 
Philadelphia. 
Health insurance. An independent variable describing whether an adolescent has 
no insurance, employee or union insurance, or other government insurance. Responses 
are drawn from variables TIS_INS_1 (position 1207-1208 in 2015, 1190-1191 in 2014) to 
indicate whether an adolescent is covered through the respondent’s employer or union 
(responding yes, coded as 1), TIS_INS_2, _3, _3A, and _4_5 (2015: positions 1211-1212, 
1213-1214, 1215-1216, and 1217-1218; 2014: positions 1194-1195, 1196-1197, 1198-
1199, and 1200-1201, respectively) to indicate other government insurance (responding 
yes to Medicaid, S-CHIP, Tricare, or Indian Health Service, coded as 2), or TIS_INS_11 
(position 1209-1210, 2014: 1192-1193) to indicate uninsured (responding yes, coded as 
3).   
Sex. An independent variable, sex reflects the gender of the adolescent as 
identified by the respondent. Responses for the variable SEX (position 315-315) can be 
male or female; as noted in the codebook, male will be coded as 1 and female will be 
coded as 2. 
Control variables. Researchers have identified a number of correlates to HPV 
vaccine initiation, completion, and physician recommendation: age of the adolescent, age 
of the mother, number of children under 18 years in the household, relationship of the 
respondent to the adolescent, mother’s marital status, and number of adolescent visits to a 
healthcare profession in the past 12 months (Burdette et al., 2017). These correlates may 
confound results, and therefore I will control for each in my four research questions. 
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However, age of the adolescent will be included as an independent variable in research 
question 4, as researchers have shown a significant relationship between age of the 
adolescent and physician recommendation. Any additional confounding variables among 
the aforementioned independent variables will be determined using logistic regression 
(described in the Data Analysis Plan section). 
Data Analysis Plan 
The datasets, formats, and codebooks will be downloaded from the NIS-Teen 
website, and all analyses will be conducted using the Complex Samples procedures in 
SPSS version 24 for Mac OS Sierra when possible to account for the complexity of the 
weighted survey data.  
CDC analysts prepare and process the household and provider data collected 
through NIS-Teen (CDC et al., 2015; 2016). Editing and cleaning procedures follow the 
standards set by the National Health Interview Survey, and are completed after every 
quarter of data collection (CDC et al., 2015; 2016). The CDC uses a computer-assisted 
telephone interviewing system to reconcile any critical errors during the household 
interview in real time, followed by a review of data values for any out-of-range values 
and extraneous codes, production of cross tabulations, recoding of any verbatim 
responses, and creation of several composite variables (CDC et al., 2015; 2016). Provider 
data are edited through an initial manual review of the returned immunization history 
forms, removal of any responses for the incorrect adolescent, consolidation of multiple-
provider responses for a single teen merged into one single history, and then cleaned.  
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Household and provider data are merged, with any multiple-provider responses 
for a single adolescent merged into one single history. Analysts conduct a quality 
assessment using an adolescent’s date of birth, gender, and name to confirm eligibility of 
the teen (by age) and to ensure the correct adolescent is matched with the correct provider 
(CDC et al., 2015; 2016). Finally, analysts perform imputations using a sequential hot-
deck method for any non-responses to socioeconomic and demographic variables used in 
weighting. Missing value codes are used for household data, while missing or other 
provider data are recoded using a vaccination recoding table and reviewed by the 
National Center for Immunization and Respiratory Diseases (CDC et al., 2015; 2016).        
NIS-Teen is the only survey that includes provider-reported vaccination data 
along with household-reported history; even with this corroboration and standardized 
editing and cleaning procedures, there may be some inconsistent data present in the data 
file, as households are not re-contacted to verify any differences in provider reporting 
(CDC et al., 2015; 2016). As provider data are considered more accurate than household-
reported vaccine history, the CDC uses the subset of data of adolescents with adequate 
provider data for reported estimations of vaccine coverage, and assigns a separate weight 
to these records (CDC et al., 2015; 2016). 
Research questions. The objective of this study is to test the relationship between 
HPV vaccine initiation and completion, socioeconomic and demographic variables, and 
physician recommendation. In addition, I will test the relationship between HPV vaccine 
initiation, physician recommendation, and social vulnerability. I will attempt to answer 
four research questions: 
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Research Question 1: Is there a relationship between HPV vaccination initiation 
(1 dose) and socioeconomic status and demographic variables in selected local areas, 
using data from the 2015 NIS-Teen?  
H01: There is no relationship between HPV vaccination initiation and 
socioeconomic and demographic variables in selected local areas. 
Ha1: There is a relationship between HPV vaccination initiation and at least one 
socioeconomic or demographic in selected local areas. 
Research Question 2: Is there a relationship between HPV vaccination completion 
(3 doses) and socioeconomic status and demographic variables in selected local areas 
using data from the 2015 NIS-Teen? 
H02: There is no relationship between HPV vaccination completion and 
socioeconomic and demographic variables in selected local areas. 
Ha2: There is a relationship between HPV vaccination completion and at least one 
socioeconomic or demographic variable in selected local areas. 
Research Question 3: Is there a relationship between HPV vaccination initiation 
(1 dose) and social vulnerability by select local area county in the United States using 
data from the 2014 NIS-Teen and 2014 Social Vulnerability Index?  
H03: There is no relationship between HPV vaccination initiation and social 
vulnerability by select local area county in the United States. 
Ha3: There is a relationship between HPV vaccination initiation and social 
vulnerability by select local area county in the United States. 
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Research Question 4: Is there a relationship between physician recommendation 
(yes/no) and social vulnerability by select local area county in the United States using 
data from the 2014 NIS-Teen and 2014 Social Vulnerability Index?  
H04: There is no relationship between physician recommendation and social 
vulnerability by select local area county in the United States. 
Ha4: There is a relationship between physician recommendation and social 
vulnerability by select local area county in the United States. 
Statistical analyses. The pre-determined α level for all tests is < 0.05. First, I will 
conduct a descriptive, univariate analysis to calculate weighted frequencies and 95% 
confidence intervals for all study variables to describe the survey respondent population.  
Second, I will conduct inferential bivariate analyses, using chi-square tests, to 
determine the interactions between adolescent characteristics and the three dependent 
variables: HPV vaccine initiation, completion, and physician recommendation.  
Third, I will conduct a preliminary series of logistic regression models to test for 
multicollinearity, which indicates if two or more independent variables are highly 
correlated. Multicollinearity, which increases the standard errors of the coefficients and 
thus decreases the reliability of the outcome data, can be tested by calculating the 
Variance Inflation Factors. A VIF greater than 10 indicates multicollinearity; depending 
on the variable in question, I may remove the variable, recode it, or control for it in the 
analysis. In addition, I will assess the results of the Wald test in the regression output to 
understand the contribution of each independent variable to the model, as well as its 
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statistical significance. I will include independent variables with p ≤ 0.05 in the final 
model and exclude those with p > 0.05.  
Finally, I will conduct a binomial logistic regression to test associations between 
the independent and selected dependent variables that were statistically significant in the 
preliminary regression analysis. My study meets the assumptions for binomial logistic 
regression, as I have dichotomous dependent variables (all are yes or no), one or more 
independent variables measured on a continuous or nominal scale (with ordinal variables 
treated as continuous or nominal), the data have independence of observations, and no 
multicollinearity (as tested in the third analysis step). The final results will be presented 
as odds ratios with 95% confidence intervals.  
Threats to Validity 
Threats to validity may arise from external, internal, statistical conclusion, or 
construct factors. External threats include extrapolating inferences from the sample data 
to populations or settings that do not reflect the sample population, as well as the 
interaction between population selection, taking the survey, and the setting in which they 
take the survey. The CDC employs oversampling techniques and weights responses to the 
NIS-Teen survey in order to calculate a population-level estimate of vaccine coverage 
and minimize any interaction between selection and taking the survey. In addition, CDC 
collects data at a number of administrative levels (such as national, state, and select local 
area) to address the interaction between selection and the setting in which the population 
live and experience differing external events. However, I cannot control for any unknown 
confounders that may influence the relationships between the independent and dependent 
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variables, especially if these confounders are not measurable or vary according to 
unidentified population characteristics.  
Internal threats to validity include the procedures or experiences of the 
respondents that influence whether I can correctly infer conclusions about the population. 
As NIS-Teen is a one-time survey, factors such as history, maturation, experimental 
mortality, diffusion of treatment, or statistical regression do not apply to the survey or 
analysis. In addition, respondents are selected through random digit-dialing for both 
landline and cell phones, phone numbers are updated quarterly, and the CDC uses 
probability sampling adjustments to reduce any potential for sampling errors; these 
efforts address threats of selection bias and history. Respondents are not compensated, 
mitigating any compensatory demoralization or rivalry factors. The CDC collects data 
from both parents and providers of the HPV vaccine to verify parental recall. There are 
no pre- or post-test interviews and the survey is routinely reviewed, thus removing any 
concerns about instrumentation. Finally, I will conduct analyses to determine any 
presence of multicollinearity in research variables, and will not assign causality to 
variable relationships as my statistical model is not designed for that purpose. 
Threats to construct validity result from insufficient measures or definitions of 
variables in the study. To minimize this threat, the CDC reports on data from respondents 
with adequate provider verification; in addition, comparison to other health surveys such 
as the National Health Interview Survey, which uses different methodology and sampling 
procedures, shows comparable coverage estimates. In my study, I have defined the 
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variables using the body of HPV literature and the CDC’s reports as guides to ensure I 
will be measuring and defining the same variables for testing. 
Finally, threats to statistical conclusion can occur if the analysis is not powered 
adequately, or statistical assumptions are violated. According to a preliminary analysis of 
sample size using the G*Power (version 3.1.9.2), the sample size required for 95% power 
ranges from 1,649 to 1,653 for females and 1,629 to 2,318 for males in 2014, far below 
the 10,084 females and 10,743 males in the 2014 sample (the smaller of the two years’ 
samples in the full U.S. sample). To obtain this sample estimate, I used the following 
parameters: a two-tailed test, an odds ratio of 1.2 for a small effect size, α > 0.05, and 
hypothesized HPV vaccine coverage ranging from 39.7% to 60.0% in females and 21.6% 
to 41.7% in males, based on 2014 data (the lower of the two years’ samples) (Reagan-
Steiner et al., 2015). Using the same parameters, the sample size required for 95% power 
for the select local area ranges from 310 for females and 274 for males, again below the 
367 females and 394 males in 2014 (the smaller of the two years’ samples in the select 
local area sample).  
In addition, the statistical assumptions for the planned statistical tests are met: for 
chi-square goodness of fit and independence, I have categorical variables, independence 
of observations, cross-sectional sampling, and an expected frequency of at minimum 5 
cases per group in each categorical variable. For binomial logistic regression, I have a 
dichotomous dependent variable, two or more independent variables (continuous or 
nominal), independence of observations, mutually exclusive and exhaustive categories 
within each variable, a lack of multicollinearity, and an expected frequency of at 
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minimum 15 cases per group in each variable. If the assumptions are not met in the chi-
square tests, I may collapse the cells with other sample groups where possible to increase 
the sample. If the assumptions are not met in the binomial logistic regression test, I may 
collapse the cells or transform or remove outliers where applicable.  
Ethical Procedures 
The CDC and all other staff involved with the NIS-Teen are bound by 
confidentiality agreements to protect the privacy and confidentiality of protected health 
information, including disclosure of data (CDC et al., 2015; 2016). The collected data can 
be used only for research, and the public-use data file is reviewed by the National Center 
for Health Statistics Disclosure Review Board prior to release to ensure privacy and 
confidentiality are maintained (CDC et al., 2015; 2016). In addition, some variables that 
could potentially identify participants are not included in the public-use data file or have 
the categories collapsed and reported in aggregate.  
Summary 
I will conduct a quantitative secondary analysis of the NIS-Teen and Social 
Vulnerability Index databases to test the relationship between HPV vaccine initiation, 
completion, socioeconomic and demographic variables, physician recommendation, and 
social vulnerability in selected local areas in the United States. Specifically, I will use 
descriptive, univariate analysis to calculate weighted frequencies and 95% confidence 
intervals for all study variables to describe the survey respondent population, followed by 
chi-square tests and weighted frequencies to determine the interactions between HPV 
vaccination, physician recommendation, and select adolescent characteristics. Next, I will 
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test for multicollinearity using logistic regression, followed by binomial logistic 
regression to test associations between the independent and selected dependent variables 
that were statistically significant in the preliminary regression analysis. Finally, I will 
evaluate my research questions in the context of what is known in the literature and how 
this study can contribute to progress in the field. Data collection and results will be 
discussed in the following section.  
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Section 3: Presentation of the Results and Findings 
Introduction 
The purpose of this study was to test the relationship between HPV vaccine initiation and 
completion, socioeconomic and demographic variables, and physician recommendation. 
In addition, I tested the relationship between HPV vaccine initiation and completion, 
physician recommendation, and social vulnerability using the 2014 NIS-Teen and 2014 
Social Vulnerability Index databases. I attempted to answer four research questions: 
Research Question 1: Is there a relationship between HPV vaccination initiation 
(1 dose) and socioeconomic status and demographic variables in selected local areas, 
using data from the 2015 NIS-Teen?  
H01: There is no relationship between HPV vaccination initiation and 
socioeconomic and demographic variables in selected local areas. 
Ha1: There is a relationship between HPV vaccination initiation and at least one 
socioeconomic or demographic in selected local areas. 
Research Question 2: Is there a relationship between HPV vaccination completion 
(3 doses) and socioeconomic status and demographic variables in selected local areas 
using data from the 2015 NIS-Teen? 
H02: There is no relationship between HPV vaccination completion and 
socioeconomic and demographic variables in selected local areas. 
Ha2: There is a relationship between HPV vaccination completion and at least one 
socioeconomic or demographic variable in selected local areas. 
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Research Question 3: Is there a relationship between HPV vaccination initiation 
(1 dose) and social vulnerability by select local area county in the United States using 
data from the 2014 NIS-Teen and 2014 Social Vulnerability Index?  
H03: There is no relationship between HPV vaccination initiation and social 
vulnerability by select local area county in the United States. 
Ha3: There is a relationship between HPV vaccination initiation and social 
vulnerability by select local area county in the United States. 
Research Question 4: Is there a relationship between physician recommendation 
(yes/no) and social vulnerability by select local area county in the United States using 
data from the 2014 NIS-Teen and 2014 Social Vulnerability Index?  
H04: There is no relationship between physician recommendation and social 
vulnerability by select local area county in the United States. 
Ha4: There is a relationship between physician recommendation and social 
vulnerability by select local area county in the United States. 
The remainder of this chapter will describe the data collection for the study, 
followed by the results of the retrospective, quantitative analysis of the secondary dataset. 
Data Collection of Secondary Data Set 
As noted above in Sampling and Sampling Procedures, 2015 recruitment resulted 
in completed household interviews for 44,773 teens, of which 22,214 had adequate 
provider data, while in 2014 there were a total of 38,703 teens, 21,057 with adequate 
provider data (CDC et al., 2015; 2016). For the 2015 NIS-Teen, data were collected 
between January 26, 2014 and February 15, 2015 for the household interviews and from 
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March 2015 through April 2016 for the provider surveys (CDC et al., 2016). For the 2014 
NIS-Teen, data were collected between January 9, 2014 and February 8, 2015 for the 
household interviews and between from February 2014 through April 2015. For the 2014 
SVI, data were collected using the Census Bureau’s 2010-2014 American Community 
Survey (CDC & ATSDR, 2017).  
For the 2015 NIS-Teen data, this study was limited to 11,855 adolescents in the 
full U.S. sample and 1,564 adolescents in selected local areas, while the 2014 dataset was 
limited to 11,488 adolescents in the U.S. sample and 1,235 adolescents in selected local 
areas (see Figure 2). Adolescents in the sample met the following criteria: adequate 
provider data; between 0 and 3 HPV shots received; fewer than 8 visits to a physician in 
the past 12 months; of Non-Hispanic White, Hispanic, or Non-Hispanic Black race and 
ethnicity; and living in one of the eight select local areas (for the select local area sample 
only). Finally, respondents answering don’t know or refused or marked as missing data 
were excluded from the analysis. No variables contained more than 10% missing data, 
with the exception of whether an adolescent had a well-child visit at ages 11 or 12 years 
(13.6% [2015] and 15.0% [2014] of the full U.S. sample). Assessments using listwise 
deletion and imputation showed the differences in the population were not significant, 
t(83379) = 0.03, p > .05 for 2015 and  t(71715) = 0.05, p > .05 for 2014.  
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Figure 2. Criteria used to determine the final full U.S. sample and Select Local Area 
sample from the 2015 NIS-Teen. The same criteria were used for the 2014 dataset. 
In addition, Little’s MCAR test showed that the 2015 well-check data were missing 
completely at random, χ2(1) = 0.53, p > .05 for select local area and χ2(1) = 2.78, p > .05 
for age of teen. The missing data were missing completely at random in 2014 as well, 
109 
 
according to Little’s MCAR test, χ2(1) = 0.35, p > .05 for select local area and χ2(1) = 
0.03, p > .05 for age of the teen.   
Survey design allows respondents to recall the teen receiving up to 9 HPV shots, 
despite the series having only three shots at the time of the interviews; as such, those 
answering 4 or more shots (n = 78) were excluded from the sample. In addition, a number 
of researchers have reported that physicians typically do not offer vaccines during acute 
illness visits or if the adolescent has a chronic illness or is immunocompromised (Malo et 
al., 2016b; Richards, Peters, & Sheeder, 2016; Vadaparampil et al., 2011). Therefore, 
respondents answering that the teen had seen a health care professional more frequently 
than every two months (n = 866, or 5.6% of the sample, having 8 or more visits per year) 
were excluded from the sample. 
Tests indicated a low level of multicollinearity, as assessed by the tolerance and 
VIF collinearity statistics in a linear regression analysis. All independent variables had a 
tolerance greater than .10 and a VIF between 1 and 10, suggesting the independent 
variables were not correlated and the effects of each on the dependent variable were 
similar regardless of other independent variables in the model (see Tables B1-2 in 
Appendix B).  
Data Analysis Plan Revisions 
The SPSS program did not account for the weighted sample’s total population, so 
when weighting cases using the provider-phase weight variable (PROVWT_D) the 
standard error assumed √ using the sum of the weight variable rather than the sum of 
the sample population and predictors were all highly significant (IBM Support, 2016). To 
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account for this, I used two methodologies, the Complex Samples option in SPSS and a 
scaled weight approach, and compared the two regarding agreement on rejection or 
acceptance of the null hypothesis on each research question. In the Complex Samples 
approach, I created a sample plan using the sum of the provider-phase weight variable, 
stratified by the STRATUM variable, and included a Bonferroni correction for multiple 
comparisons (Glantz, 2005; IBM Support, n.d.). In the scaled weight approach, I applied 
a factor ([∑PROVWT_D/N) to the provider-phase weight variable to create a scaled √ 
for the standard error (IBM Support, 2016). 
As the dependent variables were dichotomous, I had more than three variables, 
and the independent variables were measured at nominal and continuous levels, binomial 
logistic regression was more appropriate than a chi-square test to analyze the dataset 
(Laerd Statistics, 2015). Given this determination, running chi-square analyses to identify 
variables to include in the binomial logistic regression model was not necessary. Last, 
independent variables must be either continuous or nominal when using binomial logistic 
regression analyses, so I recoded the ordinal variables from Table 9 and included them as 
categorical variables (Laerd Statistics, 2015).  
Finally, with the SVI rankings recoded as categorical variables, and with the SVI 
ranking and select local area county variables containing more than two categories, the 
chi-square test for independence was more appropriate than a binomial logistic regression 
(Laerd Statistics, 2016). 
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Baseline Sample Characteristics 
The 2015 NIS-Teen unweighted dataset included 11,855 teens in the full U.S. 
sample and 1,564 teens in the select local area sample. Table 10 summarizes the 
descriptive and sociodemographic characteristics of the sample.  
Table 10 
 
Characteristics of adolescents aged 13-17 years with adequate provider data: 2015 NIS-
Teen 
 
 
United States Local Area 
Gender   
Male 50.9 50.1 
Female 49.1 49.9 
Adolescent’s age (years)   
13 12.6 12.2 
14 20.6  22.2  
15 23.6  22.3  
16 22.6  21.8  
17 20.7 21.5  
Race/ethnicity   
Non-Hispanic White 63.0 24.3** 
Hispanic 22.3 48.6** 
Non-Hispanic Black 14.7 27.2** 
Poverty status   
Above $75K 44.9 30.9** 
Poverty to $75K 34.5 36.0 
Below 20.6 33.1** 
Mother’s education   
Less than high school 10.0 17.6** 
High school graduate 21.4 22.5 
Some college 26.0 23.4* 
College graduate 42.7 36.4** 
Physician recommendation of HPV 
vaccine 
  
Yes 71.9 74.7* 
No 28.1 25.3* 
HPV vaccination status   
No shots 43.5 37.8** 
(table continues) 
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United States Local Area 
Initiation (1 shot) 23.6 30.1** 
Completion (3 shots) 32.9 32.0 
Well-child checkup   
Yes 95.8 96.6 
No 4.2 3.4 
Type of health insurancea   
Employee-based 62.8 48.2** 
Public (government) 37.2 51.8** 
Ever uninsured, since age 11   
Yes 7.6 9.7** 
No 92.4 90.3** 
Mother’s marital status   
Married 64.2 50.7** 
Not married 35.8 49.3** 
Mother’s age (years)   
≤ 34 7.9 9.2 
35-44 43.1 48.2** 
≥ 45 49.0 42.6** 
Number of children under 18 years 
in house 
  
One 32.4 32.3 
Two to three 55.6 53.6 
Four or more 12.0 14.1* 
Number of visits to HCP in past 12 
months 
  
None 11.0 9.6 
One 32.4 32.6 
Two to three 39.1 41.8* 
Four to five 12.8 13.3 
Five to six 4.7 2.6** 
Relationship to teen   
Mother / female guardian 72.6 77.2** 
Father / male guardian 21.5 16.2** 
Grandparent 3.8 4.2 
Other 2.1 2.4 
 
Note. In the Complex Samples columns, all percentages were weighted with the 
PROVWT_D sampling weight using a weighted sum population size of 10,773,199 (U.S. 
sample) and 550,303 (local area sample) and stratified by the STRATUM variable. In the 
Scaled Sample columns, all percentages were weighted with the scaled factor weight 
[(Sum[PROVWT_D])/unweighted sample size]. Frequencies were identical between the 
Complex and Scaled populations. a Of the teens who were insured. 
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* p < .05 
** p < .01 
 
Overall the 2015 sample was split between males and females, with the majority 
of teens in the U.S. sample ages 14 years or older (87.5%), Non-Hispanic White (63.0%), 
lived above the poverty line (79.4%), had a college-educated mother (42.7%), had 
received a physician recommendation for the HPV vaccine (71.9%), had initiated or 
completed the HPV vaccine series (67.1%), had a well-child checkup at age 11 or 12 
years (95.8%), and had employee-based insurance (62.8% of the teens who were 
insured). Regarding the control variables, the majority of teens had a married mother 
(64.2%), a mother aged 35 years or older (92.1%), two to three children under 18 in the 
household (55.6%), between one and three visits to a health care professional in the past 
12 months (71.5%), and the mother completed the survey (72.6%). When compared to 
the select local area subset, the U.S. sample proportions were significantly different for 
most variables as assessed by the chi-square test, with the exception of gender, age, and 
well-checkup at ages 11 or 12. Given the differences between the two populations, I 
analyzed the select local area sample first, followed by the U.S. sample, as I would not be 
able to generalize the results of the select local area sample to the U.S. sample. 
The 2014 NIS-Teen unweighted dataset included 11,488 teens in the full U.S. 
sample and 1,235 teens in the select local area sample. Table 11 summarizes the 
descriptive and sociodemographic characteristics of the sample.  
Table 11 
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Characteristics of adolescents aged 13-17 years with adequate provider data: 2014 NIS-
Teen 
 
 
United States Local Area 
Gender   
Male 51.4 48.7 
Female 48.6 51.3 
Adolescent’s age (years)   
13 12.3 15.6** 
14 21.0  21.3  
15 21.1  16.4**  
16 23.0  23.7  
17 22.5 23.0  
Race/ethnicity   
Non-Hispanic White 64.5 20.6** 
Hispanic 20.5 47.0** 
Non-Hispanic Black 15.0 32.4** 
Poverty status   
Above $75K 44.2 27.8** 
Poverty to $75K 36.6 35.4 
Below 19.2 36.7** 
Mother’s education   
Less than high school 9.6 19.4** 
High school graduate 20.7 24.1** 
Some college 27.3 24.7 
College graduate 42.3 31.8** 
Physician recommendation of HPV 
vaccine 
  
Yes 68.0 72.7** 
No 32.0 27.3** 
HPV vaccination status   
No shots 46.6 39.5** 
Initiation (1 shot) 23.6 30.2** 
Completion (3 shots) 29.8 30.3 
Well-child checkup   
Yes 94.8 94.8 
No 5.2 5.2 
Type of health insurancea   
Employee-based 64.3 47.2** 
Public (government) 35.7 52.8** 
Ever uninsured, since age 11   
Yes 8.5 7.5 
(table continues) 
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United States Local Area 
No 91.5 92.5 
Mother’s marital status   
Married 68.7 51.9** 
Not married 31.3 48.1** 
Mother’s age (years)   
≤ 34 7.6 9.8** 
35-44 41.9 43.1 
≥ 45 50.5 47.1* 
Number of children under 18 years 
in house 
  
One 33.2 33.1 
Two to three 55.7 52.5* 
Four or more 11.1 14.4** 
Number of visits to HCP in past 12 
months 
  
None 13.7 6.3** 
One 30.4 30.9 
Two to three 39.4 47.5** 
Four to five 12.8 11.5 
Five to six 3.7 3.9 
Relationship to teen   
Mother / female guardian 74.4 78.1** 
Father / male guardian 20.5 14.8** 
Grandparent 3.4 3.6 
Other 1.7 3.4** 
 
Note. In the Complex Samples columns, all percentages were weighted with the 
PROVWT_D sampling weight using a weighted sum population size of 10,799,442 (U.S. 
sample) and 478,148 (local area sample) and stratified by the STRATUM variable. In the 
Scaled Sample columns, all percentages were weighted with the scaled factor weight 
[(Sum[PROVWT_D])/unweighted sample size]. Frequencies were identical between the 
Complex and Scaled populations. a Of the teens who were insured. 
* p < .05 
** p < .01 
 
Overall the 2014 sample was split between males and females; the majority of 
teens in the U.S. sample were ages 14 years or older (87.6%), Non-Hispanic White 
(64.5%), lived above the poverty line (80.8%), had a college-educated mother (42.3%), 
had received a physician recommendation for the HPV vaccine (68.0%), had initiated or 
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completed the HPV vaccine series (53.4%), had a well-child checkup at age 11 or 12 
years (94.8%), and had employee-based insurance (64.3% of teens who were insured). 
Regarding the control variables, the majority of teens had a married mother (68.7%), a 
mother aged 35 years or older (92.4%), two to three children under 18 in the household 
(55.7%), between one and three visits to a health care professional in the past 12 months 
(69.8%), and the mother completed the survey (74.4%). When compared to the select 
local area subset, the U.S. sample proportions were significantly different as assessed by 
the chi-square test, with the exception of gender, well-child checkup at ages 11 or 12, and 
ever being uninsured. As with the 2015 population, given the differences between the two 
populations, I analyzed both the select local area and U.S. samples, focusing specifically 
on select local area for my research questions.  
Results 
Research Question One 
In RQ1, I used binomial logistic regression to examine whether there is a 
relationship between initiation of the HPV vaccine series and socioeconomic and 
demographic variables in the 2015 select local area dataset, controlling for known 
confounders (Table 12). Model 1 included gender, race and ethnicity, poverty status, 
mother’s education level, and select local areas of interest; Model 2 added clinical 
parameters: well-check visits, number of visits in the past 12 months, type of health 
insurance, and if the teen was ever uninsured since age 11. Model 3 added control 
factors: age of teen, relationship of respondent to teen, number of children in house under 
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18, mother’s marital status, and age of the teen’s mother. Variables meeting statistical 
significance (p < .05) were carried into the next iteration. 
Table 12 
 
Relationships between HPV vaccine initiation and socioeconomic and demographic 
variables, Select Local Area, 2015 
 
 
Model 1 
OR [95% CI] 
Model 2 
OR [95% CI] 
Model 3 
OR [95% CI] 
Gender    
Male 1.18 [.94-1.47] -  -  
Female -    
Race/ethnicity    
Hispanic 1.10 [.80-1.52] -  -  
Black .95 [.67-1.35] -  -  
White -    
Poverty    
Below 1.35 [.95-1.92] 1.34 [.90-1.98] -  
Poverty to $75K 1.49 [1.10-2.03]** 1.41 [1.02-1.97] -  
Above $75K -    
Mother’s 
education 
   
< 12 years 1.74 [1.20-2.53]** 1.74 [1.19-2.53]** 1.87 [1.34-2.62]*** 
High school 1.06 [.76-1.49] 1.06 [.76-1.49] 1.16 [.84-1.60] 
Some college 1.31 [.95-1.80] 1.30 [.95-1.79] 1.41 [1.04-1.93]* 
College -    
Select local area    
New York 1.08 [.78-1.49] 1.14 [.83-1.58] 1.15 [.84-1.60] 
Washington, 
D.C. 
1.00 [.47-2.10] .99 [.47-2.09] 1.00 [.47-2.11] 
Philadelphia .95 [.59-1.53] .95 [.59-.1.53] .98[.60-1.59] 
Hidalgo County .45 [.26-.80]** .49 [.28-.84]** .51 [.29-.89]* 
El Paso County .59 [.34-1.03] .68 [.40-1.16] .66 [.39-1.12] 
Houston .43 [.27-.69]*** .43 [.27-.68]*** .42 [.26-.68]*** 
Bexar County .75 [.49-1.15] .85 [.56-1.29] .85 [.56-1.29] 
Chicago -    
 
Note. CI, Confidence Interval. OR, odds ratio. Model 3 was the best fit as determined by 
-2 Log likelihood at α = .05, χ2(4) < 21.92. Fit was calculated by comparing the chi-
square distribution value given degrees of freedom (the difference in parameters between 
the two models) with the difference of -2LL between the two models. If the chi-square 
value was larger, H0 was accepted and the smaller model was the better fit (IBM 
Knowledge Center, n.d.).  
* p < .05 
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** p < .01 
*** p < .001 
 
Model 1 was statistically significant, χ2(15) = 55.53, p < .001. The model 
explained 4.9% (Nagelkerke R2) of the variance in vaccine initiation and correctly 
classified 70.4% of cases. Of the five predictors, education (p < .05), poverty (p < .05), 
and select local area (p < .001) were significantly associated with initiation of the HPV 
vaccine series (Table 12). Teens with mothers having less than 12 years of education 
were 74% were more likely to initiate the series than teens with college-educated mothers 
(OR = 1.74, CI [1.20-2.53], p < .01). Teens living just above the poverty line were 49% 
more likely to initiate the HPV vaccine series compared to those living at the highest 
income level (OR = 1.49, CI [1.10-2.03], p < .01). Finally, teens living in Hidalgo County 
and Houston were 55% and 57% less likely, respectively, to initiate the series than teens 
living in Chicago (OR = .45, CI [.26-.80], p < .01 and OR = .43, CI [.27-.69], p < .001).  
Model 2 was statistically significant, χ2(19) = 63.37, p < .001. The model 
explained 5.6% (Nagelkerke R2) of the variance in vaccine initiation and correctly 
classified 69.3% of cases. Of the predictors, education, select local area (p < .001), and 
ever being uninsured (p < .05), were statistically significant. Teens with mothers having 
less than 12 years of education were 74% more likely to initiate the series than teens with 
college-educated mothers (OR = 1.74, CI [1.19-2.53], p < .01). Teens living in Hidalgo 
County and Houston were 51% and 57% less likely, respectively, to initiate the series 
than teens living in Chicago (OR = .49, CI [.28-.84], p < .01 and OR = .43, CI [.27-.68], p 
< .001). Of the clinical variables added to the model, teens who had not been covered by 
119 
 
insurance at least once since age 11 were 52% more likely to initiate the vaccine than 
teens who had been covered since age 11 (OR = 1.52, CI [1.02-2.27], p < .05). 
Model 3 was statistically significant, χ2(23) = 85.29, p < .001. The model 
explained 7.5% (Nagelkerke R2) of the variance in vaccine initiation and correctly 
classified 69.5% of cases. Of the predictors, education (p < .01), select local area (p < 
.001), and respondent’s relationship to the teen (p < .05) were statistically significant. 
Teens with mothers having less than 12 years of education or some college were 87% and 
41% more likely, respectively, to initiate the series than teens with college-educated 
mothers (OR = 1.87, CI [1.34-2.62], p < .001 and OR = 1.41, CI [1.04-1.93], p < .05). 
Teens living in Hidalgo County and Houston were 49% and 58% less likely, respectively, 
to initiate the series than teens living in Chicago (OR = .51, CI [.29-.89], p < .01 and OR 
= .42, CI [.26-.68], p < .001). Of the remaining variables added to the model, teens whose 
friends or other family members and grandparents answered the survey were 108% and 
74% more likely, respectively, to have initiated the HPV vaccine (OR = 2.08, CI [1.05-
4.13], p < .05, and OR = 1.74, CI [1.02-2.97], p < .05).  
Overall, for RQ1 I rejected the null hypothesis, showing instead that there was a 
relationship between initiation of the HPV vaccine series and at least one socioeconomic 
or demographic variable in select local areas in unadjusted and adjusted models. Across 
all three models, teens whose mothers had less than a college degree were more likely to 
initiate the HPV vaccine, while teens living in Houston and Hidalgo County were less 
likely to initiate the HPV vaccine. The null hypothesis was rejected using the Complex 
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Samples methodology as well, based on significant relationships between initiation and 
select local area (Table A1 in Appendix A). 
Research Question Two 
In RQ2, I examined whether there is a relationship between completion of the 
HPV vaccine series and socioeconomic and demographic variables in the 2015 select 
local area dataset, controlling for known confounders (Table 13). As with RQ1, Model 1 
included gender, race and ethnicity, poverty status, mother’s education level, and select 
local areas of interest; Model 2 added clinical parameters: well-check visits, number of 
visits in the past 12 months, type of health insurance, and if the teen was ever uninsured 
since age 11. Model 3 added control factors: age of teen, relationship of respondent to 
teen, number of children in house under 18, mother’s marital status, and age of the teen’s 
mother.  
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Table 13 
 
Relationships between HPV vaccine completion and socioeconomic and demographic 
variables, Select Local Area, 2015 
 
 
Model 1 
OR [95% CI] 
Model 2 
OR [95% CI] 
Model 3 
OR [95% CI] 
Gender    
Male .65 [.52-.81]*** .67 [.54-.84]*** .64 [.51-.80]*** 
Female -    
Race/ethnicity    
Hispanic 1.28 [.93-1.74] -  -  
Black 1.12 [.79-1.57] -  -  
White -    
Poverty    
Below 1.15 [.82-1.63] -  -  
Poverty to $75K 1.07 [.80-1.44] -  -  
Above $75K -    
Mother’s education    
< 12 years .55 [.38-.81]** .64 [.45-.92]* .71 [.51-.1.00] 
High school .82 [.60-1.13] .90 [.66-1.21] 1.11 [.82-1.50] 
Some college .57 [.41-.78]*** .60 [.44-.81]*** .69 [.51-.95]* 
College -    
Select local area    
New York .95 [.68-1.32] .95 [.68-1.34] .93 [.66-1.31] 
Washington, D.C. 1.41 [.68-2.90] 1.37 [.67-2.83] 1.35 [.65-2.82] 
Philadelphia 2.00 [1.25-3.19]** 1.98 [1.25-3.16]** 2. 03 [1.26-3.26** 
Hidalgo County 1.18 [.70-1.99] 1.29 [.78-2.15] 1.33 [.79-2.22] 
El Paso County 1.24 [.74-2.09] 1.34 [.81-2.21] 1.41 [.84-2.35] 
Houston 1.46 [.96-2.21] 1.46 [.97-2.22] 1.64 [1.07-2.51]* 
Bexar County 1.09 [.71-1.67] 1.13 [.75-1.71] 1.09 [.72-1.66] 
Chicago -    
 
Note. CI, Confidence Interval. OR, odds ratio.  
* p < .05 
** p < .01 
*** p < .001 
 
Model 1 was statistically significant, χ2(15) = 48.65, p < .001. The model 
explained 4.3% (Nagelkerke R2) of the variance in vaccine initiation and correctly 
classified 68.2% of cases. Of the five predictors, gender, education (p < .001), and select 
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local area (p < .05) were statistically associated with completion of the HPV vaccine 
series (Table 13). Males were 35% less likely than females to complete the series (OR = 
.65, CI [.52-.81], p < .001). Teens with mothers having less than 12 years of education or 
some college were 45% and 43% less likely, respectively, to complete the series than 
teens with college-educated mothers (OR = .55, CI [.38-.81], p < .01, and OR = .57, CI 
[41-.78], p < .001). Last, teens living in Philadelphia were 100% more likely to complete 
the series than teens living in Chicago (OR = 2.00, CI [1.25-3.19], p < .01). 
Model 2 was statistically significant, χ2(18) = 53.12, p < .001. The model 
explained 4.7% (Nagelkerke R2) of the variance in vaccine initiation and correctly 
classified 67.8% of cases. Of the predictors, gender (p < .010), education (p < .01), and 
select local area (p < .05) were statistically associated with completion of the HPV 
vaccine series. Males were 33% less likely than females to complete the series (OR = .67, 
CI [.54-.84], p < .001). Teens with mothers having less than 12 years of education or 
some college were 36% and 40% less likely, respectively, to complete the series than 
teens with college-educated mothers (OR = .64, CI [.45-.92], p < .05, and OR = .60, CI 
[.44-.81], p < .001). Last, teens living in Philadelphia were 98% more likely to complete 
the series than teens living in Chicago (OR = 1.98, CI [1.25-3.16], p < .01). None of the 
clinical variables added to the model were significantly associated with completing the 
HPV vaccine series. 
Model 3 was statistically significant, χ2(23) = 111.56, p < .001. The model 
explained 9.6% (Nagelkerke R2) of the variance in vaccine initiation and correctly 
classified 69.5% of cases. Of the predictors, education (p < .05), select local area (p < 
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.01), relationship of the respondent to the teen, age of the teen, and gender (p < .001) 
were significantly associated with completing the HPV vaccine series. Males were 36% 
less likely than females to complete the series (OR = .64, CI [.51-.80], p < .001). Teens 
with mothers having some college were 31% less likely to complete the series than teens 
with college-educated mothers (OR = .69, CI [.51-.95], p < .05). Teens living in 
Philadelphia and Houston were 103% and 64% more likely, respectively, to complete the 
series than teens living in Chicago (OR = 2.03, CI [1.26-3.26], p < .01, and OR = 1.64, CI 
[1.07-2.51], p < .05). Teens were less likely to complete the series if other family 
members or friends (70% less likely), grandparents (67%), or fathers (39%) answered the 
survey rather than mothers (all p < .01). Last, teens were 41% less likely to complete the 
series if they were 14 years old (p < .01) but 63% more likely to complete the series if 
they were 15 years old (p < .01) compared to teens aged 17 years old.  
Overall, for RQ2 I rejected the null hypothesis, showing instead that there was a 
relationship between completion of the HPV vaccine series and at least one 
socioeconomic or demographic variable in select local areas in unadjusted and adjusted 
models. Across all three models, males and teens whose mothers had less than a college 
education were less likely to complete the HPV vaccine series, while teens living in 
Philadelphia and Houston were more likely to complete the series. The null hypothesis 
was rejected using the Complex Samples methodology as well, based on significant 
relationships between completion and gender (Table A2 in Appendix A). 
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Research Question Three 
In RQ3, I examined whether there is a relationship between initiation of the HPV 
vaccine series and social vulnerability by select local area county, using a chi-square test 
of independence and data from the 2014 NIS-Teen and the 2014 Social Vulnerability 
Index (Table 14). All expected cell frequencies were greater than five.  
Table 14 
 
Relationship between HPV vaccine initiation and overall county social vulnerability 
ranking, 2014 
 
 
Social Vulnerability 
percentile ranking 
HPV Vaccine Initiation 
  Yes No 
Washington, D.C. .59 (Med-High)  
Count  20 54 
Expected Count  19.7 54.3 
Adjusted Residuals  0.1 -0.1 
Philadelphia .91 (High)   
Count  73 148 
Expected Count  58.9 162.1 
Adjusted Residuals  2.6 -2.6 
El Paso County .95 (High)   
Count  47 139 
Expected Count  49.6 136.4 
Adjusted Residuals  -.05 0.5 
Bexar County .82 (High)   
Count  63 218 
Expected Count  74.9 206.1 
Adjusted Residuals  -2.0 2.0 
 
Note. Med-High indicates a medium-high vulnerability, or being in the third-highest 
percentile of vulnerability. 
 
There was not a statistically significant association found between the two 
variables, χ2(3) = 7.37, p = .06. The adjusted standardized residuals were greater than or 
equal to 2 in Philadelphia and Bexar County, with the largest difference between 
observed and expected counts in Philadelphia. 
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For RQ3 I could not reject the null hypothesis, as the relationship between HPV 
vaccine initiation and social vulnerability ranking did not meet statistical significance. 
The null hypothesis was not rejected using the Complex Samples methodology as well, as 
there was no significant relationship between the variables (Table A3 in Appendix A). 
Research Question Four 
In RQ4, I examined whether there is a relationship between physician 
recommendation of the HPV vaccine series and social vulnerability by select local area 
county, using a chi-square test of independence and data from the 2014 NIS-Teen and the 
2014 Social Vulnerability Index (Table 15). 
Table 15 
 
Relationship between physician recommendation and overall county social vulnerability 
ranking, 2014 
 
 
Social Vulnerability 
percentile ranking 
Physician Recommendation 
  Yes No 
Washington, D.C. .59 (Med-High)  
Count  60 14 
Expected Count  51 23 
Adjusted Residuals  2.4 -2.4 
Philadelphia .91 (High)   
Count  168 53 
Expected Count  152.2 68.8 
Adjusted Residuals  2.7 -2.7 
El Paso County .95 (High)   
Count  128 57 
Expected Count  127.4 57.6 
Adjusted Residuals  .1 -.1 
Bexar County .82 (High)   
Count  168 113 
Expected Count  193.5 87.5 
Adjusted Residuals  -4.1 4.1* 
 
Note. Med-High indicates a medium-high vulnerability, or being in the third-highest 
percentile of vulnerability. 
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* p < .05 
 
There was a statistically significant association between the two variables, χ2(3) = 
21.23, p < .001, and the association was small, Cramer’s V = 0.17, p < .001. The adjusted 
standardized residuals were greater than 2 in Washington, D.C., Philadelphia, and Bexar 
County, with the largest difference between observed and expected counts in Bexar 
County.  
For RQ4 I rejected the null hypothesis, as the relationship between physician 
recommendation and social vulnerability ranking was statistically significant. The null 
hypothesis was rejected using the Complex Samples methodology as well, as there was a 
significant relationship between the two variables (Table A4 in Appendix A). 
Although the following analyses were not included in the original research 
questions, they provide additional context in the testing of relationships between HPV 
vaccination, physician recommendation, and select independent variables.  
U.S. Sample Analyses 
Initiation. In the U.S. sample (Table 16), initiation of the HPV vaccine series 
correlated with gender, race and ethnicity, poverty status, and select local area across all 
three models. 
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Table 16 
 
Relationships between HPV vaccine initiation and socioeconomic and demographic 
variables, United States, 2015 
 
 
Model 1 
OR [95% CI] 
Model 2 
OR [95% CI] 
Model 3 
OR [95% CI] 
Gender    
Male .80 [.74-.87]*** .80 [.73-.87]*** .80 [.74-.87]*** 
Female -    
Race/ethnicity    
Hispanic 1.11 [.98-1.26] 1.13 [1.00-1.28]* 1.15 [1.02-1.31]* 
Black 1.28 [1.12-1.45]*** 1.25 [1.09-1.42]*** 1.27 [1.11-1.45]*** 
White -    
Poverty    
Below 1.37 [1.19-1.58]*** 1.33 [1.16-1.53]*** 1.33 [1.16-1.51]*** 
Poverty to $75K .97 [.87-1.08] .95 [.85-1.06] .95 [.86-1.06] 
Above $75K -    
Mother’s education    
< 12 years 1.13 [.95-1.34] -  -  
High school .97 [.85-1.10] -  -  
Some college 1.00 [.89-1.12] -  -  
College -    
Select local area    
New York 1.09 [.66-1.81] 1.06 [.64-1.76] 1.06 [.64-1.76] 
Washington, D.C. .89 [.27-2.90] .90 [.27-2.94] .88 [.27-2.90] 
Philadelphia .90 [.42-1.92] .95 [.59-.1.53] .89 [.42-.1.91] 
Hidalgo County .53 [.22-1.26] .52 [.22-1.25] .51 [.21-1.22] 
El Paso County .69 [.30-1.60] .68 [.29-1.58] .68 [.29-1.58] 
Houston .45 [.21-.95]* .43 [.20-.90]* .41 [.20-.88]* 
Bexar County .81 [.42-1.58] .84 [.43-1.62] .82 [.42-1.59] 
Chicago -    
 
Note. CI, Confidence Interval. OR, odds ratio.  
* p < .05 
** p < .01 
*** p < .001 
Model 1 was statistically significant, χ2(65) = 192.49, p < .001. The model 
explained 2.4% (Nagelkerke R2) of the variance in vaccine initiation and correctly 
classified 76.4% of cases. Of the five predictors, gender, race, poverty (p < .001), and 
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select local area (p < .01) were significantly associated with initiation of the HPV vaccine 
series (Table 16). This differed from the select local area sample, in which mother’s 
education level was significant and gender was not (Table 12). Teens were less likely to 
initiate the HPV vaccine series if they were male (20% less) or lived in Houston (55%), 
compared to females or teens who lived in Chicago. Teens were more likely to initiate the 
series if they were Black (28% more) or lived below the poverty level (37%) than teens 
who were White or lived at the highest income level.  
Model 2 was statistically significant, χ2(69) = 235.77, p < .001. The model 
explained 3.0% (Nagelkerke R2) of the variance in vaccine initiation and correctly 
classified 76.4% of cases. Of the predictors, gender, poverty, number of visits to a health 
care professional in the past year, (p < .001), race, and select local area (p < .01) were 
significantly associated with initiation of the HPV vaccine series (Table 16). This 
differed from the select local area sample, in which only mother’s education level, ever 
being uninsured, and select local area were significant (Table 12). Teens were less likely 
to initiate the HPV vaccine series if they were male (20% less) or lived in Houston (57% 
less), compared to females or teens who lived in Chicago. Teens were more likely to 
initiate the series if they were Hispanic (13% more), Black (25%) or lived below the 
poverty level (33%) compared to teens who were White or lived at the highest income 
level. Last, teens who had between one and five visits with a health care professional in 
the past 12 months were 43% to 58% more likely to initiate the vaccine than teens who 
had no visits. 
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Model 3 was statistically significant, χ2(76) = 306.40, p < .001. The model 
explained 3.8% (Nagelkerke R2) of the variance in vaccine initiation and correctly 
classified 76.5% of cases. Of the predictors, gender, poverty, race, select local area, 
number of visits to a health care professional in the past year, relationship of the 
respondent to the teen, number of children in the household under age 18 years, age of 
the teen, (p < .001), and mother’s marital status (p < .05) were significantly associated 
with initiation of the HPV vaccine series (Table 16). This differed from the select local 
area sample, in which only mother’s education level and select local area were significant 
(Table 12). Teens were less likely to initiate the HPV vaccine series if they were male 
(20% less) or lived in Houston (59%), compared to females or teens who lived in 
Chicago. Teens were more likely to initiate the series if they were Hispanic (15% more), 
Black (27%) or lived below the poverty level (33%) compared to teens who were White 
or lived at the highest income level.  
Completion. In the U.S. sample (Table 17), completion of the HPV vaccine series 
was associated with gender, mother’s education, and select local area across all three 
models. 
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Table 17 
 
Relationships between HPV vaccine completion and socioeconomic and demographic 
variables, United States, 2015 
 
 
Model 1 
OR [95% CI] 
Model 2 
OR [95% CI] 
Model 3 
OR [95% CI] 
Gender    
Male .52 [.48-.56]*** .52 [.48-.56]*** .52 [.48-.56]*** 
Female -    
Race/ethnicity    
Hispanic 1.13 [1.00-1.26]* 1.12 [1.00-1.26]* 1.10 [.98-1.24] 
Black .93 [.82-1.05] .94 [.83-1.07] .91 [.80-1.04] 
White -    
Poverty    
Below .94 [.82-1.07]   
Poverty to $75K .90 [.82-1.00]   
Above $75K -    
Mother’s education    
< 12 years .98 [.83-1.15] .97 [.83-1.14] 1.01 [.87-1.18] 
High school .81 [.72-.92]*** .79 [.71-.89]*** .85 [.76-.96]** 
Some college .86 [.77-.95]** .85 [.76-.94]*** .86 [.77-.95]** 
College -    
Select local area    
New York .98 [.58-1.68] 1.03 [.60-1.76] 1.04 [.61-1.79] 
Washington, D.C. 1.50 [.47-4.77] 1.54 [.48-4.95] 1.60 [.49-5.19] 
Philadelphia 2.20 [1.05-4.63]* 2.24 [1.06-4.72]* 2.30 [1.08-4.90]* 
Hidalgo County 1.13 [.50-2.54] 1.11 [.49-2.52] 1.17 [.51-2.67] 
El Paso County 1.28 [.57-2.87] 1.33 [.59-2.99] 1.38 [.61-3.13] 
Houston 1.46 [.75-2.86] 1.46 [.75-2.86] 1.52 [.77-3.00] 
Bexar County 1.12 [.58-2.18] 1.21 [.62-2.35] 1.24 [.63-2.42] 
Chicago -    
 
Note. CI, Confidence Interval. OR, odds ratio.  
* p < .05 
** p < .01 
*** p < .001 
Model 1 was statistically significant, χ2(65) = 482.08, p < .001. The model 
explained 5.5% (Nagelkerke R2) of the variance in vaccine completion and correctly 
classified 66.8% of cases. Of the predictors, gender, mother’s education level, select local 
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area (p < .001), and race (p < .05) were significantly associated with completion of the 
HPV vaccine series (Table 17). This differed from the select local area sample, in which 
only gender, mother’s education level, and select local area were significant (Table 13). 
Teens were less likely to complete the HPV vaccine series if they were male (48% less), 
if their mothers were high school graduates (19%) or had some college education (14%) 
compared to females or teens whose mothers had less than 12 years of education or a 
college degree. Teens were more likely to complete the vaccine series if they were 
Hispanic (13% more) or lived in Philadelphia (120%) compared to teens who were White 
or lived in Chicago.  
Model 2 was statistically significant, χ2(70) = 576.64, p < .001. The model 
explained 6.6% (Nagelkerke R2) of the variance in vaccine completion and correctly 
classified 67.7% of cases. Of the predictors, gender, mother’s education level, select local 
area, a well-check visit at age 11 or 12, number of visits to a health care professional in 
the past 12 months (p < .001), and race (p < .05) were significantly associated with 
completion of the HPV vaccine series (Table 17). This differed from the select local area 
sample, in which only gender, mother’s education level, and select local area were 
significant (Table 13). Teens were less likely to complete the HPV vaccine series if they 
were male (48% less), if their mothers were high school graduates (21%) or had some 
college education (15%) compared to females or teens whose mothers had less than 12 
years of education or a college degree. Teens were more likely to complete the vaccine 
series if they were Hispanic (12% more) or lived in Philadelphia (124%) compared to 
teens who were White or lived in Chicago.  
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Model 3 was statistically significant, χ2(80) = 847.79, p < .001. The model 
explained 9.6% (Nagelkerke R2) of the variance in vaccine completion and correctly 
classified 69.4% of cases. Of the predictors, gender, select local area, a well-check visit at 
age 11 or 12, number of visits to a health care professional in the past 12 months, number 
of children in the household under 18 years, age of the teen, (p < .001) mother’s 
education level (p < .01), and mother’s age (p < .05) were significantly associated with 
completion of the HPV vaccine series (Table 17). This differed from the select local area 
sample, in which only gender, mother’s education level, and select local area were 
significant (Table 13). Teens were less likely to complete the HPV vaccine series if they 
were male (48% less), if their mothers were high school graduates (15%) or had some 
college education (14%) compared to females or teens whose mothers had less than 12 
years of education or a college degree. Teens were more likely to complete the vaccine 
series if they lived in Philadelphia (130% more) compared to teens who lived in Chicago.  
Finally, the relationship between HPV initiation and completion was significant 
across the United States (Table D1 in Appendix D). Teens were less likely to initiate the 
vaccine series if they lived in Arizona, Florida, Iowa, Louisiana, Missouri, New Mexico, 
Ohio, Pennsylvania, Tennessee, and Texas than teens who lived in Chicago. Teens were 
more likely to complete the series if they lived in Arizona, California, Iowa, Maine, 
Massachusetts, New Hampshire, Oklahoma, Pennsylvania, and Rhode Island.  
No Shots Analysis 
Binominal logistic regression was used to test the relationship between receiving 
no shots in the HPV vaccine series in the United States and select local areas (Table 18). 
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Table 18 
 
Relationships between no receipt of HPV vaccine and socioeconomic and demographic 
variables, United States and Select Local Areas, 2015 
 
 
U.S. sample 
OR [95% CI] 
Select Local Area sample 
OR [95% CI] 
Gender   
Male 2.14 [1.98-2.31]*** 1.30 [1.05-1.60]* 
Female -   
Race/ethnicity   
Hispanic .83 [74-.93]*** .73 [.54-.98]* 
Black .88 [.78-.99]* .94 [.68-1.30] 
White -   
Poverty   
Below 0.82 [.72-.93]** .69 [.49-.95]* 
Poverty to $75K 1.13 [1.03-1.24]* .67 [.51-.89]** 
Above $75K -   
Mother’s education   
< 12 years .91 [.77-1.06] 1.04 [.72-1.51] 
High school 1.24 [1.11-1.38]*** 1.15 [.84-1.58] 
Some college 1.15 [1.04-1.27]** 1.33 [.98-1.79] 
College -   
Select local area   
New York .95 [.58-1.58] .98 [.71-1.34] 
Washington, D.C. .77 [.24-2.52] .73 [.35-1.52] 
Philadelphia .48 [.22-1.09] .50 [.30-.83]** 
Hidalgo County 1.57 [.72-3.41] 1.69 [1.03-2.78]* 
El Paso County 1.13 [.52-2.48] 1.29 [.78-2.13] 
Houston 1.35 [.70-2.58] 1.37 [.92-2.06] 
Bexar County 1.11 [.59-2.08] 1.20 [.80-1.79] 
Chicago -   
 
Note. CI, Confidence Interval. OR, odds ratio.  
* p < .05 
** p < .01 
*** p < .001 
In the U.S. sample, teens were more likely to receive no shots if they were male 
(114% more likely), living just above the poverty level (13%), or had mothers with a high 
school (24%) or some college education (15%) compared to the reference groups. Teens 
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were less likely to receive no shots if they were Hispanic (17% less likely), Black (12%), 
or lived below the poverty level (18%).  
In the select local area sample, teens were more likely to receive no shots if they 
were male (30% more likely) compared to females or lived in Hidalgo County (69%) 
versus Chicago; teens were less likely to receive no shots if they lived below (31% less 
likely) or just above the poverty line (33%), were Hispanic (27%), or lived in 
Philadelphia (50%) compared to the reference groups. 
Select Local Area and Vulnerability Analyses 
Using a chi-square test of independence, I tested the relationships between receipt 
of no HPV shots, completion of the HPV series, and select local area county using data 
from the 2014 NIS-Teen and the 2014 Social Vulnerability Index (Table 19).  
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Table 10 
 
Relationship between no shots, completion of the series, and overall county social 
vulnerability ranking, 2014 
 SVI rank No shots Completion 
  Yes No Yes No 
Washington, D.C. .59 (Med-High)     
Count  23 51 31 43 
Expected Count  29 45 25.5 48.5 
Adjusted 
Residuals 
 -1.5 1.5 1.4 -1.4 
Philadelphia .91 (High)     
Count  62 159 86 135 
Expected Count  86.5 134.5 76.1 144.9 
Adjusted 
Residuals 
 -4.0 4.0* 1.7 -1.7 
El Paso County .95 (High)     
Count  67 118 72 113 
Expected Count  72.4 112.6 63.7 121.3 
Adjusted 
Residuals 
 -.9 .9 1.5 -1.5 
Bexar County .82 (High)     
Count  146 135 73 208 
Expected Count  110 171 96.7 184.3 
Adjusted 
Residuals 
 5.5 -5.5** -3.8 3.8* 
 
Note. Med-High indicates a medium-high vulnerability, or being in the third-highest 
percentile of vulnerability. 
* p < .05 
* p < .01 
 
There was a statistically significant association between the counties and receipt 
of no shots, χ2(3) = 33.46, p < .001, and the association was small to moderate, Cramer’s 
V = 0.21, p < .01. The adjusted standardized residuals were greater than 2 in Bexar 
County and Philadelphia. With completion of the series and the select counties, there was 
a statistically significant association, χ2(3) = 14.34, p < .01, and the association was 
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small, Cramer’s V = 0.14, p < .001. The adjusted standardized residuals were greater than 
2 in Bexar County.  
Select Local Areas Versus States Analysis 
As select local area samples were removed from states as a whole in NIS-Teen, I 
conducted a chi-square test of independence to test the association between no shots, 
HPV vaccine initiation, vaccine completion, and physician recommendation between 
select local areas and their states (Table 20). 
Table 11 
 
Significant Relationships between Select Local Areas and States, 2015  
 No shots 
χ2(df) 
(Cramer’s V) 
Initiation 
χ2(df) 
(Cramer’s V) 
Completion 
χ2(df) 
(Cramer’s V) 
Recommendation 
χ2(df) 
(Cramer’s V) 
New York City vs. 
New York  
χ2(1) = 2.13 χ2(1) = 12.32*** χ2(1) = 2.99 χ2(1) = .09 
 (.06) (.13)*** (.07) (.01) 
Philadelphia vs. 
Pennsylvania 
χ2(1) = 5.35* χ2(1) = 5.06* χ2(1) = .28 χ2(1) = .96 
 (.11)* (.11)* (.03) (.05) 
Chicago vs.  
Illinois 
χ2(1) = 3.71 χ2(1) = 5.68* χ2(1) = .01 χ2(1) = 1.73 
 (.08) (.10)* (.01) (.06) 
Hidalgo County vs. 
Texas 
χ2(1) = 1.18 χ2(1) = .06 χ2(1) = 1.45 χ2(1) = .30 
 (.04) (.01) (.04) (.02) 
El Paso County vs. 
Texas 
χ2(1) = 2.96 χ2(1) = .38 χ2(1) = 2.45 χ2(1) = .78 
 (-.06) (.02) (.05) (.03) 
Houston vs.  
Texas 
χ2(1) = 2.71 χ2(1) = .21 χ2(1) = 5.99* χ2(1) = 4.66* 
 (.05) (.02) (.08)* (.07)* 
Bexar County vs. 
Texas 
χ2(1) = 4.68* χ2(1) = 1.38 χ2(1) = 2.21 χ2(1) = 2.31 
 (.07)* (.04) (.04) (.05) 
  
Note. df, degrees of freedom.  
* p < .05 
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*** p < .001 
There was a significant relationship between Philadelphia and Pennsylvania and 
Bexar County and Texas in receiving no HPV shots, both with small effects as measured 
by Cramer’s V. Fewer teens than expected received no shots in Philadelphia and Bexar 
County. Regarding HPV vaccine initiation, there was a significant relationship between 
New York City, Philadelphia, and Chicago and their respective states, all with small 
effects. Fewer teens than expected initiated the HPV vaccine in New York state, 
Pennsylvania, and Illinois. The only significant relationship for completion of the HPV 
vaccine series was observed between Houston and Texas, in which fewer teens than 
expected in Texas completed the series, with a small effect. Last, there was a significant 
relationship between Houston and Texas regarding physician recommendation, in which 
fewer teens than expected in Texas had a physician recommendation, with small effect. 
Finally, physician recommendation differed significantly by state (Table D1 in 
Appendix D). Teens who lived in Alabama, Arkansas, Mississippi, Missouri, Tennessee, 
and Texas were less likely to receive a physician recommendation, while teens who lived 
in Rhode Island were more likely to receive a physician recommendation.  
Summary 
In summary, I rejected the null hypothesis for research question 1, as there was a 
significant relationship between HPV vaccine initiation, the mother’s level of education, 
and select local area. Teens whose mothers had less than a college degree were more 
likely to initiate the HPV vaccine, while teens living in Houston and Hidalgo County 
were less likely to initiate the HPV vaccine.  
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I rejected the null hypothesis for research question 2, as there was a significant 
relationship between HPV vaccine completion, teen’s gender, the mother’s level of 
education, and select local area. Teens living in Philadelphia and Houston were more 
likely to complete the series, while males and teens whose mothers had less than a 
college education were less likely to complete the HPV vaccine series. 
I did not reject the null hypothesis for research question 3, as there was not a 
significant relationship between HPV vaccine initiation and select local area county. 
Finally, I rejected the null hypothesis for research question 4, as there was a significant 
relationship between physician recommendation of the HPV vaccine and select local area 
county. 
I presented several additional analyses of the 2014 and 2015 NIS-Teen data, 
including analyses of the U.S. sample; relationships between receipt of no HPV shots and 
independent variables; relationships between receipt of no shots, completion of the series, 
and select local area county; and relationships between select local area and respective 
states with the dependent variables.  
In the following chapter, I discuss the interpretation of the results and how these 
results reflect findings in the peer-reviewed literature, as well as present 
recommendations for professional practice and the implications for social change. 
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Section 4: Application to Professional Practice and Implications for Social Change  
Introduction 
Rates of the HPV vaccine and physician recommendation for the vaccine continue 
to be lower than any other adolescent vaccine, and vary across gender, socioeconomic 
status, racial and ethnic background, and geographic location (Henry et al., 2017; 
Mohammed et al., 2016; Reagan-Steiner et al., 2016; Rutten et al., 2017). Researchers 
have focused on inter- and intra-personal efforts to promote behavior change regarding 
vaccination, but these interventions have had little effect on increasing HPV vaccination 
rates (Askelson et al., 2016; Brandt et al., 2016). Additional research on other potential 
factors influencing vaccination is needed to increase rates, as well as physician 
recommendation of the HPV vaccine, to better protect against multiple HPV-related 
cancers (Maness et al., 2016; Perkins, 2016). 
The purpose of this quantitative, retrospective, secondary analysis of national, 
publicly available data was to test the relationships between HPV vaccine initiation and 
completion, socioeconomic and demographic variables, physician recommendation, and 
social vulnerability in select local areas in the United States. In these analyses, I showed 
that teens were more likely to initiate the HPV vaccine series if their mothers had less 
education than a college degree versus teens whose mothers had graduated college; teens 
were less likely to initiate the series if they lived in Houston or Hidalgo County versus 
teens living in Chicago. Teens were more likely to complete the HPV vaccine series if 
they lived in Philadelphia or Houston versus teens living in Chicago; teens were less 
likely to complete the series if they were males or their mothers had less than a college 
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education versus those who had graduated college. Finally, I did not find a relationship 
between initiation of the series and select local area, but did find a relationship between 
physician recommendation of the vaccine and select local area.  
Interpretation of the Findings 
Socioeconomic Variables  
The definition of socioeconomic status is complex and dynamic, and how it is 
measured within a study affects the findings and interpretations (Joshua et al., 2015; 
Ratnapradipa et al., 2017; Willis & Fitton, 2016). In peer-reviewed literature, most 
researchers used metrics including poverty level and the mother’s level of education, and 
have found an inverse relationship between HPV vaccination, poverty, and education 
level in the United States (Galbraith et al., 2016; Henry et al., 2017; Jeudin et al., 2014; 
Monnat et al., 2016; Perkins, 2016; Polonijo et al., 2016; Reagan-Steiner et al., 2016).  
My findings reflected the literature regarding a significant relationship between 
mother’s level of education and HPV vaccination, in which an inverse relationship has 
been demonstrated between educational attainment, the teen’s vaccination, and physician 
recommendation (Mohammed et al., 2016; Henry et al., 2017). Of note, teens whose 
mothers had less than a high school education or some college were more likely to 
initiate the HPV vaccine, but teens whose mothers had some college were less likely to 
complete the series than teens whose mothers had a college education. The higher 
likelihood of initiation may have reflected greater access to the HPV vaccine through the 
Vaccines For Children program to initiate the series, while the lower likelihood of 
completion may have been due to lower rates of physician recommendation within lower 
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educational attainment levels, or less awareness of the importance of completing the 
series (Mohammed et al., 2016; Henry et al., 2017). 
My findings within the select local area sample regarding the relationship 
between poverty and vaccination were not consistent with current literature, although my 
findings using the U.S. sample did align with published findings that teens living below 
the poverty level were more likely to be vaccinated than teens at the highest income 
levels (see Additional Analyses section below). Poverty was not significantly associated 
with HPV vaccine initiation or completion in the final models in research questions 1 and 
2. The discrepancy between my findings regarding poverty and those in the literature may 
have been due to the differences in sample selection, both geographically and in the 
dataset.  
Researchers have demonstrated variations in relationships using the same 
socioeconomic data across different geographic levels, a phenomenon known as the 
modifiable area unit problem (Krieger et al., 2005; Pruitt & Schootman, 2010; Rutten et 
al., 2017). For example, Henry et al. (2017) found an inverse relationship between 
poverty level and Zip code tabulation areas across the United States using 2012-2013 
NIS-Teen data; Rutten et al. (2017) showed a positive relationship between 
socioeconomic status and census block group with American Community Survey data; 
and Pruitt and Schootman (2010) and Krieger et al. (2005) demonstrated that the 
relationship between socioeconomic status and variables changed across state, county, 
block group, census tract, and Zip code. While I could not discount the small sample size 
in the select local areas as a potential influence on my findings, I believe the 
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inconsistency between my findings at the select local area versus other published research 
supported the importance of using multiple geographic areas of analysis and working 
within each local community when assessing public health needs to distribute resources 
where they are most needed.  
Demographic Variables  
In peer-reviewed literature, the majority of researchers have shown a relationship 
between gender, race, age, and HPV vaccination, as well as physician recommendation, 
across geographic levels (Bodson et al., 2016; Gilkey et al., 2016; Jeudin et al., 2014; 
Mohammed et al., 2016; Malo et al., 2016b; Rahman et al., 2015; Reagan-Steiner et al., 
2016; Rutten et al., 2017; Vadaparampil et al., 2016). My findings regarding HPV 
vaccine completion were consistent with the current literature, in that males were 
significantly less likely to complete the vaccine series than females. These results were 
consistently demonstrated across datasets, geographic levels, and over time, and were 
likely due to the 5-year delay in approval and insurance coverage of the HPV vaccine for 
males, as well as lower rates of physician recommendation for males versus females 
(ACIP, 2016; Jeudin et al., 2014; Vadaparampil et al., 2016; Walker et al., 2017).  
In addition, researchers have argued that knowledge and awareness of HPV’s role 
in several male cancers was low, as was male awareness of the HPV vaccine (Boakye et 
al., 2017; Osazuwa-Peters et al., 2017). I did not find a significant relationship between 
gender and HPV vaccine initiation in the select local area sample, although I did find 
males were less likely to be vaccinated in the U.S. sample as reported in the literature 
(see Additional Analyses). This may have been due to the lower rates of physician 
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recommendation for males, as once males began the series based on a recommendation, 
they would have been more likely to complete it (see Limitations). However, this 
hypothesis was not testable using the NIS-Teen database. In addition, while males living 
below the poverty line were more likely to initiate the vaccine series, there was a higher 
frequency of males in the above poverty categories in this study. 
My findings regarding HPV vaccination and race were not consistent with the 
current literature, as there was no relationship between the two variables, or with 
physician recommendation. I did find a significant relationship between race and 
ethnicity and HPV completion in the U.S. sample, however, with Hispanics and Non-
Hispanic Blacks more likely to initiate the HPV vaccine series than Non-Hispanic Whites 
(see Additional Analyses). This may have been due to the small number of select local 
areas used for comparison, as well as the significant difference in race and ethnicity 
populations between the United States and select local area samples (Table 11). In 
addition, there was not a significant relationship between physician recommendation and 
race and ethnicity (see Limitations).  
Social Vulnerability 
As noted previously, direct measurement of vulnerability may not be possible, 
and within geographic areas the same exposure to a risk factor does not mean each 
individual has the same vulnerability (Burnell, 2012; Ratnapradipa et al., 2017). 
Researchers recently have begun to test vulnerability rankings from the Social 
Vulnerability Index with a variety of health behaviors. For example, An and Xiang 
(2015) demonstrated differences in physical inactivity and vulnerability in a national 
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sample, while Ratnapradipa et al. (2017) found a difference in incidence of Lyme Disease 
by vulnerability ranking across the United States. Given the importance of social 
determinants of health connected with vulnerability and with HPV vaccination, I used a 
novel approach to test any potential links between vulnerability and factors contributing 
to HPV vaccination by matching vulnerability rankings from the SVI with data in NIS-
Teen at the county level (Gay et al., 2016; Grabovschi et al., 2013; Juster et al., 2016).  
There was a significant relationship between overall social vulnerability ranking 
at the county level and physician recommendation, as teens who lived in Washington, 
D.C. and Philadelphia were more likely to receive a physician recommendation than 
teens in Bexar County, but not with initiation of the HPV vaccine series. There was a 
relationship between no shots and completion of the series as well; teens who lived in 
Philadelphia were less likely to receive no shots, while teens who lived in Bexar county 
were more likely to receive no shots and less likely to complete the vaccine series (see 
Additional Analyses). The findings were an important proof of concept in showing 
differences in dependent variables at the county level within NIS-Teen, and can provide a 
foundation for a number of questions for future research examining vulnerability in HPV 
vaccination and physician recommendation.  
Additional Analyses  
As noted above, my findings regarding the relationships between poverty, gender, 
race and ethnicity, HPV vaccination, and physician recommendation were consistent with 
findings in the current literature, as the sample population in this study reflected other 
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research with national samples (Tables 16 and 17; Henry et al., 2017; Reagan-Steiner et 
al., 2016; Walker et al., 2017).  
Few researchers have examined the relationship between socioeconomic and 
demographic variables and receipt of no HPV shots, as they would be expected to be the 
reverse of relationships with initiation and completion. While most of the independent 
variables were in line with these expectations, the findings regarding poverty were of 
note. In the United States, teens living just above the poverty level were more likely to 
receive no HPV shots. This may have been due to several factors; for example, the teens 
may not have qualified for free shots through Vaccines For Children, or they may have 
lived in marginally impoverished or wealthier areas with little access to free or low-cost 
health care clinics (Lin et al., 2015; Monnat et al., 2016; Tsui et al., 2013). In the select 
local area sample, teens living just above the poverty line were less likely to receive no 
shots; this may have reflected the influence of the federal Section 317 funds to purchase 
vaccines in these select local areas (Reagan-Steiner et al., 2016). 
Theoretical Considerations 
The theories underpinning this study were the fundamental cause theory (FCT) 
and bhavioral economics (BE). Together, the two stress the value in considering multiple 
levels of behavior and social determinants when assessing problems and solutions in 
public health (Bickel et al., 2016; Link & Phelan, 1995).  
Link and Phelan (1995) posited in the FCT that resources and the capacity to use 
resources and innovations to avoid risks or minimize morbidity and mortality are 
distributed unequally. I found that resources such as education and poverty were unequal 
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within the U.S. and select local area samples, as well as between the two samples, 
suggesting that the capacity to be proactive or to cope with health issues differs among 
populations (Clouston et al., 2016; Link & Phelan, 1995; Mackenbach, 2017). In 
addition, I found that uptake of the innovative HPV vaccine was unequal within and 
between populations in my study. While testing FCT directly is outside the scope of my 
study, I believe my findings support considering HPV vaccination as a modern empirical 
test of the FCT (Polonijo & Carpiano, 2013).   
However, even if individuals have similar access (or lack of access) to health-
promoting resources, Frank (2004) and Dovidio and Fiske (2012) argued that humans 
tend to make irrational decisions about health despite evidence pointing to the benefit of a 
more rational choice. The authors and others have advanced the use of BE in patient and 
physician decision-making, and in particular with physicians (Arrow, 1963; Mackenbach, 
2017). I found that physician recommendation differs across geographic areas, as well as 
a number of socioeconomic and demographic variables that have been associated with 
HPV vaccination (Table C1 in Appendix C). Although NIS-Teen does not collect data on 
physician decision-making, and direct testing of behavioral economics is outside the 
scope of this study, I believe my findings provide initial evidence that physician decision-
making (as measured by recommendation) is not consistent across geographic areas 
despite the body of evidence supporting HPV vaccination. In addition, I believe that the 
difference in recommendation across select local areas highlighted the role local biases 
and heuristics play in decision-making, as well as the importance of assessing and 
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intervening in public health issues at the local level (Blumenthal-Barby & Krieger, 2015; 
Saini et al., 2017). 
Limitations of the Study 
There were several limitations to generalizability and validity in my study. First, 
as a national survey reliant on current, active telephone numbers for non-institutionalized 
heads of household, the NIS-Teen may have been subject to non-response and sampling 
biases. For example, data for teens whose guardians did not have a cell phone or landline 
number, or those with institutionalized guardians, were not captured. CDC used random-
digit dialing methods and probability sampling adjustments to reduce any potential for 
sampling errors in the eligible population, but the data were not reflective of the above-
mentioned population and should not be used to generalize to teens ineligible for the 
survey (CDC et al., 2015; 2016). Second, guardian recall or understanding of the 
questions in the self-reported survey may have been inaccurate or biased. CDC collected 
data from providers to verify household-reported data, and I used only data from teens 
with adequate provider data verification; using both household- and provider-collected 
data may have altered my findings and interpretation of the data (CDC et al., 2015; 
2016). Third, provider data collected by NIS-Teen could not be analyzed for individual 
teens, given privacy and confidentiality constraints, and therefore analyzing trends in 
provider recommendation by specialty, facility type, or other characteristics was not 
possible. While quantifiable data on physician recommendation could provide direction 
to researchers, the use of such data would be of limited use without an understanding of 
the context in which physicians practice, as this may have influenced their 
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recommendations. Fourth, sample sizes for states and select local areas were smaller than 
those of the nation as a whole, and therefore the confidence intervals were wider; as such, 
estimates of vaccine coverage were interpreted with caution (CDC et al., 2015; 2016). In 
addition, population characteristics were significantly different between the U.S. and 
select local area samples, preventing any generalizability from my select local area 
findings to the states or U.S. population as a whole. Fifth, the cross-sectional design of 
the NIS-Teen survey precluded any causal inferences about the relationships among 
variables.  
The two limitations with the highest potential to influence my findings were the 
exclusion of physician recommendation from research questions one through three, and 
the specific geographic areas in which data for the NIS-Teen and SVI were collected. 
Physician recommendation across select local areas was tested in research question four, 
and would have been a redundant independent variable in the prior three questions. 
However, researchers consistently have shown the importance of physician 
recommendation on HPV vaccine initiation and completion (Burdette et al., 2017; Gilkey 
et al., 2016; Mohammed et al., 2016).  
For example, in the select local area sample, physician recommendation was 
significantly associated with gender, poverty, mother’s education level, select local area, 
number of visits to a health care professional in the past 12 months, mother’s age, and 
age of the teen (Table C1 in Appendix C). In addition, in the absence of any confounding 
variables, the odds of initiating the series if a physician recommended the HPV vaccine 
were 5.21 times greater (95% CI, [3.68-7.37]) than if the physician did not recommend 
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the HPV vaccine; the odds of completion were 35.69 times greater (95% CI, [17.53-
72.46]) with a physician recommendation; and the odds of not receiving a shot if the 
physician recommended the vaccine were .04 times smaller than if a physician did not 
recommend the vaccine (Table C2 in Appendix C). While outside the scope of my study, 
the exclusion of physician recommendation from research questions one through three 
may have influenced my findings and interpretation of the data.  
Finally, while Social Vulnerability Index data were available at the census tract 
level, the smallest geographic levels in NIS-Teen data were the teen’s county in the 
public-use data file and Zip codes in the restricted data set. One strength of the SVI was 
the demonstration of intra-county variability in vulnerability among several factors; 
however, the reported vulnerability ranking scores were reported for the county as a 
whole, and each individual in that county had the same vulnerability score (CDC et al., 
2017). As a result, comparisons to dependent variables could be made only between 
counties as a whole, rather than variations within a county compared to variations within 
another county, and a single value may have masked underlying disparities. While 
additional granularity could shed light on any flexible resources described in the 
fundamental cause theory, and Henry et al., (2017) recently demonstrated the value of 
using Zip code tabulation areas in NIS-Teen analyses, the scope of this study and the 
level of measurement in the SVI precluded testing relationships at this level of detail. 
Recommendations for Professional Practice 
Analyzing the NIS-Teen data in the context of social vulnerability is a unique 
contribution to the existing literature, and my findings indicate that additional exploration 
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into the relationships among social vulnerability, HPV vaccination, and physician 
recommendation is warranted. Given the limitations of one vulnerability score being 
applied to each person within a county, however, future researchers may want to consider 
using more granular geographic areas, such as Zip codes or census tracts, to understand 
the true effect of variation of fundamental causes and vulnerability on health outcomes. 
In addition, assessing vaccination and physician recommendation by the four SVI themes 
may help researchers identify specific local factors that influence patient and physician 
behavior, and provide a foundation for testing the FCT through HPV vaccination. In 
particular, given the continued diversification of the U.S. population, an understanding of 
the racial and ethnic makeup of a specific area may be critical in interpreting results in 
the future (Chin, 2017). These recommendations highlight the importance of data 
collection and needs assessment by public health practitioners at the local level when 
allocating public health resources, as well as moving away from individual- and 
interpersonal-level models toward an ecological approach to managing HPV infection 
and related cancers. In doing so, researchers can design and practitioners can implement 
more cost-effective and tailored interventions for the specific environments in which 
vaccine initiation and completion decisions are made (Burger et al., 2016; Ferrer et al., 
2015). 
My findings regarding differences in physician recommendation across teen 
variables and geographic area suggest the need for future researchers to better understand 
what drives physician behavior on a structural, interpersonal, and individual level. 
Assessing recommendations rates from a quantitative perspective tells only part of the 
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story; the lack of behavioral economics-informed studies is a missed opportunity, and in 
the future researchers should investigate how and why physicians make patient care 
decisions to supplement their quantitative data. Public health practitioners could apply 
these findings in efforts to nudge physician behavior qualitatively and quantitatively to 
reflect evidence-based health care.   
Implications for Social Change 
While overall HPV vaccination in the United States is rising slowly, incidence 
and prevalence of HPV-associated cancer in the United States are growing quickly, and 
disparities in vaccination rates and cancer mortality persist. As there is not consensus on 
which population and structural variables are most strongly associated with HPV vaccine 
initiation and completion, public health practitioners may continue to struggle to reduce 
disparities in vaccination, physician recommendation, and future HPV-related outcomes 
(Ferrer et al., 2015; Oliver et al., 2016). Using national and local data can help elucidate 
the influential factors in HPV infection, HPV morbidity and mortality, and HPV 
vaccination, as well as how these factors interact.  
This locally-focused, ecological approach may help identify populations, 
geographic areas, and multi-level factors relating to HPV infection and vaccination 
(McCree, Purcell Cleveland, & Brooks, 2017; Montez, Zajacova, & Hawyard, 2017). 
This knowledge could advance positive social change by encouraging evaluation and 
management of the fundamental causes of social and health disparities at the local level; 
fostering an environment in which healthy choices about HPV vaccination can be made; 
and equitably improving HPV vaccination rates among teens across the United States. 
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Conclusion 
The HPV vaccine has been available for a decade, but physician recommendation, 
initiation and completion of the series is persistently low and varies across 
socioeconomic, demographic, and geographic variables (Henry et al., 2017; Perkins, 
2016). Disparities also are noted in HPV-associated genital warts and cancers (Burger et 
al., 2016). The purpose of this study was to test the relationship between HPV vaccine 
initiation and completion, socioeconomic and demographic variables, and physician 
recommendation using data from the NIS-Teen 2015 survey. In addition, I tested the 
relationship between HPV vaccine initiation and completion, physician recommendation, 
and social vulnerability using the 2014 NIS-Teen and 2014 Social Vulnerability Index 
databases. I found that significant relationships between variables within select local 
areas in the United States differed from other select local areas as well as relationships 
detected at the national level. These findings could contribute to positive social change by 
identifying local structural, interpersonal, and individual factors that affect HPV 
vaccination and informing more effective interventions. Future studies should examine 
needs and population patterns at the local level, as well as seek to determine the context 
in which HPV vaccination decisions are made among physicians and teens in the United 
States. By reducing incidence and prevalence of HPV infections through vaccination, 
practitioners and providers may reduce disparities in HPV-associated cancers and 
facilitate improved health and wellbeing in individuals and communities.  
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Appendix A: Complex Samples Results 
Research Question One 
In RQ1, I examined whether there is a relationship between initiation of the HPV 
vaccine series and socioeconomic and demographic variables in the 2015 select local area 
dataset, controlling for known confounders (Table A1). Model 1 included gender, race 
and ethnicity, poverty status, mother’s education level, and select local areas of interest; 
Model 2 added clinical parameters: well-check visits, number of visits in the past 12 
months, type of health insurance, and if the teen was ever uninsured since age 11. Model 
3 added control factors: age of teen, relationship of respondent to teen, number of 
children in house under 18, mother’s marital status, and age of the teen’s mother.  
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Table A1 
 
Relationships between HPV vaccine initiation and socioeconomic and demographic 
variables, Select Local Area, 2015 
 
 
Model 1 
(OR, 95% CI) 
Model 2 
(OR, 95% CI) 
Model 3 
(OR, 95% CI) 
Gender     
Male 1.18 [0.81-1.71] - -  
Female -  - - 
Race/ethnicity    
Non-Hispanic White -   - 
Hispanic 1.10 [0.63-1.93] - - 
Non-Hispanic Black 0.95 [0.52-1.75] - - 
Poverty status    
Above (> $75,000) -  - - 
Above (≤ $75,000) 1.49 [0.87-2.54] - - 
Below 1.35 [0.72-2.54] - - 
Mother’s education level    
Less than high school 1.74 [0.90-3.35] - - 
High school graduate 1.06 [0.57-1.96] - - 
Some college 1.31 [0.77-2.24] - - 
College graduate -  - - 
Select local area    
New York City 1.08 [0.61-1.91] 1.05 [0.60-1.84] 1.07 [0.60-1.88] 
Washington, D.C. 1.00 [0.57-1.75] 0.89 [0.52-1.51] 0.93 [0.53-1.62] 
Philadelphia 0.95 [0.55-1.65] 0.90 [0.53-1.55] 0.89 [0.50-1.57] 
Chicago -  -  -  
El Paso 0.59 [0.33-1.06] 0.68 [0.41-1.13] 0.63 [0.37-1.07] 
Houston 0.43 [0.23-0.83]* 0.41 [0.22-0.77]** 0.42 [0.22-0.82]** 
Bexar County 0.75 [0.42-1.34] 0.79 [0.46-1.36] 0.79 [0.46-1.37] 
Hidalgo County 0.45 [0.25-0.82]** 0.52 [0.31-0.88]* 0.55 [0.32-0.94]* 
 
Note. CI, Confidence Interval. OR, odds ratio.  
* p < .05 
** p < .01 
 
Overall, for RQ1 I rejected the null hypothesis, showing instead that there was a 
relationship between initiation of the HPV vaccine series and at least one socioeconomic 
or demographic variable in select local areas in unadjusted and adjusted models. Teens 
were significantly less likely to initiate the vaccine if they lived in Houston (58% less 
likely) or Hidalgo County (45%) than teens who lived in Chicago.  
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Research Question Two 
In RQ2, I examined whether there is a relationship between completion of the 
HPV vaccine series and socioeconomic and demographic variables in the 2015 select 
local area dataset, controlling for known confounders (Table A2).  
Table A2 
 
Relationships between HPV vaccine completion and socioeconomic and demographic 
variables, Select Local Area, 2015 
 
 
Model 1 
(OR, 95% CI) 
Model 2 
(OR, 95% CI) 
Model 3 
(OR, 95% CI) 
Gender     
Male 0.65 [0.45-0.93]* 0.68 [0.48-0.95]* 0.65 [0.46-0.92]* 
Female -  - - 
Race/ethnicity    
Non-Hispanic White -  - - 
Hispanic 1.28 [0.76-2.14] -  - 
Non-Hispanic Black 1.12 [0.64-1.94] -  - 
Poverty status    
Above (> $75,000) -  - - 
Above (≤ $75,000) 1.07 [0.65-1.75] -  - 
Below 1.15 [0.67-1.98] -  - 
Mother’s education level    
Less than high school 0.55 [0.30-1.04] -  - 
High school graduate 0.82 [0.47-1.44] -  - 
Some college 0.57 [0.34-0.94] -  - 
College graduate -  - - 
Select local area    
New York City 0.95 [0.53-1.70] -  - 
Washington, D.C. 1.41 [0.81-2.45] -  - 
Philadelphia 2.00 [1.14-3.51] -  - 
Chicago -  - - 
El Paso 1.24 [0.71-2.17] -  - 
Houston 1.46 [0.78-2.72] -  - 
Bexar County 1.09 [0.61-1.93] -  - 
Hidalgo County 1.18 [0.66-2.11] -  - 
 
Note. CI, Confidence Interval. OR, odds ratio.  
* p < .05 
** p < .01 
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Overall, for RQ2 I rejected the null hypothesis, showing instead that there was a 
relationship between completion of the HPV vaccine series and at least one 
socioeconomic or demographic variable in select local areas in unadjusted and adjusted 
models. In the select local area sample, only gender was significantly associated. Males 
were significantly less likely to initiate the vaccine (35%) than females.  
Research Question Three 
In RQ3, I examined whether there is a relationship between initiation of the HPV 
vaccine series and social vulnerability by select local area county, using logistic 
regression and data from the 2014 NIS-Teen and the 2014 Social Vulnerability Index 
(Table A3).  
Table A3 
 
Relationship between HPV vaccine initiation and overall county social vulnerability 
ranking, 2014 
 
 
Social Vulnerability 
percentile ranking 
HPV Vaccine Initiation 
  OR 95% CI 
Washington, D.C. .59 (Med-High) 1.29 .68 – 2.43 
Philadelphia .91 (High) 1.71 .94 – 3.12 
El Paso County .95 (High) 1.17 .61 – 2.24 
Bexar County .82 (High) -  -  
 
Note. Med-High indicates a medium-high vulnerability, or being in the third-highest 
percentile of vulnerability. CI, Confidence Interval. OR, odds ratio.  
 
Overall, for RQ3 I could not reject the null hypothesis, as the relationship 
between HPV vaccine initiation and social vulnerability ranking did not meet statistical 
significance.  
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Research Question Four 
In RQ4, I examined whether there is a relationship between physician 
recommendation of the HPV vaccine series and social vulnerability by select local area 
county, using logistic regression and data from the 2014 NIS-Teen and the 2014 Social 
Vulnerability Index (Table A4). 
Table A4 
 
Relationship between physician recommendation of the HPV vaccine and overall county 
social vulnerability ranking, 2014 
 
 
Social Vulnerability 
percentile ranking 
Physician Recommendation 
  OR 95% CI 
Washington, D.C. .59 (Med-High) 2.90 1.54 – 5.46*** 
Philadelphia .91 (High) 2.14 1.19 – 3.87* 
El Paso County .95 (High) 1.50 .83 – 2.70 
Bexar County .82 (High) -  -  
 
Note. Med-High indicates a medium-high vulnerability, or being in the third-highest 
percentile of vulnerability. CI, Confidence Interval. OR, odds ratio.  
* p < .05 
*** p < .001      
Overall, for RQ4 I rejected the null hypothesis, as the relationship between HPV 
vaccine initiation and social vulnerability ranking was significantly different. Teens were 
significantly more likely to receive a physician recommendation if they lived in 
Washington, D.C. (190% more likely) and Philadelphia (114%) than teens living in 
Chicago.  
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Appendix B: Multicollinearity Tests 
Table B1 
 
Multicollinearity Model Summaries 
 
 
R R2 Adjusted R2 SEM 
HPV Initiation .31 .09 .08 .44 
HPV Completion .40 .16 .15 .43 
No Shots .61 .37 .37 .39 
 
Note. SEM, Standard Error of the Mean. 
 
Table B2 
 
Multicollinearity Tolerance and Variance Inflation Factors 
 
 
HPV Vaccine Initiation 
VIF (Tolerance) 
Physician recommendation 1.04 (.96) 
Gender 1.06 (.94) 
Race and ethnicity 1.27 (.79) 
Poverty level 2.21 (.45) 
Mother’s education level 1.60 (.62) 
Select local area 1.04 (.96) 
Number of visits 1.04 (.96) 
Type of health insurance 1.68 (.59) 
Ever uninsured 1.05 (.95) 
Well-check visit 1.02 (.98) 
Relationship to teen 1.08 (.93) 
Children under 18 in household 1.13 (.89) 
Mother’s marital status 1.24 (.81) 
Mother’s age 1.26 (.80) 
Teen’s age 1.08 (.93) 
 
Note. VIF, Variance Inflation Factor. A VIF between 1 and 10 and a tolerance value 
closer to 1.0 (versus closer to 0) indicate no multicollinearity.  
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Appendix C: Physician Recommendation 
Table 12 
 
Relationships between physician recommendation and socioeconomic and demographic 
variables, Select Local Area 
 
 
2014 
χ2 (df) 
2015 
χ2 (df) 
Gender 37.90 (1)*** 15.29 (1)*** 
Race/ethnicity 4.29 (2) 1.58 (2) 
Poverty status 6.88 (2)* 14.45 (2)*** 
Mother’s education level 14.05 (3)** 11.32 (3)** 
Select local area 21.23 (3)*** 17.74 (7)** 
Number of visits in 12 months 18.23 (4)*** 10.96 (4)* 
Type of health insurance .29 (1) .04 (1) 
Ever uninsured since age 11 .16 (1) .48 (1) 
Well-check visit 31.92 (1)*** 3.22 (1) 
Respondent relationship to 
teen 
3.27 (3) 27.25 (3)*** 
Number of children under 18  1.32 (2) 15.58 (2)*** 
Mother’s marital status 1.18 (1) .58 (1) 
Mother’s age 7.19 (2)* 26.23 (2)*** 
Teen’s age 12.59 (4)** 10.61 (4)* 
HPV vaccine initiation 30.03 (1)*** 100.92 (1)*** 
HPV vaccine completion 95.57 (1)*** 220.64 (1)*** 
No shots received 209.23 (1)*** 567.31 (1)*** 
 
Note. χ2, chi-square statistic. df, degrees of freedom.  
* p < .05 
** p < .01 
*** p < .001 
 
Table 13 
 
Relationships between physician recommendation and vaccination, Select Local Area 
 
 
2014 
OR [95% CI] 
2015 
OR (95% CI) 
HPV vaccine initiation 3.08 [2.03-4.66] 5.21 [3.68-7.37] 
HPV vaccine completion 8.20 [5.12-12.13] 35.64 [17.53-72.46] 
No shots received .08 [.06-.12] .04 [.03-.05] 
 
Note. CI, Confidence Interval. OR, odds ratio 
  
211 
 
Appendix D: HPV Vaccination and States 
Table 14 
 
HPV vaccine initiation, completion, and physician recommendation by U.S. state, 2015 
 
 
Initiation 
OR [95% CI] 
Completion 
OR [95% CI] 
Physician 
recommendation 
OR [95% CI] 
Alabama  -  -  .46 [.26-.82]** 
Arizona .60 [.35-1.00]* 1.82 [1.09-3.05]* -  
Arkansas  - - .55 [.30-1.00]* 
California - 1.70 [1.07-2.72]* - 
Florida .60 [.38-.95]* -  -  
Iowa .52 [.28-.98]* 1.90 [1.05-3.41]* -  
Louisiana .45 [.26-.79]** -  -  
Maine - 2.17 [1.06-4.46]* -  
Massachusetts - 1.68 [1.00-2.84]* -  
Mississippi  -  -  .37 [.20-.68]*** 
Missouri .55 [.32-.93]* -  .53 [.31-.90]* 
New Hampshire -  2.18 [1.09-4.37]* - 
New Mexico .46 [.23-.94]* -  - 
Ohio .50 [.31-.82]** -  - 
Oklahoma -  2.03 [1.14-3.64]* - 
Pennsylvania  .49 [.29-.80]** 1.80 [1.10-2.96]* - 
Rhode Island  -  2.67 [1.24-5.78]* 3.89 [1.20-12.57]* 
Tennessee .46 [26-.80]** -  .47 [.27-.82]** 
Texas .58 [.37-.92]* -  .55 [.33-.89]* 
 
Note. CI, Confidence Interval. OR, odds ratio. Only states with a statistically significant 
relationship are included in the table. Data from 2015 U.S. NIS-Teen sample; all 
dependent variables were controlled for significant sociodemographic variables. 
* p < .05 
** p < .01 
*** p < .001 
 
Of note, teens who lived in three states were both less likely to initiate and more 
likely to complete the HPV vaccine than teens who lived in Chicago: Arizona, Iowa, and 
Pennsylvania. In addition, teens living in three states who were less likely to initiate the 
HPV vaccine series were also less likely to receive a physician recommendation: 
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Missouri, Tennessee, and Texas. Teens who lived in Rhode Island were more likely to 
complete the HPV vaccine series as well as receive a physician recommendation. 
However, teens who lived in Alabama, Arkansas, and Mississippi were less likely to 
receive a physician recommendation, but the relationships between these states in 
initiating or completing the HPV vaccine were not significant compared with teens living 
in Chicago.  
